Characterisation of Dof, an essential adaptor molecule in fibroblast growth factor signalling in Drosophila melanogaster by Csiszar, Agnes
  
 
 
Characterisation of Dof, an essential adaptor 
molecule in fibroblast growth factor signalling in 
Drosophila melanogaster 
 
 
Inaugural-Dissertation 
 
zur Erlangung des Doktorgrades 
der Mathematisch-Naturwissenschaftlichen Fakultät 
der Universität zu Köln 
 
 
vorgelegt von 
 
Ágnes Csiszár 
aus Orosháza, Ungarn 
 
 
 
Köln 2005 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Berichterstatter:   Prof. Dr. Maria Leptin 
          Priv.-Doz. Frank Sprenger 
Tag der Disputation: 03. Februar 2005 
TABLE OF CONTENTS 
  
Table of contents 
1. Introduction .......................................................................................................... 1 
1.1 Adaptor proteins.......................................................................................................................1 
1.1.1 Adaptors in the context of the specificity of cellular processes...............................................1 
1.1.2 Modular assembly of adaptor molecules .................................................................................2 
Structural domains preferentially found in PTK-activity-linked adaptors...............................3 
Classification of PTK-activity-linked adaptors based on their structural domains .................4 
1.1.3 Functional dissection – adaptors as molecular interneurons of the cells .................................6 
1.1.4 Tools to regulate adaptor protein activity ................................................................................6 
Posttranslational modifications ................................................................................................6 
Tyrosine phosphorylation ....................................................................................................6 
Serine/Threonine phosphorylation.......................................................................................7 
Caspase cleavage.................................................................................................................8 
Dimerisation/oligomerisation ..............................................................................................9 
Intramolecular interactions, conformational changes ......................................................10 
Protein degradation ...........................................................................................................10 
1.2 FGF signalling-dependent morphogenetic processes in flies ................................................11 
1.2.1 Regulation of tracheal morphogenesis...................................................................................11 
1.2.2 Regulation of mesoderm development ..................................................................................13 
1.3 Molecular mechanism of FGF signalling...............................................................................14 
1.3.1 Downstream signalling cassettes activated by FGFR............................................................15 
Ras mediated signalling .........................................................................................................15 
The Ras-MAPK cascade.....................................................................................................16 
Other Ras effectors.............................................................................................................16 
Rap1 – a parallel pathway to activate known Ras effectors ..................................................16 
1.3.2 Negative regulators in FGF signalling ...................................................................................17 
1.3.3 Learning from the fly - specialities of FGF signalling in Drosophila ...................................18 
1.4 The protein Dof......................................................................................................................18 
1.5 Specific aim of this thesis ......................................................................................................19 
2. Results.................................................................................................................. 20 
2.1 Revisiting yeast Dof-interactors in Drosophila S2 cells ........................................................20 
2.1.1 Summary of Dof interaction data...........................................................................................20 
2.1.2 Signalling molecules ..............................................................................................................22 
TABLE OF CONTENTS 
  
Dof self-association................................................................................................................22 
Heartless.................................................................................................................................23 
i19 ..........................................................................................................................................23 
i51 ..........................................................................................................................................24 
i249 ........................................................................................................................................25 
i173 ........................................................................................................................................25 
i234 ........................................................................................................................................27 
2.1.3 Cytoskeleton proteins.............................................................................................................27 
i6 ............................................................................................................................................27 
i8 ............................................................................................................................................27 
2.1.4 Components of the SUMOylation machinery........................................................................28 
i77 ..........................................................................................................................................28 
i184 ........................................................................................................................................30 
2.1.5 Other candidates.....................................................................................................................30 
i25 ..........................................................................................................................................30 
i188 ........................................................................................................................................32 
i14 ..........................................................................................................................................32 
2.1.6 Nuclear proteins .....................................................................................................................34 
i133 ........................................................................................................................................34 
i163 ........................................................................................................................................34 
2.2 Interaction study of Dof with the FGF receptor Heartless.....................................................35 
2.2.1 Interaction of different forms of Heartless with Dof .............................................................35 
2.2.2 Domain mapping in Dof  for receptor interaction..................................................................37 
2.2.3 The effect of Dof binding on the activation level of Heartless in S2 cells ............................39 
2.2.4 Large Dof-FGF receptor complexes are present in S2 cells ..................................................41 
2.3 Tyrosine phosphorylation of Dof...........................................................................................44 
2.3.1 Identification of tyrosine residues phosphorylated in Dof.....................................................44 
2.3.2 Conservation of Dof phosphorylation sites in Dof homologues............................................49 
2.4 The role of sumoylation in Dof function ...............................................................................53 
2.4.1 Dof sumoylation assay in Drosophila S2 cells ......................................................................53 
2.4.2 Analysis of the role of the SUMO conjugation pathway in FGF dependent developmental 
processes ............................................................................................................................................55 
Ubc9.......................................................................................................................................55 
Smt3 .......................................................................................................................................58 
TABLE OF CONTENTS 
  
2.5 Identification of Dof as caspase substrate and analysis of the role of Dof cleavage .............62 
2.5.1 Dof is cleaved in S2 cells.......................................................................................................62 
2.5.2 Cleavage of Dof depends on caspase activity........................................................................63 
2.5.3 Cleavage of Dof requires an intact caspase cleavage site in the molecule ............................65 
2.5.4 Searching for the molecular role of caspase cleavage in Dof function..................................66 
2.5.5 Analysis of the in vivo function of Dof cleavage and caspase activity in FGF signalling.....68 
2.6 Indications for the translational control of Dof protein levels in S2 cells .............................71 
2.7 The role of Ras effectors in FGF signalling in Drosophila ...................................................75 
2.7.1 The capacity of effector loop mutant Ras transgenes to rescue dof mutant phenotypes .......76 
Rescue of mesoderm development ........................................................................................76 
Rescue of tracheal development ............................................................................................78 
2.7.2 Capacity of known downstream effectors of Ras to rescue dof mutant phenotypes..............80 
2.7.3 Dominant effects of constitutively active Ras effectors..........................................................83 
2.7.4 Ras and/or Rap? – searching for the in vivo players in FGF signalling.................................85 
3. Discussion ............................................................................................................ 89 
3.1 Interaction of Dof with yeast two hybrid interactors .............................................................89 
3.2 Conclusions from subcellular localisations of Dof ................................................................90 
3.3 Interaction of Dof with the FGF receptor ..............................................................................91 
3.4 The role of lysine 297 in the interaction of Dof with the FGF receptor ................................92 
3.5 Sumoylation of Dof................................................................................................................92 
3.6 Phosphorylation sites in Dof ..................................................................................................93 
3.7 Functional relevance of the identified phosphorylation sites.................................................94 
3.8 Phosphorylation as a landmark of full length Dof .................................................................94 
3.9 Dof is a substrate for caspases in S2 cells – and in flies? ......................................................95 
3.10 Potential translational regulation of Dof and its relationship to caspase cleavage ................95 
3.11 The role of different Ras effector pathways in FGF signalling .............................................97 
3.11.1 Mesodermal studies of Ras effectors .....................................................................................97 
3.11.2 Studies of Ras effectors in the tracheae .................................................................................98 
3.11.3 Implications for a role of Rap1 ..............................................................................................99 
4. Materials and Methods .................................................................................... 100 
DNA constructs....................................................................................................................100 
Expression vectors ...........................................................................................................100 
Dof constructs for S2 cell expression...............................................................................100 
TABLE OF CONTENTS 
  
pUAS-FLAGDofD587E .......................................................................................................101 
i-clones for S2 cell expression .........................................................................................101 
Heartless constructs for S2 cell expression .....................................................................102 
Cell culture, transient transfection, immunoprecipitation and Western blot analysis .........102 
Size exclusion chromatography ...........................................................................................102 
RNAi in Drosophila S2 cells ...............................................................................................103 
Caspase inhibition in transiently transfected Drosophila S2 cells.......................................103 
Metabolic [35S]-methionin radioactive labelling of Drosophila S2 cells ............................103 
Dof protein stability analysis in Drosophila S2 cells ..........................................................104 
Real-time RT-PCR...............................................................................................................104 
Immunocytochemistry .........................................................................................................105 
Drosophila strains and genetics ...........................................................................................105 
Immunohistochemistry ........................................................................................................106 
Eggshell preparation ............................................................................................................106 
5. Bibliography...................................................................................................... 107 
Abstract .................................................................................................................... 118 
Zusammenfassung ................................................................................................... 119 
Abbreviations........................................................................................................... 120 
Acknowledgements .................................................................................................. 121 
Erklärung ................................................................................................................. 122 
Lebenslauf ................................................................................................................ 123 
INTRODUCTION 
 1
1. Introduction 
 
Fibroblast Growth Factor (FGF) signalling is a conserved mechanism from worms to humans. 
It regulates several cellular processes including cell growth, survival, differentiation and migration 
in developing and adult organisms. In Drosophila melanogaster the development of the mesoderm 
and the tracheal system are processes regulated by FGF signalling. In the search for additional 
mutations that affect the migration of tracheal and mesodermal cells or the differentiation of 
mesodermal derivatives, and thus, eventually interfere with the propagation of FGF signalling three 
groups found mutant alleles of the gene dof/heartless/stumps independently (Imam et al., 1999; 
Michelson et al., 1998; Vincent et al., 1998). Homozygous mutant embryos showed similar defects 
in the mesoderm and the tracheae as mutants of the two known Drosophila FGF receptor genes. 
Genetic epistasis analysis showed that dof is an essential component of FGF signalling and placed it 
downstream of the FGF receptors and upstream or in parallel to Ras in the signalling cascade 
(therefore the name downstream of FGFR). The gene encodes a large molecule with no structural 
signs of known enzymatic domains characteristic for protein families with known functions. It 
shows weak homology to the B-cell receptor adaptors BCAP and BANK. The predicted domains of 
Dof (two ankyrin repeats and a coiled coil motif) are protein-protein interaction domains. In 
addition, several tyrosine residues of the sequence are located in consensus sites that could serve as 
binding sites for signalling molecules in their phosphorylated forms. Biochemical studies showed 
that Dof is tyrosine phosphorylated in an FGF receptor dependent manner and is able to form a 
complex with Drosophila FGF receptors (Wilson et al., 2004). Thus, its molecular characteristics, 
biochemical behaviour as well as genetic interactions indicated Dof to be an adaptor molecule in 
FGF signalling specific for Drosophila. 
 
1.1 Adaptor proteins 
 
The specific and appropriate response of cells to extracellular stimuli requires the integration 
of multiple signalling pathways. An emerging class of proteins that are major contributors in the 
regulation of cellular signalling networks are adaptor proteins. Adaptors are molecules of modular 
structure without enzymatic activity composed exclusively of multiple protein-protein or protein-
lipid interacting domains. They link proteins to other proteins or to the plasma membrane, form 
large signalling complexes and specify subcellular localisation of other molecules thereby 
contributing to the specificity and efficiency of cellular responses in a spatio-temporal manner. 
Docking and scaffolding molecules are subgroups of the adaptor family with specialised functions. 
Docking proteins anchor interacting partners to subcellular structures, often membranes and so 
frequently contain protein-lipid interaction domains or sites for lipid modifications. Scaffolding 
proteins serve as interaction platforms for enzymatic cascades of multimeric signalling complexes. 
An alternative view also defines molecules as adaptors despite their enzymatic activity if they serve 
as a multi-modular platform for signalling complex assembly with a “built-in” enzymatic function 
or if the two functions are clearly distinguishable in different cellular responses. 
 
1.1.1 Adaptors in the context of the specificity of cellular processes 
 
Adaptors are described in studies of signalling and sorting processes. They have pivotal role 
in cell surface receptor signalling including receptor tyrosine kinase (RTK) signalling, G protein 
coupled receptor (GPCR) signalling, the Toll-like receptor (TLR) mediated inflammatory signalling 
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pathway as well as T- and B-cell receptor activation during lymphocyte development and immune 
response. Neurotransmission works with many structural and signalling adaptors on the side of the 
sensing (post-synaptic density) as well as on the side of the signal release. Adaptors have a general 
role in membrane and vesicle trafficking, e.g. in protein sorting in the Trans-Golgi network (TGN) 
and in endocytosis. The regulation of cell adhesion, cytoskeletal dynamics and active cell 
movements require whole sets of adaptors which act in integrin signalling, focal adhesion assembly 
and disassembly and actin polymerisation and crosslinking. Nuclear adaptors play role in 
transcriptional regulation. Even death needs the help of specific adaptors that form the 
“apoptosome”, a multiple protein complex essential to promote apoptosis. 
Along the study of these different processes a growing body of evidence emerged for the 
existence of many adaptors which are involved in several signalling events. It is also known that the 
same canonical signalling cassettes are activated by many different signals. What are actually the 
tools in the hand of adaptors to increase specificity? 
One way is that different combination of adaptors is utilised in different signalling events, 
called the combinatorial control. This can be emphasized and more specialised in a cell type 
dependent expression of adaptors. In general, interaction studies pointed out, that large protein 
complexes are the rule where simultaneous interaction of several components is required for signal 
transmission and the removal or exchange of a single component might modify the action of the 
complex. The assembly of signalling complexes might be influenced by mutually exclusive binding 
properties of the molecules and so factors might be displaced from a complex despite their ability to 
interact with components of the complex. These interfering interactions can be based on 
competitory or overlapping binding sites as well as on interaction surfaces which are dependent on 
conformational changes of the molecule and influenced by other interacting partners or 
modifications. 
No less important is the subcellular compartmentalisation of active and inactive adaptors. 
Activation often means the recruitment to specific places of signalling at the cell membrane, the so 
called lipid rafts (membrane microdomains enriched in glyco-sphingolipids). Another example of 
specific recruitment is served by scaffolding molecules, binding platforms of enzymatic cascades. 
They synergise enzyme activity for one signalling and in parallel can keep away enzymes from 
other processes. 
Even if same signalling cascades are activated by several signals, their amplitude and 
duration can be characteristic for the appropriate signalling event. This is achieved by the 
presence/absence of specific scaffolding molecules, by the capability of adaptors to oligomerise and 
thereby increase the local concentration of signalling molecules or by the fact that activation of 
cascades can happen in several alternative routes, which might be used with different redundancy in 
the one or the other signalling process. 
 
Since Dof plays a role in FGF signalling - a subtype of RTK signalling – we focus in this 
work on adaptors which are involved in RTK signalling or linked directly to other protein tyrosine 
kinase (PTK) activity. 
 
1.1.2 Modular assembly of adaptor molecules 
 
A characteristic feature of adaptor proteins is the ability to bind at least two different 
molecules simultaneously. This capability derives from their multi-modular structure. They have 
protein domains with independent folding and binding capacity. Some of these domains are 
characteristic for the protein family of PTK-activity-linked adaptors and have defined binding sites 
whilst others are widely distributed modules often without preferring a defined binding domain. 
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Structural domains preferentially found in PTK-activity-linked adaptors  
 
Src homology 2 (SH2) domains are protein modules of about 100 amino acids which bind phospho-
tyrosine containing peptide motifs of 5-10 amino acids length, generally C-terminal to a negatively 
charged region. They do not have affinity for unphosphorylated sequences and so are exclusive 
modules of tyrosine kinase signalling. The phosphopeptide binding site is bipartite. The pTyr 
binding pocket is highly conserved, whereas the second binding surface is more variable, and 
allows specific recognition of amino acids immediately C-terminal to the pTyr. These amino acids 
are decisive in binding specificity of different SH2 domains (Table 1) (Songyang et al., 1993; 
Songyang et al., 1994). Thus, tyrosine phosphorylation functions as an on-off switch for SH2 
binding, while enabling the sequence context of the pTyr site to predict which SH2 domains, and so 
which signalling proteins are bound. 
 
Table 1. Binding specificity of SH2, SH3 and PTB domains of various signalling molecules 
 
SH2 domain binding specificities: 
 
Src family: pY-[E/D/T]-[E/N/D]-[I/V/M/L] 
Abl:       pY-[E/T/M]-[N/E/D]-[P/V/L] 
Crk:            pY-[D/K/N]-[H/F/R]-[P/L] 
Nck:       pY-D-E-[P/D/V] 
Sem5:  pY-[L/V/I/M]-N-[v/p] 
Csk:       pY-[T/A/S]-[K/R/Q/N]-[M/I/V/R] 
3BP2:  pY-[E/M/V]-[N/V/I]-x 
fps/fes:  pY-E-x-[V/I] 
Drk:       pY-[Y/I/V]-N-[F/L/I/V] 
Grb2:      pY-[Q/Y/V]-N-[Y/Q/F] 
SHC:       pY-[I/E/Y/L]-x-[I/L/M] 
Vav:       pY-[M/L/E]-E-P 
ZAP-70:  pY-x-x-I/L 
p85 N-term: pY-[M/V/I/E]-x-M 
       C-term: pY-x-x-M 
PLCγ N-term: pY-[L/I/V]-[E/D]-[L/I/V] 
          C-term: pY-[V/I]-[I/L]-[P/I/V] 
SHP2 N-term: pY-[I/V]-x-[VILP] 
Syk C-term: pY-[Q/T/E]-[E/Q]-[L/I] 
HCP N-term: pY-F-x-F 
 
SH3 domain binding sites: 
 
general rule:    x-P-p-x-P,        x aliphatic 
Src:           R-x-x-P-p-x-P 
Abl:           T-x-x-P-p-x-P 
Grb2 C-term: P-x3-R-x3-P 
Grb2 N-term: P-x-x-P 
 
 
 
 
 
PTB domain binding sites: 
 
Dok:                         Y/M-x-x-N-x-L-pY 
minimal consensus:  N-P-x-Y 
 
Consensus sequence motifs were generated in a random peptide binding assay. Amino acids in the brackets 
separated by a slash were found without significant difference in that position. Bold letters remark outranking 
preference for that amino acid in that position. x stays for any amino acids. pY marks phosphorylated 
tyrosine residue. Modified and extended from (Songyang et al., 1993; Songyang et al., 1994). 
 
Phospho-Tyrosine Binding (PTB) domains are modules of ~200 amino acid residues. Initially, the 
study of the adaptors Shc and IRS-1 showed that they recognise phospho-tyrosine containing 
peptide motifs that form a β turn. Binding to target sequences is determined by residues N-terminal 
to the pTyr (Table 1). Later findings demonstrated that PTB domains are able to bind 
unphosphorylated tyrosine-containing peptides (Margolis et al., 1999) or even do not require 
tyrosine for their binding to targets (Ong et al., 2000). Thus, sequence binding preference of PTB 
domains is less defined than of SH2 domains, which makes target prediction difficult for this 
domain. 
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Src homology 3 (SH3) domains bind proline rich peptides of approximately 10 amino acids. The 
core binding sequence contains the consensus x-P-x/p-x-P, where prolines at defined positions are 
of structural need and ensure high affinity binding. Each SH3 domain has a distinct binding 
preference and the nature of the non-proline residues in and around the core sequence serves for 
specificity (Table 1) (Pawson, 1995). SH3-binding does not depend on modification like 
phosphorylation enabling theoretically a constitutive protein-protein interaction. However, serine 
and threonine phosphorylation adjacent to the proline-rich motif may influence SH3 domain 
interactions and result in uncoupling of proteins. 
Pleckstrin homology (PH) domains are lipid interacting modules of approximately 100 amino acids 
length. They bind the charged headgroups of specific poly-phosphoinositides and may thereby 
regulate the subcellular targeting of proteins to specific regions of the plasma membrane, where 
their ligand is enriched. 
 
Classification of PTK-activity-linked adaptors based on their structural domains 
 
Most of the PTK-activity-linked adaptors contain at least one of the preferentially used 
domains. Adaptors contain either exclusively the characteristic domains in single or multiple copies 
or combine these modules with diverse other domains. Some of them lack domains typical for PTK-
activity-linked adaptors. Another characteristic feature is that they often harbour proline rich 
regions and tyrosine motifs – binding sites for SH3 and SH2 domains respectively. Figure 1 gives 
an overview of the different classes of PTK-activity-linked adaptors based on their structural 
domains. 
Without going into details with each group we can make several general remarks. First, 
beside the preferential domains several other domains are represented in the different adaptors. 
Some of them appear in more then one protein, like PDZ domains, ankyrin repeats or coiled coil 
motifs whereas others are unique for a particular adaptor molecule, e.g. sorbitol homology (SoHo) 
domains in the Vinnexin family. Second, if the phospho-tyrosine binding motif SH2 is present in an 
adaptor then only in a single copy whilst conserved tyrosine motifs, potential binding sites for 
different SH2 domains are abundant. Thus, an SH2 domain-containing adaptor can bind only to a 
single phosphorylated partner which might cause a competition of molecules that contain binding 
sites for the particular SH2 domain. On the other hand tyrosine phosphorylated adaptors are able to 
recruit many SH2 containing adaptors at the same time. Third, the number of SH3 domains in an 
adaptor is less well defined and can vary from zero up to three, albeit often with different binding 
specificities. 
The same is true for their binding sites, the proline rich regions. Finally, the presence and 
order of the different domains is unique for the different adaptor families. In other words, the order 
of moduls, rather than only the presence of the identical moduls determines homology. 
What can one conclude from these structural characteristics for the function of the different 
adaptors? The conserved and unique domain structure of the different adaptor families indicates 
their important and specific role in signalling events. However, the diversity in the presence and 
combination of SH2 and SH3 domains and tyrosine and proline rich motifs alone gives already such  
high level of networking potential for these adaptors, that it makes their cellular role in signalling 
unpredictable. Indeed recent proteomics data showed the tyrosine phosphorylation of plenty of 
cytosolic proteins in the cell upon a single stimulation indicating the wide range of possibilities for 
phosphorylation based interactions. The presence of specific domains might be helpful revealing the 
function of adaptors, like the actin binding domain in Cortactin and Paxillin or the receptor binding 
PTB domain of FRS2. 
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Figure 1. Classes of PTK-activity-linked adaptors based on their structural domains. Gray bars represent the 
relative length of the proteins with the exception of IRS and MASK. Colour coded boxes show the domains 
characteristic for PTK-activity-linked adaptors, colour coded ovals represent domains that are shared by 
several members of PTK-activity-linked adaptors but do not belong to the characteristic ones and white ovals 
stand for domains which are unique among these adaptors. Dashed line separates adaptors with 
characteristic domains (top) from adaptors with non-characteristic domains (bottom). Since transmembrane 
adaptors contain no recognisable domain in their amino acid sequences beside the transmembrane region 
they are listed only by name as a separate group. The domain structure of the proteins was constructed  
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1.1.3 Functional dissection – adaptors as molecular interneurons of the cells 
 
Adaptors are linkers that couple sensing processes of the cell to effector molecules. Their 
regulation enables to modulate signalling outputs. Thus, the number of adaptors involved in a 
signalling pathway might reflect the fine-tuning capacity of the appropriate system. Most extreme 
examples are T- and B-cell receptor signalling events, where up to eight components are utilised to 
activate the Ras-MAPK cascade (Simeoni, 2004). In other systems e.g. in case of several RTKs a 
single adaptor is sufficient to activate the same cascade. 
It raises an interesting option to distinguish adaptors based on the criterion if they can 
directly bridge activator and effector, bind activator or effector or function as intermediator by 
linking adaptors together. It could give a kind of hierarchy of adaptors in the signalling cascades. 
However the position of an adaptor might be different in the activation of the one or the other 
signalling cascade. Taken the example of the adaptor Grb2: it can directly bridge EGF receptors to 
the Ras activator Sos. In B-cell activation it links the adaptor LAT to the effector Sos, whereas in 
FGF signalling it links the sensor/receptor binding FRS2 adaptor to Sos. It acts also as an 
intermediator adaptor in FGF signalling by binding to FRS2 and recruiting the adaptor Gab1, which 
then activates the effector PI3K.  The validity of such a positioning relays on the selective 
specificity of the interactions; it is not an intrinsic feature of the adaptors. The identification of 
domains in the adaptors with binding specificity for receptors/activators or effectors might help for 
positioning but a particular position should not be generalised for all signalling events. 
An alternative way to classify adaptors might be their specificity to different signalling 
pathways. Several adaptors are involved only in one signalling cascade – e.g. scaffolding proteins 
of enzymatic cascades, many B- and T-cell adaptors or the adaptor FRS2 in mammalian FGF 
signalling – whilst others are utilised by many signalling events, e.g. members of the Grb2, Crk, 
Gab or Nck adaptor families. The first group might provide specificity to the different signalling 
events whereas the second group might enable crosstalk and balancing between signalling events in 
the cell. 
 
1.1.4 Tools to regulate adaptor protein activity 
 
Adaptor proteins function as molecular switches in signal transduction. Their activity 
requires a tight regulation to ensure signal propagation or inhibition. Diverse strategies are used for 
both positive as well as negative regulation including phosphorylation, proteolytic cleavage, 
proteosomal degradation and changes in the conformation or in the oligomerisation capacity of the 
molecules. Regulatory changes can have temporary/reversible effects like phosphorylation and 
conformational changes or definitive/irreversible consequences like cleavage or degradation. 
 
Posttranslational modifications 
 Tyrosine phosphorylation 
Tyrosine phosphorylation acts as a general switch for activation in signalling cascades. Most 
PTK-activity-linked adaptors are tyrosine phosphorylated in a stimulation dependent manner and a 
 
using PFAM (http//:www.sanger.uk/Pfam). act.b, actin binding domain; Ank, ankyrin repeat; CARD, caspase-
recruitment domain; CC, coiled coil; Cort, cortactin repeat; GK, guanylate kinase-like; GM, Grb7/Mig-10 
homology region; KH, Kash homology; LIM, lin-11/isl-1/mec-3 domain; LZ, leucine zipper; MRE,MAGUK 
recruitment domain; PDZ, PSD-95/Discs-large/ZO-1 domain; PH, Pleckstrin homology; PTB, phospho-
tyrosine binding domain; SAM, sterile α motif; SH2, Src-homology 2; SH3,Src-homology 3; SoHo, Sorbitol 
homology.  
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cooperative action of kinases and phosphatases balances the actual tyrosine phosphorylation state of 
these adaptors during signalling. Only very few of them do not show detectable tyrosine 
phosphorylation, like the adaptor E3B1/Abi2 (Ichigotani et al., 2002). 
The primary role of phosphorylated tyrosine residues is to provide signalling-dependent 
binding surface for the highly specialised SH2 domains thereby recruiting downstream transducers 
which propagate signalling and activate effectors. 
However, we also find inhibitory effects of tyrosine phosphorylation. Cortactin, an actin 
binding adaptor protein is phosphorylated on tyrosine residues adjacent to its SH3 domain. This 
blocks the binding capacity of the SH3 domain (Martinez-Quiles et al., 2004). Crk function is 
regulated by tyrosine phosphorylation-dependent auto-inhibition. Its SH2 domain interacts with a 
phosphorylated tyrosine residue of the own molecule (Feller, 2001). This has dual consequences: 
SH2 domain is occupied for other interactors in a competitive manner and interactors of the SH3 
domain are lost due to the conformational changes caused by the intramolecular interaction. 
 
 Serine/Threonine phosphorylation 
If tyrosine phosphorylation is the general switch then serine/threonine phosphorylation is the 
modifier in signalling events. It serves as fine tuner in the regulation of adaptor proteins. A broad 
range of Ser/Thr kinases and phosphatases can act on adaptors. They are either activated by the 
same signalling the respective adaptor involved in (often as feedback regulators) or by independent 
signalling cascades thereby providing cross talk between different signalling processes in the cell. 
We find examples of constitutive as well as signalling dependent phosphorylation of adaptors on 
Ser/Thr residues with positive or negative regulatory role. Ser/Thr phosphorylation acts through its 
allosteric effect on the molecule and can cause diverse functional changes. It can sensitise or 
desensitise adaptors for specific interactions by inducing changes in the conformation of the 
molecule (e.g. IRS, FRS2 and Grb7/10/14). A local allosteric effect of Ser/Thr phosphorylation is 
the disruption of the phospho-tyrosine binding capacity of SH2 domains (Gab1 and IRS). The local 
effect of Ser/Thr phosphorylation in binding site disruption can cause global conformational 
changes through the inhibition of intramolecular interaction (Cortactin) or interfering with the auto-
inhibitory binding of adaptors (AFAP-110).  
IRS proteins are examples for complex roles of S/T phosphorylation. In quiescent cells a 
basal level of S/T phosphorylation on particular residues is necessary for an effective subsequent 
tyrosine phosphorylation by the insuline receptor. On the other hand, elevated S/T phosphorylation 
on different residues inhibits the binding of IRS-1 and -2 to the juxtamembrane region of the 
insuline receptor impairing their ability to undergo tyrosine phosphorylation. Thus, position of S/T 
phosphorylation in IRS determines the positive or negative influence on insuline receptor binding 
affinity. Further negative regulatory mode is the specific phosphorylation of serine and threonine 
residues adjacent to SH2 binding motifs thereby decreasing the binding affinity of SH2 domain 
based interactors to IRS. Additional observation is that S/T phosphorylation commits IRS to 
proteosomal degradation (reviewed in (Johnston et al., 2003)). 
The activity of the adaptor FRS2, key mediator of FGF signalling stands also under the dual 
control of tyrosine and threonine phosphorylation. FRS2 binds constitutively to FGF receptors in 
cells via its PTB domain (Ong et al., 2000). Upon FGF stimulation FRS2 is phosphorylated by the 
FGF receptor on several tyrosine residues that serve as docking sites for the MAPK cascade-
activating molecules Grb2 and SHP2 (Ong et al., 1997). Activated MAPK has a negative regulatory 
feedback on FRS2 by phosphorylating it on several threonine residues. Threonine phosphorylation 
inhibits further tyrosine phosphorylation of FRS2, leading to the downregulation of the signalling 
cascade (Lax et al., 2002). Similarly, threonine phosphorylation of FRS2 is induced in response to 
other growth factors (e.g. PDGF, EGF). FRS2 is able to bind to the EGF receptor in a ligand-
stimulated manner and undergo threonine and weak tyrosine phosphorylation (Wu et al., 2003). 
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Thus, MAPK dependent threonine phosphorylation of FRS2 might ensure a controlled dosage of 
signalling via FGF receptors balanced also by other growth factor signallings. Since FRS2 is 
constitutively associated with the FGF receptor, threonine phosphorylation might provide an 
additional tight control to prevent activation of FGF-dependent signalling by random receptor 
autoactivation. 
AFAP-110 and Cortactin are good examples how S/T phosphorylation can lead to 
conformational changes by altering intramolecular interactions and thereby propagate signalling. 
The phosphorylation of AFAP-110 alters its multimerisation behaviour and enables novel 
downstream interactions (Baisden et al., 2001). Cortactin SH3 C-terminal domain forms an auto-
inhibitory loop by binding to proline rich motifs of the same molecule. Upon Erk activation Erk 
phosphorylates serine residues within the proline rich motif and thereby liberates cortactin SH3 
domains to interact with proline rich regions of other molecules (Campbell et al., 1999). As 
mentioned above phosphorylation of adjacent tyrosine residues block the ability of the SH3 domain 
for effective binding (Martinez-Quiles et al., 2004). Thus, tyrosine and serine phosphorylations act 
on the interaction behaviour of the same domain with opposing effects. 
Gab1 adaptor function on PI3K activation is negatively regulated by serine/threonine 
phosphorylation (Lehr et al., 2004). Phosphorylation of serine/threonine residues adjacent to 
tyrosine motifs which are phosphorylated upon RTK signalling and serve as binding sites for the 
SH2 domain of PI3K disrupts this interaction. 
Much less is known about the role of serine/threonine phosphorylation of paxillin, 
E3B1/Abi2 and the Grb7/10/14 family adaptors. Phosphorylation of particular serine residues play a 
key role in cell migration and in the regulation of focal adhesion organisation (Huang et al., 2004). 
However, the mechanism of the modulatory effect of these phosphorylations is not uncovered as 
well as the biological relevance of other phospho-serine/threonine residues in the molecule remains 
to be elucidated. E3B1/Abi2 becomes hyperphosphorylated on serine residues following mitogenic 
stimulation (Ichigotani et al., 2002). However little is known about the clear cause and consequence 
of the phosphorylation. Grb7/10/14 family adaptors are phosphorylated on serine and threonine 
residues at basal level in quiescent cells which is increased in case of Grb10 and Grb14 upon 
growth factor stimulation (Han et al., 2001). Grb14 interacts directly with activated insulin receptor 
and its serine/threonine phosphorylation inhibits insulin signalling probably by maintaining the 
bound receptor in an inactive conformation (Cariou et al., 2004). Functional significance of 
serine/threonine phosphorylation of other Grb7 family members is not yet understood. 
 
 Caspase cleavage 
Signalling can serve as survival factor in cells. Effective shut down of signalling events is 
therefore a prerequisite of apoptosis. As a consequence many adaptor proteins are targets of 
caspases which are the major initiator and executor proteases activated in programmed cell death. 
Interestingly, caspase activity is observed and required in the regulation of some adaptors not 
exclusively under apoptotic conditions. 
Cas family adaptor proteins are involved in the assembly of multiple protein interactions at 
focal adhesion sites (Bouton et al., 2001). Human enhancer of filamentation 1, HEF1, a member of 
this family shows a cell cycle dependent regulation. In cells in G1-S-G2 phases full length forms of 
the molecule accumulate at focal adhesions, while at G2/M transition HEF1 is cleaved at a caspase 
consensus site to generate an N-terminal HEF1 form, p55HEF1, which relocalises to the mitotic 
spindle. C-terminal cleavage products are apparently degraded (Law et al., 1998). Additional 
finding was that proapoptotic stimuli or HEF1 overexpression lead also to the cleavage of HEF1 by 
caspases. The same caspase cleavage site is used as during mitosis to generate the N-terminal 55 
kDa and a C-terminal 65 kDa fragment, while a novel caspase cleavage site was identified to be 
responsible for the generation of a carboxy-terminal small 28 kDa fragment (Law et al., 2000). This 
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second caspase site is also present in p130Cas, an other member of the Cas family, which is 
similarly cleaved at this site to produce a 28 kDa protein species following proapoptotic stimulus 
(Bannerman et al., 1998). The proapoptotic activity of HEF1 was found to depend ot the expression 
of the C-terminal 28 kDa region of the protein. These findings together suggest a model in which 
separate parts of HEF1 have functions distinct from the full length molecule. Regulation of the 
cleavage and abundance of HEF1 (and p130Cas) might propagate the destruction of focal adhesion 
sites and regulate onset of mitosis or apoptosis (Law et al., 2000). Thus, modulated caspase activity 
towards Cas adaptors may be important for cytoskeletal organisation and cell cycle progression, 
while a dramatic increase or dysregulation of caspase activity is necessary to promote apoptosis. 
Another example, how caspase cleavage can regulate signalling events, is served by the 
adapter molecule Gads. Gads functions specifically in T-cell receptor signalling by linking the 
adaptor SLP-76 to tyrosine phosphorylated LAT. This linker function of Gads is essential to recruit 
SLP-76 to the membrane which than upon phosphorylation activates downstream signalling events 
(Liu et al., 2001). Apoptosis induction results detectable cleavage of Gads at a predicted caspase 
cleavage site. Cleavage products retain their binding specificity for LAT and SLP-76 respectively. 
Expression of Gads cleavage products showed a dominant inhibitory effect on signal propagation. 
Hence, the functional relevance of caspase cleavage of Gads is likely to uncouple LAT and SLP-76 
interaction (Berry et al., 2001). The surprising finding, that cell death receptor mediated signalling 
is required for activation induced proliferation of T-cells (Kennedy et al., 1999) rises the hypothesis 
that cleavage of signalling molecules downstream of the T-cell receptor could modulate the 
spectrum of activated pathways in a way that propagates proliferation. 
 
 Dimerisation/oligomerisation 
Oligomerisation of adaptors can have both posive as well as negative effects on their 
activity. It is mediated either by homophylic interaction of the same domains or by heterophylic 
interaction between two different regions of the molecules. However, based on the experimental 
approaches it is not distinguishable in each case, whether these domains are utilised for intra- or for 
intermolecular interactions. 
Preferential domains of homophylic interactions are leuzine zipper domains, coiled coil 
motifs and helix-loop-helix structures. Less defined are the domains for heterophylic interactions: 
the one part is often determined only as a molecular region without known domain structure. 
Examples below show that heterophylic interaction of adaptors is usually regulated by tyrosine 
phosphorylation. 
CIN85/CMS family adaptor proteins are involved in the regulation of RTK downregulation 
via endocytosis (reviewed in (Dikic, 2002)). They are able to homodimerise via their coiled-coil 
domains. Overexpression of CIN85 or CMS leads to the formation of multiple endosomal-like 
vesicles in the cells, the existence of which depends on the presence of the coiled-coil domain. One 
possible explanation is that homo-oligomerisation of CIN85/CMS increases the local concentration 
of recruited signalling complexes in the proximity of the receptor (cargo) and thereby positively 
regulates endocytosis. 
Members of the Dok adaptor family inhibit the Ras pathway by recruiting RasGAP in a 
tyrosine phosphorylation-dependent manner. Mutations in Dok that prevent oligomerisation also 
abrogate inhibitory activity of Dok1 without affecting the overall phosphorylation state of the 
molecule, indicating that domains involved in oligomerisation play a crucial role in downstream 
interactions without influencing Dok1 activation itself (Songyang, 2001). It is not undersood at 
present if the dual requirement of PTB domain and phosphorylated Tyr146 in Dok1 function is 
primarily due to their capability to induce oligomerisation. 
The regulation of the oligomerisation capacity of the adaptor AFAP-110 is also 
phosphorylation dependent and involves both inhibitory and activation steps. AFAP-110 has the 
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intrinsic capability to form multimers via its C-terminal leucine zipper motif. This domain has an 
auto-inhibitory binding to N-terminal regions of the molecule and this interaction keeps AFAP-110 
in a tetrameric complex  (Qian et al., 2004). Upon phosphorylation auto-inhibition is released and 
conformational changes lead to a reduction of the multimeric status of AFAP-110. Dimers are 
formed probably via new interacting surfaces in the molecule. The new conformation allows the 
binding and activation of Src kinase and increases the actin crosslinking activity of AFAP-110 
(Qian et al., 2002). 
Oligomerisation of adaptor molecules can have also inhibitory effect on interactions of 
signal transduction events. The adaptor Grb10 forms oligomers in a way, that N-terminal amino 
acid sequences of the one molecule interact with the C-terminal BPS-SH2 domains of the other 
molecule (Dong et al., 1998). BPS-SH2 domains are important functional modules, which can 
directly bind activated insulin receptor. Oligomerisation therefore may provide a reservoir of Grb10 
that is prevented to bind phospho-tyrosine containing molecules and stimulation may release Grb10 
molecules from this pool. Alternatively Grb10 oligomers may have a more active function serving 
as docking complex to recruit multiple signalling molecules. Another piece to the complexity is that 
Grb7, member of the same adaptor family was also able to interact with the C-terminal PBS/SH2 
domains of Grb10 in yeast two hybrid assay (Liu and Roth, 1998). This potentiates the homo-
/hetero-oligomerisation capacity of Grb7 family adaptors as a broader regulatory tool in signal 
transduction. However, no physiological relevance of these interaction has been shown so far. 
The Cas family adaptor protein HEF1 is also able to dimerise via its C-terminal helix-loop-
helix (HLH) domain. This motif mediates not only HEF1 homodimerisation, but also 
heterodimerisation with the HLH domain of the other Cas family member p130cas as well as with 
the transcriptional regulatory HLH proteins Id2, E12 and E47 (Law et al., 1999). Dimerisation 
capacity was analysed only for the C-terminal region of HEF1 but not for the full length molecule. 
HEF1 is processed in T cells (see above). Thus, it might be possible, that dimerisation is an intrinsic 
feature of a sole C-terminal fragment of HEF1 but not of the full length molecule. Functional 
relevance of dimerisation is not understood. 
 
 Intramolecular interactions, conformational changes 
Conformational changes are stimulation-dependent temporary alterations that affect the 
activity of adaptors. They are induced upon phosphorylation of the adaptors which causes allosteric 
distortion or frequently alters intramolecular interactions of the molecule. As discussed earlier with 
examples phosphorylation can disrupt intramolecular interactions and result an “open” molecular 
structure where new protein interaction domains become available (e.g. Cortactin). Phosphorylation 
can also generate new binding sites for own phospho-tyrosine binding domains propagating a 
“closed” form of the molecule which will mask interaction surfaces for other binding partners (e.g. 
Crk). Thus, conformational change is a potent tool to alter interaction surfaces of adaptors and 
therefore mutually exclude interacting partners in a signalling dependent manner. 
 
 Protein degradation 
Protein degradation is an irreversible way to downregulate adaptor activity. The ubiquitine 
E3 ligase Cbl plays important role in this negative signalling sending not only adaptors but several 
receptors and signalling effectors for degradation (Dikic and Giordano, 2003). It contributes in the 
poly-ubiquitination of FRS2 which leads to the proteosomal degradation of this adaptor (Wong et 
al., 2002). The adaptor Cin85, involved in the ligand-induced endocytosis of several receptors 
undergoes Cbl dependent mono-ubiquitination during this process which provides the sorting signal 
for lysosomal degradation of the whole receptor-Cbl-Cin85 complex (Dikic, 2002). SOCS proteins 
play a role in proteosomal targeting of associated proteins (Kamura et al., 1998). It has been shown 
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that they contribute to the proteosomal degradation of IRS adaptors (Johnston et al., 2003). Studies 
on IRS also showed that S/T phosphorylation promoted its degradation through an unknown 
mechanism. 
 
The discussed examples show that adaptor proteins are regulated in a complex way. 
Regulatory modifications can have opposing effects and can be a prerequisite or inducer of further 
regulatory changes. Hence, regulatory tools act in concert to achieve an appropriate activity level of 
adaptors. 
 
1.2 FGF signalling-dependent morphogenetic processes in flies 
 
Initially dof mutants were found in genetic screens affecting mesodermal and tracheal 
development in the embryo (Imam et al., 1999; Michelson et al., 1998; Vincent et al., 1998). Both 
processes are controlled by FGF (Ghabrial et al., 2003; Wilson and Leptin, 2000). Later analysis 
showed that dof is generally involved in developmental processes where FGF signalling plays a 
role, e.g. also in the migration of midline glia cells (Vincent et al., 1998) and in the formation of air 
sacs in the pupa (Sato and Kornberg, 2002). Here I will focus on the embryonic development of the 
mesoderm and the tracheae since the in vivo function of dof and other components of the FGF 
signalling cascade were studied in these developmental processes to the greatest detail including 
experimental results presented in this work. Thus, mesoderm and tracheal development are the two 
FGF-dependent processes in Drosophila about the regulation of which we understand the most at 
present. 
 
1.2.1 Regulation of tracheal morphogenesis 
 
The Drosophila embryonic trachea is a tubular network and serves as the respiratory organ 
throughout larval life (reviewed in (Affolter et al., 2003; Ghabrial et al., 2003). It derives from ten 
clusters of dorsal ectodermal cells from both side of the embryo, the so called tracheal placodes 
(Figure 2a). They invaginate into the mesoderm to form the tracheal pits, each containing 
approximately 80 cells. Without further cell division the 20 sacs establish independent tracheal 
metamers with highly similar branching patterns through stereotypic, directed migration and cell 
shape changes (Figure 2b,c). Six primary branches are formed into different directions and each 
branch contains a well defined, invariable number of tracheal cells. The metamers become 
interconnected by subsequent fusion events through specialised fusion cells of particular tracheal 
branches (Figure 2d). As last step fine subcellular extensions, the terminal branches grow out to 
deliver oxygen to target tissues guided directly by different oxygen requirement of the cells (Figure 
2g). Tracheal branches migrate into different parts of the embryo invading different tissues. The 
surrounding tissue provides additional specific interactions for the corresponding branches and 
thereby contributes to the final pattern of the tracheal network (reviewed in (Uv et al., 2003)). 
At molecular level the JAK/STAT pathway is responsible to initiate tracheal cell fate. It 
induces the expression of the transcription factor Trachealess in the tracheal placodes. Trachealess 
is responsible to make tracheal cells competent for migration by inducing the expression of Dof and 
the FGF receptor Breathless (Btl). The Btl specific FGF ligand Branchless (Bnl) is expressed in 
dynamic pattern in surrounding cells of the tracheal placodes and predefines the directional 
outgrowth of the six primary branches (Figure 2e) (Sutherland et al., 1996). Bnl is acting as a 
chemoattractant for tracheal cells that is nicely demonstrated by its ability to reroute tracheal cells if 
ectopically expressed or to attract fine terminal branches in larvae towards oxygen-starved cells that  
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Figure 2. Schematic representation of the developmental stages of tracheal morphogenesis during 
embryogenesis. (a-d) Schematic drawing of Drosophila embryos from lateral view at developmental stages 
11, 12, 13 and 15 respectively. Anterior to the left. Gray structures show the morphology of tracheal 
anlage/tissue at different stages. (a) Invaginated tracheal palcodes prior branching, (b) Initial branching of 
the six primary branches, (c) trachea metamers with branched out primary branches prior fusion and (d) 
tracheal network after fusion occurred and secondary branches are formed. (e-g) blow ups of regions in a, b 
and d highlighted with red. (e) shows the arrangement of Branchless expression clusters (blue) surrounding 
a trachea placode (red). (f) Regional differentiation of tracheal cells at early primary branching stage. Colour 
code shows the regionally acting signalling pathways which determine different cellular fates of the 
developing primary branches according their anterior-posterior, dorsal-ventral position in the placode. (g) 
tracheal unit of one hemisegment showing the positions of specified tracheal cells for fusion and terminal 
branching. CA, cerebral anastomosis; CaB, caudal branch; CB, cerebral branch; DB, dorsal branch; DC, 
dorsal cephalic branch; DTa, dorsal trunk anterior; DTp, dorsal trunk posterior; GB, ganglionic branch; HB, 
hindgut branch; LC, lateral cephalic branch; LG, lateral group branch G; LTa, lateral trunk anterior; LTp, 
lateral trunk posterior; PB, pharyngeal branch; SB, spiracular branch; TC, trancverse connective; VB, 
visceral branch. Figures were taken and modified from (Bate, 1993) (a-d), (Metzger and Krasnow, 1999) (e) 
and (Uv et al., 2003) (f-g). 
 
express it at high levels. In the absence of Bnl, Btl or Dof cell migration and subsequent 
development of the tracheae fails to occur (reviewed in (Ribeiro et al., 2003)). 
Tracheal cells show a regional differentiation at placode stage as a consequence of the 
differentially localised activity of Decapentaplegic (Dpp), Rhomboid (Rho) and Wingless (Wg) 
(Figure 2f) (reviewed in (Uv et al., 2003)). Their activity is manifested by a selective expression of 
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transcription factors that act as sorting markers of tracheal cells for different primary branches. FGF 
signalling controls motility of tracheal cells by inducing filopodia formation in a spatially specific 
manner but is not sufficient for successful outgrowth of tracheal branches (Ribeiro et al., 2002). 
Regional differentiation might prepare and specialise cells of different branches for oriented 
migration towards the sources of Bnl along distinct substrates. Signalling systems provided by the 
regional differentiation integrate cell motility and thereby allowing the correct morphogenesis of 
individual branches. 
 
1.2.2 Regulation of mesoderm development 
 
The mesoderm invaginates as an epithelial layer on the ventral side of the embryo driven by 
cell shape changes (Figure 3a). After the central part of the mesoderm is fully internalised and the 
ventral furrow is closed, the epithelial tube initiates contact with the ectoderm (Figure 3b), followed 
by epithelial mesenchymal transition (Figure 3c). Mesodermal cells dissociate, resume mitosis and 
spread out on the ectoderm to form a single-cell layer (Figure 3d). Based on dorso-ventral inductive 
signals from the underlying ectoderm mesodermal cells differentiate into specific tissues along the 
dorso-ventral axis (Figure 3d). Thus, the formation of mesodermal derivatives requires a sequential 
interplay of cell migration and cell differentiation (reviewed in (Michelson et al., 1998). 
 
 
 
Figure 3. Schematic representation of mesoderm morphogenesis. (a-d) Schematic drawings of cross-
sections of embryos at four successive stages of mesoderm development. (a) Mesoderm invagination begins 
with the formation of the ventral furrow by the most ventral cells. Presumptive mesoderm expresses Twist 
(red). (b) Invaginated mesoderm forms an epithelial tube and begins to make contact with the ectoderm. 
Heartless and Dof are expressed in the mesoderm (yellow) and the two FGF ligands in the complementary 
parts of the ectoderm (green). (c) Mesodermal tube flatten against the ectoderm, cells loose their epithelial 
integrity and begin to divide. Note that at this time germ band extension is in a progressive stage. (d) 
Mesodermal cells (orange) migrated out dorsally on the surface of the underlaying ectoderm and start to 
differentiate. The dorsal-most cells of the mesodermal sheet form Eve-positive cell clusters (blue) upon 
inductive signals of the ectoderm (Dpp, Wg). FGF signalling is also required for this process; expression of 
the two FGF ligands becomes higher/stays longer in the dorsal ectoderm (green) and Heartless and Dof 
expression is upregulated in the dorsal-most mesodermal cells (not shown here). The germ band is in a fully 
extended stage. 
 
Mesodermal fate is adopted through the action of a series of maternal genes of the so-called 
dorsal goup. It results in a nuclear concentration gradient of the Dorsal transcription factor. Specific 
expression pattern of zygotic genes is established based on the different binding affinity of their 
promoters to Dorsal. On the ventral side of the embryo the highest nuclear levels of Dorsal turn on 
twist and snail, the two major sequester transcription factors of mesoderm formation and 
development (Figure 3a). Dorsal participates with Twist in activating dof and the FGF receptor 
heartless (htl) ventrally (reviewed in (Michelson et al., 1998)). The recently identified Htl specific 
FGF ligands FGF8-like1/pyramus and FGF8-like2/thisbe are activated laterally by lower levels of 
Dorsal (Gryzik and Muller, 2004; Stathopoulos et al., 2004).  It is likely that Snail represses their 
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expression in the ventral cells thereby generating a strict complementary expression pattern of FGF 
ligands and their receptor (Figure 3b,c). FGF signalling is immediately needed after invagination to 
establish initial contact between ectodermal and mesodermal cells and then later for effective and 
coordinated spreading. It remains to be elucidated how Htl ligands act: in a permissive or in an 
instructive manner. 
In addition to its migratory role Htl has a second function in mesodermal cell fate 
specification (Michelson et al., 1998). Different regions of the ectoderm send different inductive 
signals to the contacting mesoderm. The dorsal-most mesodermal cells are induced by Dpp that 
gives them the competence to differentiate into visceral, cardiac or dorsal somatic muscle 
derivatives. Superimposed activation of Heartless or Heartless and Drosophila EGF receptor 
together serves to distinguish the fate of a subgroup of three cells in each hemisegment 
characterised by Even-skipped (Eve) expression (Figure 3d): two pericardial progenitors and a 
single dorsal somatic muscle cell respectively. Thus, the presence of Eve-positive mesodermal 
clusters relays on the dual function of FGF signalling. First, it controls cell migration allowing that 
mesodermal cells acquire a precise position relative to the ectoderm and second, contributes to cell 
fate determination. 
 
1.3 Molecular mechanism of FGF signalling 
 
FGF receptors (FGFR) belong to the family of receptor tyrosine kinases (RTK). FGFRs are 
monomers in the cell membrane. Ligand binding induces dimerisation of the receptors resulting in 
trans-autophosphorylation of their cytoplasmic domains on several tyrosine residues. 
Autophosphorylation is necessary to “wake up” kinase activity, but most auto-phosphorylated 
tyrosines are located in non-catalytic regions of the receptor molecule. These sites function as 
binding sites for SH2 or PTB domain containing signalling molecules which then upon recruitment 
activate diverse signalling pathways commonly used by RTKs (reviewed in (Schlessinger, 2000). A 
key mediator for FGF receptor functions is the adaptor protein FRS2. It binds constitutively to FGF 
receptors and is tyrosine phosphorylated upon FGFR activation (Ong et al., 2000). It links the 
receptor to downstream signalling cassettes by recruiting multiple protein complexes through 
phospho-tyrosine based interactions (Figure 4). Grb2-dependent interaction of FRS2 leads to the 
activation of PI3K by the recruitment of the FRS2-Grb2:Gab1-PI3K complex to the FGF receptor 
(Ong et al., 2001). FRS2-Grb2:Sos-Ras interaction activates the MAPK cassette (Kouhara et al., 
1997), but FRS2 is also able to bind to the protein phosphatase SHP2 (Hadari et al., 1998) 
providing an alternative route for the recruitment of Grb2:Sos-Ras through SHP2. FGF receptors 
can directly interact with and phosphorylate the adaptor molecule Shb, which contributes to FRS2 
phosphorylation in an SHP2 dependent manner (Cross et al., 2002) – a potential additional 
regulation for FRS2 activation and recruitment. 
Beside adaptor molecules FGFR can interact directly with and activate enzymes: 
phospholipase Cγ (PLCγ), thereby directly activating the PLCγ signalling cascade (Falasca et al., 
1998) and RasGAP (Cross et al., 2002), a Ras family specific GTPase activating protein. The fact 
that FGFR can activate Ras and also recruit RasGAP, an inhibitor of Ras signalling shows tightly 
coupled regulatory tools for the timing, amplitude and duration of FGF signalling. Studies on Torso, 
a Drosophila RTK showed that SHP2 dephosphorylates RasGAP binding site on Torso thereby 
increasing MAPK activity (Cleghon et al., 1998). This might be also utilised in FGF signalling 
supported by the fact that phosphatase activity of SHP2 is necessary for the activation of the MAPK 
cascade. 
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Figure 4. Model for the molecular 
mechanism and regulation of FGF 
signalling. (A) In non-stimulated cells 
FGFR is in monomeric form and 
constitutively binds the adaptor 
molecule FRS2. The adaptor 
molecule Grb2 forms constitutive 
cytosolic complexes with the adaptor 
Gab1 or the RasGEF protein Sos. 
Ras GTPase is in an inactive, GDP 
bound form. (B) In FGF stimulated 
cells FGFRs dimerise, trans-
autophosphorylate each other and 
phosphorylate FRS2 and other 
signalling molecules which are 
recruited to the plasmamembrane. 
These molecules form signalling 
complexes via phospho-tyrosine-
SH2 domain mediated interactions. 
Grb2:Sos complexes are membrane 
recruited by phosphorylated FRS2 or 
SHP2 and activate Ras that in turn 
activate the MAPK cascade. As a 
result phosphorylated Erk enters the 
nucleus. FRS2 binds also Grb2 in 
complex with Gab1 which than 
activates the PI3K cascade. PLCγ 
binds directly to phosphorylated 
FGFR and iniciates a cascade that 
leads to the activation of Protein 
kinase C (PKC). JAK-STAT pathway 
is activated by the FGFR and 
phosphorylated STAT is translocated 
to the nucleus. Negative regulatory 
feedback loops depend also on phosphorylation: (i) rasGAP binds to the phosphorylated FGFR and 
interferes with Ras signalling, (ii) phosphorylated Sprouty inhibits MAPK signalling at several levels and (iii) 
activated Erk inhibits interaction of FRS2 with the FGFR by phosphorylating FRS2. 
 
1.3.1 Downstream signalling cassettes activated by FGFR 
 
Activated FGFRs transmit the signal to numerous signalling cascades: the JAK/STAT 
pathway, PLCγ, PI3K and Ras-MAPK cassettes and thus activate effector molecules in the nucleus 
and in the cytoplasm (Figure 4) (reviewed in (Schlessinger, 2000)). Signalling cassettes work in 
cross talk creating a network of stimulatory and inhibitory modifying signals. This work focuses on 
signalling events transmitted by Ras from two reasons: first, the Ras-MAPK pathway is essential 
for transduction of the FGF signal in Drosophila and second, activated form of Ras can circumvent 
many effects caused by mutations of Drosophila FGF receptors or Dof (Gisselbrecht et al., 1996; 
Imam et al., 1999; Michelson et al., 1998; Reichman-Fried et al., 1994; Vincent et al., 1998) 
indicating that Ras activity is important for effective FGF signalling. 
 
Ras mediated signalling 
 
Ras is a small molecule with GTP hydrolising activity localised to the plasma membrane 
through lipid modification. It has the capacity to recruit effector molecules in a GTP-dependent 
INTRODUCTION 
 16
manner. FGF signalling activates it by relocating the guanine nucleotide exchange factor Sos into 
its vicinity thereby enriching its GTP bound, active form. Up today there are seven Ras effectors 
known: the serine/threonine kinase Raf, the phospholipid kinase PI3K, the guanine nucleotide 
dissociation stimulator for Ral GTPases RalGDS (White et al., 1995), phospholipase Cε (Wing et 
al., 2003), the polarity protein AF6/Canoe (Kuriyama et al., 1996), the Ras inhibitor RIN1 (Wang et 
al., 2002)  and IMP, a regulator of MAPK signalling (Matheny et al., 2004). 
 
 The Ras-MAPK cascade 
The core structure of the MAPK signalling cascade is a module of three kinases: Raf 
(MAPK kinase kinase), Mek (MAPK kinase) and Erk (MAPK), which become sequentially 
activated. Phosphorylated Erk enters the nucleus and activates set of transcription factors. The 
cascade is effectively assembled and localised to the appropriate subcellular site by scaffolding 
proteins (reviewed in (Morrison and Davis, 2003). In quiescent cells Raf as well as Mek in complex 
with the scaffolding protein Kinase suppressor of Ras (Ksr) are bound to 14-3-3 proteins through 
phosphorylated serine residues which keep them in the cytoplasm (Figure 5A). Upon Ras activation 
they become partially dephosphorylated that allows Raf to relocate to the membrane via interacting 
with GTP bound Ras. The Ksr complex released from the inhibitory binding of 14-3-3 recruits Erk 
and also translocates to the membrane where Raf-Mek-Erk activation occurs (Figure 5B). The 
protein phosphatase PP2A is responsible for the Ras stimulation-dependent dephosphorylation of 
Raf and Ksr, thus acting as a regulator at the level of Raf activation (Ory et al., 2003). Another 
regulator of the MAPK cascade at this level is the Ras effector RIN1. It directly competes with Raf 
for Ras binding (Wang et al., 2002). RKIP (Raf Kinase Inhibitor Protein) and the Ras effector IMP 
regulate MAPK cascade at the level of Mek activation. RKIP uncouples Raf-Mek signal 
transmission by directly inhibiting Raf-Mek interaction (Yeung et al., 2000; Yeung et al., 1999) 
whereas IMP inactivates the scaffolding protein Ksr. Binding of IMP to Ras blocks its inhibitory 
activity on Ksr (Matheny et al., 2004). Thus, Ras has dual effector inputs on the MAPK cascade: 
initiating Raf activation while derepressing Ksr-dependent Raf-Mek complex formation. 
 
 Other Ras effectors 
Ras is a branching point in signalling since it can activate effectors with diverse functions. 
Beside the Raf-MAPK cascade discussed above it activates the lipid modifying enzymes PI3K and 
PLCε. They produce second messengers by lipid phosphorylation and hydrolysis respectively to 
propagate signalling. 
The Ras effector RalGDS activates the Ras family small GTPase Ral. Ral is involved in 
membrane trafficking by regulating the formation of the exocyst complex (Lipschutz and Mostov, 
2002) and the ligand-induced endocytosis of growth factor receptors (Nakashima, 1999). It 
influences cytoskeletal organisation and filopodia formation through filamin binding and by 
controlling the activity of Rac/Cdc42 (Ohta, 1999; Sugihara, 2002). It can also influence gene 
expression by interacting with the Ras-MAPK cascade (Okazaki, 1997). Thus, Ral GTPase might 
be a good candidate to interconnect signalling cascades downstream of FGF signalling. 
 
Rap1 – a parallel pathway to activate known Ras effectors 
 
Ras signalling is not the exclusive way to activate known effectors of Ras. In some cases 
Ras effectors are reported to be recruited through the activation of Rap1 to the site of action. Rap1 
is a Ras family GTPase with a virtually identical effector domain to that of Ras, suggesting that 
both proteins theoretically interact with similar effectors. Yeast two hybrid and in vitro binding 
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assays showed that both can bind Raf, RalGDS and AF6/Canoe (Boettner et al., 2003; Ohtsuka et 
al., 1996). In overexpression situations they behaved antagonistically, but evidence is accumulating 
that Rap1 functions independently of Ras protein signalling in vivo, utilising effectors similar or 
identical to those of Ras (Asha et al., 1999; Boettner et al., 2003; York et al., 1999). The activation 
is also independent of the two proteins. Ras is activated by the Grb2:Sos complex. Although Rap1 
activation follows the same mechanism and thus, requires the binding of GEF proteins, which are 
recruited upon phosphorylation-dependent interactions to the plasma membrane, it uses different 
molecules. The Crk adaptor:C3G Rap1GEF compex is recruited to activate Rap1 upon stimulation 
(Ishimaru et al., 1999). The specific and exclusive affinity of the GEFs to the respective GTPases 
ensures independent activation of the two pathways. The in vivo role of Rap1 is of emerging 
importance in the activation of Ral and AF6/Canoe upon EGFR stimulation (Boettner et al., 2003; 
Mittar et al., 2004; Mott et al., 2003). However, a direct role of Rap1 in FGF signalling remains to 
be elucidated. 
 
Figure 5. Model for the regulation of the 
MAPK pathway by Ras activation. (A) In non-
stimulated cells, binding of 14-3-3 to 
phosphorylated Raf and Ksr retains both 
complexes in the cytoplasm. In addition, Ksr 
is docked to Triton-insoluble cellular fraction 
via IMP interaction which also triggers the 
inhibitory phosphorylation of Ksr. The PP2A 
core enzyme (A and catalytic C subunit) is 
bound to Raf and Ksr. Inactive Mek is also 
part of the Ksr complex. RKIP inhibits Raf-
Mek interaction. (B) Stimulation of the cells 
results in the assembly of the active PP2A 
holoenzyme leading to dephosphorylation of 
particular residues in Raf and Ksr. 14-3-3 is 
displaced from these sites which facilitates 
the membrane recruitment of both proteins 
and enables Raf to interact with Ras. 
Simultaneously, IMP releases Ksr upon 
binding to activated Ras. Interaction of IMP 
with Ras induces IMP auto-ubiquitination. 
Liberated Ksr mediates the complex formation 
between Raf, Mek and Erk. RKIP is 
competitory inhibitor of the Raf-Mek 
interaction. Ras activation recruits an 
additional negative regulator RIN1. It 
competes with Raf for the same binding site 
in GTP-bound Ras. 
 
 
1.3.2 Negative regulators in FGF signalling 
 
Negative regulators ensure the correct cellular fate by enabling to manipulate signalling 
levels over a time course or to tune the sensibility of cells to a common signal source. Sprouty was 
discovered in flies and owes its name to prevent excessive tracheal branching (Hacohen et al., 
1998). Meanwhile a whole family of Sprouty(-like) molecules has been identified as general 
inhibitors of RTK signalling. They can uncouple Ras signalling on multiple levels based on their 
capacity to interact with Grb2, Gap1 and Raf (Figure 4B). Tyrosine phosphorylation is essential for 
Sprouty function indicating that it represents a negative feedback loop of the system (reviewed in 
(Dikic and Giordano, 2003). 
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Negative regulatory elements of the MAPK cascade itself were discussed above. MAPK 
activation induces a negative feedback mechanism that has general consequences on FGF 
signalling: Erk dependent phosphorylation of the key adaptor FRS2 leads to the downregulation of 
FGF signalling (Figure 4B) (Lax et al., 2002).  
 
1.3.3 Learning from the fly - specialities of FGF signalling in Drosophila 
 
Results of the mammalian cell culture studies helped to reconstitute FGF signalling in flies. 
The example of Sprouty shows that reverse inputs were similarly fruitful to brighten our knowledge 
on signalling regulation. In vivo studies in Drosophila mesoderm and tracheae indicated that cells 
respond with different levels of FGF-dependent MAPK activity based on their position in the 
migrating tissue. In the mesoderm only the first 3-4 row of cells contacting the underlying ectoderm 
show MAPK activity (Wilson, 2004). In the tracheae - after an initial broad activation - MAPK 
activity is restricted to the cells that form the leading front of migration (Gabay et al., 1997). It 
showes that intercellular cross talk regulates differential downregulation of FGF signalling in order 
to shape the developing tissue. 
Most fly homologues of the conserved FGF signal transduction machinery have been 
identified. However there was a missing link in Drosophila FGF signal transduction for a long time, 
namely the functional equivalent of FRS2. The Drosophila homolog of FRS2 does not have the 
function of an FGF receptor specific adaptor (personal communication to M. Krasnow). First hint 
for a solution came with the identification of Dof. Genetic and biochemical studies provided 
evidence that Dof might be the FGF receptor specific adaptor in Drosophila. It is essential for all 
known functions of Drosophila FGF receptors but at present it is not fully understood how and to 
what extent it “copies” FRS2 functions and what is a solely Dof specific contribution in FGF 
signalling. 
 
1.4 The protein Dof 
 
dof is a fast evolving gene (Wilson et al., 2004). Two weak vertebrate homologues of Dof are 
known, B-cell adaptor for PI3K (BCAP) (Okada et al., 2000) and B-cell scaffolding protein with 
ankyrin repeats (BANK) (Yokoyama et al., 2002). Highest level of conservation is found in their 
DBB domain, a unique domain of the family (Wilson et al., 2004). Two ankyrin repeats and a 
coiled coil region as well as a C-terminal proline rich sequence strech are also common structural 
elements of the three proteins. Dof contains several potential sites of post-translational 
modifications: (i) eight tyrosine motifs which could serve as binding sites for different SH2 
domains in their phosphorylated form, (ii) four consensus sites for sumoylation and (iii) a caspase 
cleavage site (Figure 6). Dof is able to form a complex with the activated FGFR and is tyrosine 
phosphorylated in an FGFR dependent manner (Petit et al., 2004; Wilson et al., 2004). 
Phosphorylation of Tyr 515 recruits the protein phosphatase Corkscrew to Dof (Petit et al., 2004). 
Dof has several further potential phosphorylation-dependent interaction partners like Grb2, PI3K, 
RasGAP and Crk and many phosphorylation-independent putative interactors identified in a yeast 
two hybrid screen, e.g. components of the sumoylation machinery (Battersby et al., 2003). Dof has 
the capability for self-association (Battersby et al., 2003). Two regions are important in the protein 
for interaction: the most conserved DBB domain in the N-terminal half of the molecule and the C-
terminal part including the coiled coil region. Whereas the DBB domain is able both to dimerise 
with itself and to bind the C-terminal part, the C-terminal part fails to bind itself and can only trans-
interact with the DBB domain. This gives rise to several possible assembly models based either on 
intermolecular or on intramolecular interactions or on both. It was found in yeast that the C-terminal  
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Figure 6. Domain organisation and consensus sequence motifs of Dof. Coloured boxes mark DBB (Dof, 
BCAP and BANK) domain (red), Ankyrin repeats (green) and coiled coil region (yellow). Thick black lines 
label recognition sequences for protein degradation (PEST). Consensus tyrosine motifs are marked by red 
lines on the scheme. In addition the potential binding partners as well as the amino acid sequence of each 
motif are depicted. The four potential SUMO attachment sites are labelled with a green S on the drawing, 
amino acid sequence and position of the consensus sites is marked. Lysine residue of SUMO attachment is 
labelled in red. Amino acid position and sequence of the consensus caspase cleavage site is given and the 
corresponding position is labelled with a black C on the scheme. 
 
part weakened self-association compared to C-terminally truncated forms, supporting the presence 
of a head to tail, “closed” structure relying exclusively on intramolecular interaction. A subset of 
the yeast interactors showed conformation dependent binding to Dof in such a way, that a model for 
the existence of both a “closed”, and an “open” molecule conformation has been proposed 
(Battersby et al., 2003). Beside self-interaction the DBB domain is also essential for efficient 
receptor binding, and the presence of the C-terminal tail weakens also this interaction in yeast   
(Wilson et al., 2004). This is an additional indication that trans-interaction between DBB domain 
and C-terminal part is utilised in Dof self-association. 
 
1.5 Specific aim of this thesis 
 
Different cellular responses are triggered by FGF signalling in Drosophila, all of them seem 
to require Dof activity. How can Dof transmit all the different branches of FGF signalling? 
One way to achieve such a diverse function is to interact with many different molecules. In 
this work potential Dof interactors found in an earlier yeast two hybrid screen were studied for their 
Dof-binding capability with special attention on the Drosophila FGF receptor Heartless. Common 
feature of adaptor proteins is that signalling-dependent post-translational modifications influence 
the dynamics of their interaction behaviour. Predicted post-translational modifications of Dof - 
phosphorylation, sumoylation and caspase cleavage - were identified in this work with the aim to 
find their functional relevance in the regulation of signal transduction. 
Alternatively or in parallel to this FGF signalling might raise its diversity downstream of Dof. 
Given that Ras can partially circumvent upstream dysfunctions in FGF signalling and has many 
known effectors, it might provide the major branching point in FGF signalling. This work also 
aimed to dissect known Ras functions and to analyse their contribution in FGF signalling. 
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2. Results 
 
2.1 Revisiting yeast Dof-interactors in Drosophila S2 cells 
 
To validate the biological relevance of interactions found in a yeast two hybrid screen using a 
truncated form of Dof as bait (Battersby et al., 2003) interaction studies were performed in 
Drosophila cell culture with a subset of candidates identified in the screen. We selected 16 out of 
the 41 interactors of the yeast two hybrid screen (Figure 7). Our major point was at the selection the 
structural-functional aspects of the gene products the candidates coded for. Candidates were chosen 
that are known to be involved in FGF dependent developmental processes or encode signalling 
molecules or their regulators, cytoskeleton proteins, enzymes with potential roles on modification of 
Dof or candidates with interesting protein domains but unknown function. Among the 41 interactors 
were several nuclear proteins and transcription factors, a fact which was unexpected, since Dof is 
localised in the cytosol with enrichment at the cell membrane (Vincent et al., 1998). To investigate 
this apparent contradiction two known nuclear proteins were also chosen for further analysis. In 
addition, we selected preferentially candidates represented with more than one independent clone in 
the yeast two hybrid screen. On the other hand we have not sorted out interacting clones being out 
of the correct reading frame. Yeast two hybrid screen was carried out under two different growth 
selection conditions. Although it is believed, that difference in growth under different selection 
conditions might represent difference in strength of interaction we did not chosen this as a criterion 
of the selection. Selected candidates are sorted in Figure 1. based on their growth behaviour in 
yeast. Ade2 positives are the candidates which grow also at higher stringency, whereas Ade2 
negative stands for growth only at less stringent conditions. 
To perform interaction studies we applied a transient transfection system in Drosophila S2 
cells and expressed full length Dof together with the candidate protein with different epitope tags 
under the control of a copper inducible promoter. Dof had a FLAG epitope tag on its N-terminus 
(FLAG-Dof) whereas interacting candidates had an N-terminal HA epitope tag. If more than one 
interactor clone was found in yeast coding for the same gene the longest cDNA clone was expressed 
in S2 cells, even if it represented only C-terminal parts of the protein. If 5’ UTR was included in the 
yeast clone it resulted than additional N-terminal amino acids. As only alteration the reading frame 
of interactor clones was changed if the original yeast clone was not in frame with the Gal4 
activation domain. Immunoprecipitation assay was carried out on lysates of S2 cells expressing 
FLAG-Dof together with the listed candidates. Interaction was tested by precipitating the 
interacting candidate via the HA epitope tag and monitoring the co-precipitation of FLAG-Dof and 
vica versa. To precipitate FLAG-Dof, in addition to the FLAG epitope tag also Dof specific 
antibody was used, thereby increasing the reliability of the assay. 
As an independent analysis for potential interaction, co-localisation studies were performed 
with some of the candidates in transiently transfected Drosophila S2 cells. 
 
2.1.1 Summary of Dof interaction data 
 
The immunoprecipitation results of Dof with the yeast interactors are summerised in Figure 
7. An interaction was verified as positive if co-precipitation of FLAG-Dof or the interactor clone (i-
clone) was detected at least in one immunoprecipitation reaction. A positive interaction was defined 
as strong if FLAG-Dof co-immunoprecipitated the interactor and vice versa. If co-precipitation was 
observed only from the side of the one protein it was defined as weak interaction. No interaction 
ment complete failure of co-precipitation. 
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Figure 7. Interaction of Dof with yeast two hybrid interactors in immunoprecipitation assay in S2 cells. Clones 
isolated in the yeast two hybrid screen and selected for Dof interaction assay are listed on the left. The gene 
represented by the interaction clone is given in the next column. Number of clones: the number of clones of 
the corresponding gene found in the screen. Frame: open reading frame of the i-clone transcript relative to 
the Gal4 activation domain in the yeast expression vector. 0 denotes the reading frame identical with that of 
the activation domain (in-frame fusion). Domain structure is represented of the protein encoded by the 
interacting clone. The reference transcript is shown as a thin bar, the open reading frame as a thick bar, 
described protein domains and PFAM motifs are shown as rectangles indicating their names above the 
diagram. Part of the transcript coded by the interacting clone is shaded in blue; if more than one clone was 
identified of the gene, the position of the first amino acid of the shortest clone is indicated by an arrow. 
Immunoprecipitation assay of i-clones with Dof: first column shows if i-clone was successfully expressed in 
S2 cells. For immunoprecipitation three antibodies (columns FLAG, Dof and HA) were used. + in columns 
FLAG and Dof means that the i-clone co-precipitated with FLAG-Dof. + in column HA means that FLAG-Dof 
co-precipitated with the i-clone. Minus indicates no co-precipitation, + weak co-precipitation and question 
mark stays if the co-precipitation could not be reliably detected. Strong interaction, co-precipitation was  
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Out of the 16 candidates selected for cell culture experiments three did not give conclusive 
results due to unsufficient protein levels for biochemical analysis (i249, i6, and i163). The clone 
i173 was not finally included in the analysis (for details see Subchapter i173). The twelve candidate 
proteins, which showed high expression levels in S2 cell lysates divided into three groups according 
their interaction behaviour with Dof. Eight of them showed strong interaction (Dof, Heartless, i19, 
i51, i234, i25, i188 and i14). Three candidates – i8, i77 and i133 – fell into the weak interaction 
category. Although i77 belonged to the class of strong interactors upon the criteria defined above, 
we considered it as weak interactor because the co-expression of SUMO protein was required for 
efficient interaction with Dof. i184 was the only candidate that clearly failed to interact with Dof in 
the cell culture assay. 
In summary, none of the candidates of the Ade2 positive group, thus, interactors which grow 
also at more stringent selection conditions in yeast belonged to the no interaction category. 
Furthermore, many of the Ade2 negative yeast interactors showed strong interaction with Dof in S2 
cells. Thus, members of both groups behaved as equally potent candidates. In general, the yeast two 
hybrid screen appeared as a reliable pre-selection for proteins that were able to form a complex with 
Dof in Drosophila S2 cells. 
The analysis of the individual candidates is presented in the following subchapters. 
 
2.1.2 Signalling molecules 
 
Dof self-association 
 
In the yeast two hybrid screen Dof as bait interacted with 9 clones representing C-terminal 
fragments of Dof itself (Battersby et al., 2003). 
In our experiments full length Dof was taken with N-terminal FLAG and HA epitope tags and co-
expressed in S2 cells. In Western blot of lysates we always detect a band of the size predicted for 
Dof (113 kDa), and additional bands that migrate at about 72 kDa and 100 kDa (Figure 8), which 
represent N-terminal fragments of Dof, since they are recognised by antibodies directed against the 
N-terminal epitope tags. Chapter 2.5 discusses a detailed analysis of these fragments. We performed 
immunoprecipitations of cell lysates with antibodies against Dof or the epitope tags and analysed 
them on Western blots (Figure 8). The FLAG and HA antibodies precipitated the appropriately 
tagged proteins, and the Dof antiserum precipitated both constructs. In addition, 
immunoprecipitation made with anti-FLAG antibody also contained proteins marked with the HA-
tag and vice versa. This indicates that FLAG-Dof and HA-Dof were present in one complex. Yeast 
two hybrid data showed that the presence of the C-terminal tail of Dof weakened self-association 
and proposed a model of “closed” conformation where self-association is based on intramolecular 
interaction. Our result shows that even in the presence of the C-terminal part of the protein, Dof is 
able to form dimers or multimeric complexes in S2 cells. However, this was an overexpression 
situation, and in vivo protein levels are not known for comparison. The probability of complex 
formation and the existence of different conformations might be concentration dependent. Nor can 
be excluded that certain factors, which are absent in Drosophila S2 cells might influence Dof self-
association in vivo. 
 
 
 
observed in both directions; weak, only the one protein pulled down successfully the other; no interaction, 
the proteins did not co-precipitate. n.d., no data. Modified and extended from (Battersby et al., 2003). 
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Figure 8. Interaction of Dof with itself. N-terminally FLAG and HA epitope-tagged Dof proteins were 
expressed transiently in Drosophila S2 cells under the control of the metallothionein promoter. At 24 hours 
after induction, cell lysates were immunoprecipitated with anti-FLAG, anti-Dof or anti-HA antibodies. Western 
blots were probed for the tagged proteins by anti-FLAG (left) or by anti-HA (right) antibodies. The “input” 
lanes contain 15 µl of lysate (one-sixth of the amount used for each immunoprecipitation); in each “IP” lane 
one third of an immunoprecipitation is loaded. The asterisks mark the heavy chain of the antibodies used for 
immunoprecipitation. Black arrowhead marks full length Dof, white arrowhead N-terminal Dof fragment. 
 
Heartless  
 
Five clones representing four different C-terminal fragments of Heartless, the one 
Drosophila FGF-receptor homologue were found to interact with Dof in yeast (Battersby et al., 
2003). Breathless, the other FGF-receptor homolog in flies was not found in the screen, but in a 
direct test it also showed positive interaction with Dof (Wilson et al., 2004).  
In the cell culture assay Heartless was tested for interaction. In this case we did not use the 
same fragment found in the screen, but co-expressed FLAG-Dof with a constitutively active form of 
Heartless bearing a double HA epitope tag on its C-terminus. This construct contained the entire 
intracellular part and transmembrane domain of Heartless fused to the dimerisation domain of the 
C1 protein of the λ phage. It forms dimers in the cell membrane and therefore is constitutively in an 
autophosphorylated, activated form (Wilson et al., 2004). Immunoprecipitation was performed from 
cell lysates with antibodies against Dof or the epitope tags and analysed on Western blots (Figure 
9.). The FLAG and Dof antibodies precipitated Dof, and the HA antibody precipitated Heartless. In 
addition, the FLAG and Dof antibodies co-precipitated the HA-tagged receptor and the HA 
antibody pulled down the Dof specific bands detectable with FLAG antibody. This confirms the 
yeast two hybrid data and indicates that FLAG-Dof and activated Heartless form a complex in S2 
cells. A detailed study of Heartless-Dof interaction is presented in Chapter 2.2. 
 
i19 
 
Three independent clones were isolated in the screen that code for the gene CG31536, also 
named as CDEP. CDEP is a putative guanine nucleotide-exchange factor (GEF) for Rho family 
GTPases. Its close homologue, human CDEP (chondrocyte derived ezrin protein) represents a novel 
GEF for Rho family GTPases with transforming activity and may play a role in mediating or 
modulating the action of cAMP-elevating hormones on maturing chondrocytes (Koyano et al., 
2001). Both proteins show the same domain architecture. They contain a RhoGEF/Dbl/DH domain,  
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Figure 9. Constivutively active form of Heartless interacts with Dof in S2 cells. Lysates from Drosophila S2 
cells coexpressing a constitutively active, HA-tagged form of Heartless and a FLAG-tagged full-length Dof 
protein were used for immunoprecipitation (IP) with antibody against FLAG, Dof or HA or control beads 
without antibodies. IPs were analysed by SDS-PAGE together with cell lysate (input). Western blots were 
probed for the tagged proteins by anti-FLAG (left) or by anti-HA (right) antibodies. The “input” lanes contain 
15 µl of lysate (one-sixth of the amount used for each immunoprecipitation); in each “IP” lane one third of an 
immunoprecipitation is loaded. 
 
two C-terminal Pleckstrin-homology (PH) domains and a FERM (4.1-ezrin-radixin-moesin) domain 
at their N-terminus, which potentially mediates association to the cytoskeleton. 
The i19 clone lacks the major part of the FERM domain (see Figure 7). The clone is 
detected at 85 kDa on Western blots of S2 cell lysates expressing the HA-tagged form of i19. It 
behaved as strong interactor in the immunoprecipitation assay (Figure 10A). Interestingly, the HA 
antibody pulled down a FLAG specific band corresponding the size of full length Dof but not the 
other, even more intense band about 72 kDa detectable in lysate and FLAG/Dof 
immunoprecipitates. It is a unique behaviour among the interactors tested and might indicate that 
i19 binds to a C-terminal part of Dof, which is not present in the 72 kDa N-terminal fragment.  
Nevertheless it has to be considered that the N-terminal fragment contains the DBB domain (see 
chapter 2.5), which is required and sufficient for dimerisation (Battersby et al., 2003). Therefore an 
N-terminal Dof fragment could be simply present as a consequence of Dof self-association. Since 
there is no N-terminal Dof fragment detectable, it cannot be excluded that binding of i19 to a C-
terminal part of Dof simultaneously inhibits Dof self-association. In yeast interaction studies i19 
was mapped to bind either to a region in the N-terminus or a region within or in the vicinity of the 
coiled coil motif in Dof (Battersby et al., 2003). 
 
i51 
 
One single clone belonging to the Ade2 negative group was identified in the screen which 
coded for the gene GAP69C. It codes a homologue of the adenosine diphosphate-ribosylation factor 
1 (Arf1) GTPase activating protein (GAP) ASAP1 (Brown et al., 1998). Arf GTPases are best 
characterised to regulate membrane trafficking but they have also role in cytoskeletal organisation. 
ASAP1 localises to focal adhesions and regulates cytoskeletal remodelling (Randazzo et al., 2000). 
Loss of GAP69C function resulted gaps in the embryonic tracheal network (Battersby, 2001), an 
indication that it might act on same developmental processes as Dof. In that assay the gene was 
removed as a part of a big deletion on the left arm of the 3. chromosome. Null alleles of the gene 
generated by imprecise P-element excision are homozygous viable and fertile and show no apparent 
abnormal phenotype (Frolov and Alatortsev, 2001), suggesting that the phenotype of the deficiency 
was caused by the removal of other genes of the region and indicating that Gap69C is not essential 
for tracheal development. 
i51 cDNA lacks the first 29 amino acids of the predicted GAP69C protein. The protein is 
detected at 50 kDa on Western blots of lysate from S2 cells expressing HA-i51 (calculated 
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molecular size 47 kDa). Western blots of the immunoprecipitation assay are shown on Figure 10B. 
The FLAG and Dof antibodies precipitate Dof, and the HA antibody precipitates i51 (please note, 
the heavy chain of the HA antibody used for IP has similar molecular size, and so overlaps with the 
HA-i51 specific band). It is plausible to detect any HA specific bands in the protein fraction 
precipitated by the FLAG antibody because it might be masked by the heavy chain of the FLAG 
antibody used for IP. Nevertheless the Dof antibody co-precipitates HA-i51 and the HA antibody 
pulls down preferentially the N-terminal fragment of FLAG-Dof. At very long exposure time the 
FLAG specific band corresponding to the full length Dof is also detectable (data not shown), but it 
is no more in a range, that statements could be given about quantitative ratios of the two bands in 
the different IPs. This result confirms the yeast data and indicates that Dof is able to form a 
complex with GAP69C in cells. 
 
i249 
 
A single clone was identified in the yeast two hybrid screen that encoded the gene racGAP50C, 
also known as DracGAP. It is member of the Ade2 negative interactor group and furthermore it was 
not in the same reading frame as the Gal4 activation domain - two features, which weaken the 
validity of yeast interaction data. What curioused our interest was that it was described as negative 
regulator of Rho family GTPases DRac1 and DCdc42 and showed genetic interaction with the 
EGFR/Ras pathway during wing development and morphogenesis (Sotillos and Campuzano, 2000). 
The N-terminally HA epitope tagged, frame corrected version of i249 was expressed together 
with FLAG-Dof in S2 cells. Two weak bands were detected on Western blots of cell lysate stained 
with HA specific antibody: the smaller one with a size corresponding to the calculated molecular 
size of i249 (62 kDa) (Figure 10C). In immunoprecipitation experiments the protein failed to 
precipitate to a detectable level on Western blots. Thus, i249, a truncated form of DracGAP lacking 
the first 66 amino acids of the protein might be unstable due to incorrect folding in the cells or cells 
might not tolerate and so downregulate high levels of the protein by degradation. In consistent with 
this, very weak expression of i249 was detectable in immunostained S2 cells (data not shown). 
  
i173 
 
A single clone was identified in the yeast two hybrid screen that encoded the gene RACK1 
(Receptor for Activated C Kinase). It belonged to the Ade2 negative interactor group. The cDNA 
contained 5’UTR regions of the gene and was not in frame with the Gal4 activation domain. In a 
retest with different mutant Dof constructs in yeast it showed no interactions (Battersby et al., 
2003). Several Rack1 clones were isolated in an independent yeast two hybrid screen using Dof as 
bait (M. Affolter, personal communication). Therefore it seemed initially to be a good control for  
 
 
 
 
Figure 10. Immunoprecipitation assay of Dof with i-clones encoding different signalling molecules and the 
Drosophila claudin sinuous. FLAG epitope tagged Dof and HA epitope tagged i-clones were co-expressed in 
S2 cells. Cell lysates were immunoprecipitated (IP) with anti-FLAG, anti-Dof or anti-HA antibodies. IPs were 
analysed by SDS-PAGE together with cell lysate (input). Western blots were probed for the tagged proteins 
by anti-FLAG (left) or by anti-HA (right) antibodies. The “input” lanes contain 15 µl of lysate (one-sixth of the 
amount used for each immunoprecipitation); in each “IP” lane one third of an immunoprecipitation is loaded. 
The asterisks mark the heavy and light chains of the antibodies used for immunoprecipitation. Arrows mark 
co-precipitating FLAG-Dof and HA-i-clones respectively. 
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the validity of the yeast data of our laboratory. The 5’ sequence of the i173 cDNA contains two 
STOP codons in the 5’ UTR in the first reading frame, one STOP codon in the 5’ UTR in the 
second frame (RACK1 ORF), and the third frame gave rise a peptide of 45 amino acids in length 
and completely unrelated to RACK1. Hence, even if there is a real interaction existing between the 
molecules it had been hazardous to base any further biochemical analysis on these yeast data. Thus, 
interaction assay was not performed with this clone in S2 cells. 
 
i234 
 
One single Ade2 negative clone was identified in the screen that coded a small C-terminal 
fragment of the B’ regulatory subunit of  Protein Phosphatase type 2A (PP2A-B’) (see Figure 7). 
PP2A has been shown to be involved in the regulation of signal transduction, cell proliferation, 
apoptosis and establishment of planar polarity (Lechward et al., 2001; Ory et al., 2003; Van Hoof 
and Goris, 2003). The regulatory subunits determine substrate specificity and subcellular 
localisation of the holoenzyme. 
The N-terminally HA epitope tagged version of i234 was expressed together with FLAG-Dof in 
S2 cells. On Western blots of lysates several bands were detected with the HA antibody, one with 
the predicted molecular size of i234 (45 kDa) (Figure 10D). Western blots of immunoprecipitation 
experiments are shown in Figure 10D. FLAG and Dof antibodies precipitated Dof, but it is not 
detectable if an HA specific band was present with a corresponding size for i234 in these protein 
fractions, because the heavy chains of the antibodies used for immunoprecipitation masked this part 
of the blot. The HA antibody precipitated all HA specific bands detected in the lysate and in 
addition, pulled down proteins recognised by the FLAG antibody. It indicates that FLAG-Dof was 
present in a complex containing the HA-tagged i234. 
 
2.1.3 Cytoskeleton proteins 
i6 
 
Four clones showed interaction with Dof in the yeast two hybrid screen that encoded the β-
spectrin gene. β-spectrin is essential component of the cortical cytoskeleton which confers 
mechanical stability to the membrane by establishing a bridge between the plasma membrane and 
the actin cytoskeleton (Bray, 2000). Its N-terminal calponin homology domains bind actin, while 
the C-terminal PH domain anchors it to the plasma membrane. A long stretch of 17 spectrin repeats 
space the two different binding motifs. 
The i6 clone contains the last 3 spectrin repeats and the PH domain. We expressed the N-
terminally HA epitope tagged version of i6 with FLAG-Dof in Drosophila S2 cells. On Western 
blots of lysates we failed to detect any bands with the HA antibody (data not shown). Hence, the 
clone might be a structurally unstable truncation of the molecule. Alternatively HA-i6 might be 
insoluble under the lysis conditions used preparing the samples for immunoprecipitations. 
 
i8 
 
A single clone of the Ade2 positive group of the yeast two hybrid screen encoded the gene 
sinuous. The clone was out of the reading frame of the Gal4 activation domain and contained 
RESULTS 
 28
5’UTR region of the gene. After cloning into the correct reading frame (5’UTR was retained) it 
failed to interact with Dof in yeast (Battersby, 2001). 
Sinuous was initially found in a screen for genes, which control epithelial tube size in the 
Drosophila tracheal system (Beitel and Krasnow, 2000), and recently described as a Drosophila 
claudin required for septate junction organisation in other epithelial tubular compartments (Wu et 
al., 2004). Arthropod septate junctions function as paracellular barriers and are considered to be 
analogous to the vertebrate tight junctions (Anderson, 2001; Tepass et al., 2001). 
The N-terminally HA epitope tagged, in-frame version of i8 was expressed together with FLAG-
Dof in S2 cells. To elucidate the specific expression of the tagged proteins, immunocytochemistry 
was carried out on these cells (Figure 11C-F). i8 was visualised via its HA tag and showed tight 
membrane localisation. It was consistent with the fact, that claudins are four-transmembrane 
domain proteins. In addition, FLAG-Dof showed a higher membrane enrichment in the presence of 
HA-i8, than if it was expressed alone (compare to Figure 11B). On Western blots of lysates stained 
with HA specific antibody despite our expectations to detect i8 at its predicted molecular size of 32 
kDa, numerous bands of diverse sizes appearing as a “smear” were observed (Figure 10E). This 
phenomenon was dependent on the expression of i8 and not unspecific binding of the HA antibody 
to proteins of the S2 cell lysate (compare lysates containing other HA-tagged interactors). In 
immunoprecipitation experiments the proteins precipitated by the HA antibody contained an intense 
band, which might correspond to HA-i8, but still several higher molecular weight bands were 
detected by the HA antibody (Figure 10E). In addition, this precipitate contained a band with a 
corresponding size of a FLAG-Dof N-terminal fragment detected by the FLAG antibody. FLAG 
and Dof immunoprecipitates contained bands of the FLAG-Dof construct, but no bands recognised 
by the HA antibody. 
Thus, these results show, that HA-i8 was specificly recognised in cells by the HA antibody. The 
“smear” like appearance on Western blots might be a consequence of unsatisfactory solubilisation 
of the transmembrane protein, trapped in micelli which might not have been resolved on SDS-
PAGE. It might have trapped other proteins, which made interpretations of this interaction assay 
unreliable. 
 
2.1.4 Components of the SUMOylation machinery 
 
SUMOylation is a related enzymatic mechanism to ubiquitination. The covalent attachment of 
SUMO (small ubiquitin-like modifier) to lysine side-chains of substrates requires E1 activating 
enzymes, E2 conjugating enzymes and E3 ligases, which provide selectivity to the system through 
their diversity (reviewed (Johnson, 2004)). Dof contains 4 potential consensus SUMO binding sites 
(see introduction), therefore it was exciting to find known or potential components of the 
SUMOylation pathway among the yeast interactors. Here are discussed only aspects of interaction 
of these proteins with Dof, a detailed study about Dof SUMOylation, as potential posttranslational 
modification is described in Chapter 2.4. 
 
i77 
 
Five transcripts of the Drosophila Ubiquitin-conjugating enzyme 9 (Ubc9) gene, also known as 
lesswright/semushi (Apionishev et al., 2001; Epps and Tanda, 1998) were isolated in the yeast two 
hybrid screen representing one to five amino acid shorter clones than the full length protein. They 
were in-frame, Ade2 positive interactors (see Figure 7). Ubc9 encodes a SUMO-conjugating 
enzyme. 
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Figure 11. Subcellular localisation of Dof and several i-clones in Drosophila S2 cells. S2 cells 
overexpressing FLAG epitope tagged Dof (A,B) alone or together with HA epitope tagged (C-F) i-8, (G-J) i-
77, (K-N) i-188, (O-R) i133 or (S-V) i-163 are stained with (A,C,G,K,O and S) DAPI to visualise nuclear DNA 
and with antibodies directed against (B,D,H,L,P and T) Dof and the (E,I,M,Q and U) HA epitope to detect 
localisation of Dof and of the i-clones respectively. F,J,N,R and V are merged images of the three stainings 
in case of each cell co-expressing Dof and an i-clone. Scale bar 2 µm.  
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Expressing the N-terminally HA epitope tagged version of i77 with FLAG-Dof in Drosophila S2 
cells we failed to detect any interaction of the proteins (data not shown). SUMOylation is a 
conserved posttranslational modification from yeast to human. We wondered whether Drosophila 
Ubc9 might utilise Smt3, the yeast SUMO peptide to modify and thereby interact with Dof. In other 
words, a potential additional essential component might be present in yeast to allow effective 
enzyme-substrate interaction. Based on this hypothesis we extended the cell culture co-transfection 
assay with an activated form of Drosophila Smt3. To elucidate the localisation and specific 
expression of the tagged proteins immunocytochemistry was carried out on these cells (Figure 11G-
J). i77 showed cytosolic localisation highly enriched at the membrane. FLAG-Dof showed a diffuse 
cytosolic distribution in the presence of HA-i77. Western blots of immunoprecipitation experiments 
are shown in Figure 12A. The Dof antiserum co-precipitated HA-i77 but in case of the FLAG 
antibody it could not be reliably detected because of the similar running behaviour of the light chain 
of the FLAG antibody. The HA antibody pulled down a band, which was recognised by the FLAG 
antibody and might correspond to an N-terminal fragment of the FLAG-Dof protein. This confirms 
the yeast two hybrid data and indicates that FLAG-Dof and HA-Ubc9 interacted in S2 cells in the 
presence of the activated form of Smt3. This initiated further analysis to reveal if Dof is a potential 
Ubc9 substrate (see Chapter 2.4). 
 
 
i184 
 
A single clone of the Ade2 negative interactor group was isolated in the screen that encoded the 
gene su(var)2-10, synonymous with dzimp or dpias. The transcript represents a new, 
uncharacterised C-terminal isoform of dpias (G. Karpen, personal communication). dpias is the 
Drosophila homologue of the mammalian protein inhibitor of activated stat (PIAS) gene family, 
which has been shown to encode a SUMO E3 ligase (Kotaja et al., 2002). 
Western blots of immunoprecipitation experiments from lysates of S2 cells expressing the N-
terminally HA epitope tagged version of i184 together with FLAG-Dof in Drosophila S2 cells are 
shown on Figure 12B. Both proteins could be detected in lysates via their epitope tags and 
immunoprecipitates of the antibodies contained bands with corresponding size of the appropriately 
tagged proteins (HA-i184 15 kDa), but we failed to detect any co-immunoprecipitation of the 
proteins. It is in contradiction with the yeast data and indicates that FLAG-Dof is not able to form a 
complex with HA-i184 in S2 cells under the conditions we tested. 
 
2.1.5 Other candidates 
i25 
 
One clone was identified among the Ade2 negative interactors that encoded the gene gustavus. It 
has been shown that gustavus directly interacts with VASA, a key protein in establishing the 
specialised translational activity of the Drosophila pole plasm and so is essential for the posterior 
localisation of VASA (Styhler et al., 2002). Like VASA, it localises to cytoplasmic 
ribonucleoprotein particules. Gustavus is primarily expressed in the ovaries and its transcript is 
detectable in up to 8 hours old embryos by Northern analysis (Styhler et al., 2002). Gustavus is 
highly conserved and apparent orthologs are present in a wide range of animal species with so far 
unknown function. It contains a SOCS domain at its C-terminus, initially discovered in SH2 
domain-containing proteins of the suppressor of cytokine signalling (SOCS) family (Hilton et al., 
1998). In mammalian cells, SOCS box can bind the elongin BC complex, an association proposed  
RESULTS 
 31
 
 
Figure 12. Immunoprecipitation assay of Dof with i-clones encoding components of the sumoylation 
machinery. FLAG epitope tagged Dof was co-expressed (A) with HA epitope tagged i-77 (Ubc9) and 
activated form of SUMO or (B) with HA epitope tagged i-184 (dpias) in S2 cells. Cell lysates were 
immunoprecipitated (IP) with anti-FLAG, anti-Dof or anti-HA antibodies. IPs were analysed by SDS-PAGE 
together with cell lysate (input). Western blots were probed for the tagged proteins by anti-FLAG (left) or by 
anti-HA (right) antibodies. The “input” lanes contain 15 µl of lysate (one-sixth of the amount used for each 
immunoprecipitation); in each “IP” lane one third of an immunoprecipitation is loaded. The asterisks mark the 
heavy and light chains of the antibodies used for immunoprecipitation. Arrows mark co-precipitating FLAG-
Dof and HA-i-77(Ubc9) respectively. 
 
to target proteins to ubiqutination (Kamura et al., 1998). It has a SPRY domain, first identified in 
ryanodine receptors, which mediate Ca2+ release from the sarcoplasmic reticulum (Ponting et al., 
1997).  
Western blots of immunoprecipitation experiments from lysates of S2 cells expressing N-
terminally HA epitope tagged version of i25, which contained the full length coding sequence of 
gustavus together with FLAG-Dof are shown in Figure 13A. The proteins precipitated by the HA 
antibody contained a band of 30 kDa recognised by the HA antibody, corresponding to the size of 
HA-i25. In addition, the FLAG and Dof antibodies co-precipitated HA-i25 and the HA antibody 
pulled down specifically a band, which was recognised by the FLAG antibody and might 
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correspond to an N-terminal fragment of the FLAG-Dof protein. This confirms the yeast two hybrid 
data and indicates that FLAG-Dof and HA-i25 were present in a complex in S2 cells. 
 
i188 
 
A single in-frame clone of the Ade2 negative interactor group was found in the screen that 
encoded the predicted gene CG11275. The gene is primarily expressed in midembrionic stages in 
the head region and in the hindgut during Drosophila embryogenesis (Battersby et al., 2003). 
Sequence based structural analysis predicts an N-terminal BTB/POZ (Bric à brac-Tramtrack-
Broad/Pox virus-Zinc finger) protein-protein interaction domain in the molecule. BTB domain 
containing proteins can be subgrouped according other domains present in the molecule. Nuclear 
BTB proteins contain in addition zinc finger or Pipsqueak type DNA binding motifs and are 
transcription factors. An actin binding kelch domain is present in actin-associated BTB proteins of 
the Drosophila Kelch family (Stogios and Prive, 2004). Many BTB proteins, like CG11275 do not 
have other recognisable conserved domains. It has been shown that BTB proteins are substrate-
specific adaptors in an SCF-like (Skp1-Culin1-F-box protein complex) modular ubiquitin ligase 
(Furukawa et al., 2003; Xu et al., 2003). They bind directly Cullin3, but not other cullins via the 
BTB domain, whereas their C-terminal part serves for substrate specificity of the ubiquitin ligase 
complex. Thus, BTB proteins merge the functional properties of Skp1 and F-box proteins into a 
single polypeptide. 
The N-terminally HA epitope tagged version of i188, which lacked most part of the BTB domain 
of CG11275 was expressed together with FLAG-Dof in S2 cells. To study the localisation and 
specific expression of the tagged proteins, immunocytochemistry was preformed on these cells 
(Figure 11K-N). Both HA-i188 and FLAG-Dof showed diffuse cytosolic distribution and 
furthermore complete co-localisation. In immunoprecipitation experiments using lysates from these 
cells both proteins co-precipitated each other  (Figure 13B). These experiments were repeated with 
full length CG11275 and showed, that the BTB domain does not alter the localisation of the protein; 
CG11275 co-localised with FLAG-Dof in the cytosol (data not shown). It also showed interaction 
with FLAG-Dof in the immunoprecipitation assay of S2 cell lysates (data not shown). These results 
are consistent with the yeast two hybrid data and indicate that FLAG-Dof and HA-CG11275 formed 
a complex in S2 cells. In addition, we showed that CG11275 is present in the cytosol of S2 cells. 
 
i14 
 
10 clones were found that contained cDNAs of the gene RpS10b. None of the clones were in-
frame fusion of the Gal4 activation domain, and all contained 5’UTR region of the gene. RpS10b 
encodes for the fly ribosomal subunit S10. The Drosophila genome contains another homologue for 
RpS10, RpS10a. Both are predicted genes without functional studies (http://www.flybase.org). 
The N-terminally HA epitope tagged, in-frame version of i14 was expressed together with 
FLAG-Dof in S2 cells. Western blots of immunoprecipitation experiments are shown in Figure 
13C. The FLAG and Dof antibodies precipitated Dof, and the proteins precipitated by the HA 
antibody contained a band of smaller than 20 kDa recognised by the HA antibody, corresponding to 
the size of HA-i14. In addition, the Dof antiserum co-precipitated HA-i14. In case of the precipitate 
with the anti-FLAG antibody the HA-i14 specific band was masked by the light chain of the 
antibody. The HA antibody pulled down bands, which were recognised by the FLAG antibody. This 
indicates that FLAG-Dof was present in a complex with HA-tagged i14 in S2 cells. A detailed 
analysis of Dof - RpS10 interaction is described in Chapter 2.5, where potential translational 
regulation of Dof is discussed. 
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Figure 13. Immunoprecipitation assay of Dof with i-clones encoding for diverse proteins. FLAG epitope 
tagged Dof was co-expressed with HA epitope tagged (A) i-25, (B) i-188, (C) i-14 or (D) i-133 in S2 cells. Cell 
lysates were immunoprecipitated (IP) with anti-FLAG, anti-Dof or anti-HA antibodies. IPs were analysed by 
SDS-PAGE together with cell lysate (input). Western blots were probed for the tagged proteins by anti-FLAG 
(left) or by anti-HA (right) antibodies. The “input” lanes contain 15 µl of lysate (one-sixth of the amount used 
for each immunoprecipitation); in each “IP” lane one third of an immunoprecipitation is loaded. The asterisks 
ark the heavy and light chains of the antibodies used for immunoprecipitation. Arrows mark co-precipitating 
FLAG-Dof and HA-i-clones respectively. 
 
RESULTS 
 34
2.1.6 Nuclear proteins 
 
Next we validated Dof-interaction with nuclear proteins by choosing two Ade2 negative 
interactors representing components of two basic chromatin binding complexes. 
 
i133 
 
Five independent clones were isolated in the screen that coded for the gene bap60. It is an 
essential component of the Brahma complex, the Drosophila homolog of the yeast SWI/SNF 
nucleosome remodelling complex (Moller, 2003).  
The N-terminally HA epitope tagged version of i133, a full length cDNA clone of bap60 was 
expressed together with FLAG-Dof in S2 cells. In immunostained cells HA-i133 co-localised with 
nuclear DNA and FLAG-Dof showed diffuse distribution (Figure 12O-R). We performed 
immunoprecipitations of lysates with antibodies against Dof or the epitope tags and analysed them 
on Western blots (Figure 13D). The FLAG and Dof antibodies precipitated Dof, and the proteins 
precipitated by the HA antibody contained a band of 70 kDa recognised by the HA antibody, 
corresponding to the size of HA-i133. In addition, the Dof antibody, but not the FLAG antibody 
pulled down a weak protein band, which was recognised by the HA antibody. The HA antibody 
immunoprecipitate did not contained bands detectable by FLAG antibody. Considering that FLAG-
Dof is processed in S2 cells C-terminal fragments of Dof might exist which can be precipitated only 
with the Dof antiserum. This suggests that HA-Bap60 might bind to C-terminal fragments of 
FLAG-Dof, which could not be precipitated and detected via the N-terminal FLAG epitope tag. 
 
i163 
 
Two independent interactor clones encoded the gene bip2/dTAFII155. Based on sequence 
homology, conserved domain structure (N-terminal Histon fold and C-terminal PHD finger) and 
biochemical interaction assays bip2 belongs to the familiy of TATA-box binding protein (TBP) 
associated factors (TafII) that together with TBP form TFIID, a general factor required for accurate 
and regulated transcription initiation by RNA polymerase II (Gangloff et al., 2001). Bip2 was found 
to interact with the BTB/POZ domain of the transcription factor Bric à brac, highlighting a direct 
link between transcriptional regulators and the basic transcription machinery (Pointud et al., 2001). 
The N-terminally HA epitope tagged version of i163, which lacked the N-terminal third of Bip2 
was expressed together with FLAG-Dof in S2 cells. Nuclear accumulation of HA-i163 was 
confirmed by immunocytochemistry (Figure 11S-V). Although it was expressed in cells, we failed 
to detect any bands on Western blots of lysates with HA antibody (data not shown). It indicates that 
the protein was not soluble under the lysis conditions used to prepare the sample for 
immunoprecipitation. We did not follow up the later possibility. 
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2.2 Interaction study of Dof with the FGF receptor Heartless 
 
It has been shown that Dof interacts with both Drosophila FGF receptors in yeast (Battersby et 
al., 2003). Heartless as well as Breathless constructs lacking the N-terminal smaller lobe of the 
kinase domain were found as minimal region for Dof binding (Battersby et al., 2003). This region 
of the molecules on its own has no known catalytic activity and is unlikely to be tyrosine-
phosphorylated in yeast indicating that Dof interacted with an unphosphorylated fragment of  the 
two FGF-receptors. Cell culture interaction assays indicated that Dof forms a complex with the 
constitutively active form of Heartless (λHtl) (see Chapter 2.1). These suggest that FGF receptors 
might bind Dof independently from their activated state in a constitutive manner. Nevertheless the 
two data sets derived from different experimental approaches, which might not be directly 
comparable. To bypass this problem cell culture interaction studies were extended with different 
Heartless constructs. 
 
2.2.1 Interaction of different forms of Heartless with Dof 
 
Full length wild type Heartless in C-terminal fusion with a double HA epitope tag was expressed 
with FLAG-Dof in Drosophila S2 cells. Immunoprecipitation experiments showed that wild type  
 
 
Figure 14. Interaction of Dof with wild type Heartless in S2 cells. Wild type Heartless bearing a double HA 
epitope tag on its C-terminus (Htl-2xHA) was expressed alone (left panel) or together with FLAG epitope 
tagged Dof (right panel) in S2 cells. Cell lysates were immunoprecipitated (IP) with anti-FLAG, anti-Dof or 
anti-HA antibodies. IPs were analysed by SDS-PAGE together with cell lysate (input). Western blots were 
probed for the tagged proteins by anti-FLAG (top) or by anti-HA (middle) antibodies and phosphorylation 
state of the precipitated proteins was checked by an antibody directed against phospho-tyrosine residues 
(bottom). Note the intense tyrosine phosphorylated protein band at approximately the size of wild type Htl. 
Note that in addition to the predicted size of full length Dof FLAG antibody detects a smaller fragment of 
similar intensity representing a breakdown product. Note in contrast, that the intensity of the two tyrosine 
phosphorylated protein bands with corresponding size to the two bands recognised by the FLAG antibody is 
different. The “input” lanes contain 15 µl of lysate (one-sixth of the amount used for each 
mmunoprecipitation); in each “IP” lane one third of an immunoprecipitation is loaded. The asterisks mark the 
heavy chains of the antibodies used for immunoprecipitation. 
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Heartless interacted with FLAG-Dof (Figure 14), however, expression of this receptor construct led  
to ligand-independent kinase activation, possibly due to dimer formation caused by overexpression 
(Figure 14, bottom panel). The proteins precipitated by HA antibody contained a band recognised 
by phospho-tyrosine antibody with a size corresponding to full length Heartless (~100kDa). In 
addition, FLAG- and Dof-IPs contained a strong and HA-IP a weak phospho-tyrosine specific band 
representing phosphorylated forms of FLAG-Dof. It was consistent with the finding, that Dof is 
phosphorylated in the presence of an activated FGF receptor (Petit et al., 2004; Wilson et al., 2004).  
To find an alternative way to assay the interaction of Dof with a nonactivated form of FGF 
receptor a kinase-dead version of the constitutively active Heartless construct was expressed with 
FLAG-Dof in Drosophila S2 cells. The specificity of this construct was that it appeared as dimer 
due to the dimerisation domain of the lambda phage C1 protein fused to the transmembrane and 
interacellular part of Heartless but due to a pointmutation in the ATP binding pocket kinase activity 
was blocked. Immunoprecipitation of cell lysates were performed (Figure 15). The kinase-dead 
version of Heartless still interacted with Dof, despite its inability to phosphorylate itself or the 
associated Dof protein. Thus, activation of Heartless by phosphorylation is not required for 
interaction with Dof, but the involvement of dimerisation still cannot be excluded. 
 
 
Figure 15. Interaction of Dof with kinase dead Heartless in S2 cells. A kinase dead form of constitutively 
dimerising Heartless bearing a double HA epitope tag on its C-terminus (λHtlKD-2xHA) was expressed alone 
(left panel) or together with FLAG epitope tagged Dof (right panel) in S2 cells. Cell lysates were 
immunoprecipitated (IP) with anti-FLAG, anti-Dof or anti-HA antibodies. IPs were analysed by SDS-PAGE 
together with cell lysate (input). Western blots were probed for the tagged proteins by anti-FLAG (top) or by 
anti-HA (middle) antibodies and phosphorylation state of the precipitated proteins was checked by an 
antibody directed against phospho-tyrosine residues (bottom). Note the lack of tyrosine phosphorylated 
protein bands in the IPs. The “input” lanes contain 15 µl of lysate (one-sixth of the amount used for each 
immunoprecipitation); in each “IP” lane one third of an immunoprecipitation is loaded. The asterisks mark the 
heavy and light chains of the antibodies used for immunoprecipitation. 
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2.2.2 Domain mapping in Dof  for receptor interaction 
 
In order to map the FGF receptor interaction domain in Dof a series of FLAG-Dof deletion 
constructs were co-expressed with constitutively active Heartless in Drosophila S2 cells and tested 
for their ability to co-immunoprecipitate with the FGF receptor (Figure 16). Deletions that did not 
affect the DBB region had minimal effects on the interaction. The first 446 amino acids were  
 
 
Figure 16. Interaction of activated Heartless with mutant forms of Dof in S2 cells. Western blots of whole cell 
lyastes and immunoprecipitations (IP) from S2 cells expressing a constitutively active form of HA epitope-
tagged Heartless (λHtl-2xHA) and mutant versions of Dof bearing N-terminal FLAG epitope tags. Protein 
complexes were immunoprecipitated from the lysates using antibody against Dof, FLAG or HA, and the 
precipitated proteins were detected on the Western blots using anti-FLAG or anti-HA antibodies. The asterisk 
marks the heavy chain of the FLAG antibody used for IP. In addition to a protein of approximately the size 
predicted for each of the constructs, in each lane there is also a smaller fragment representing a breakdown 
product. The sizes of these smaller fragments are in all cases consistent with a cleavage of Dof at the same 
position between ankyrin repeat and the coiled-coil region (see also Chapter 2.5). The five top panels are 
from the same experiment. The bottom panel is from a separate experiment to show the variation in the 
amount of Dof∆233-449 associated with the receptor. The expression levels in this experiment were the 
same as in Experiment (Exp.) I. Note that although Dof[168-1012] is not detectable in the lysate at this 
exposure, a certain amount is precipitable and (in experiment II) is able to co-precipitate the receptor. 
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sufficient for binding (FLAG-Dof1-446) and even FLAG-Dof168-1012, although expressed at very low 
levels, co-precipitated the receptor, albeit at similarly low levels. By contrast, constructs lacking the 
DBB region alone or in combination with the ankyrin repeats showed strongly reduced binding with 
certain experimental variations. It indicates that the region between amino acids 233 and 364 is 
required for efficient interaction. 
The DBB domain contains a consensus SUMOylation site at amino acid positions 296-299. The  
 
 
Figure 17. Lysine at position 297 in Dof is involved in efficient interaction of Dof with the FGF receptor 
Heartless. (A) Western blots of whole cell lysates and immunoprecipitations (IP) from S2 cells expressing a 
kinase dead version of the constitutively active HA epitope-tagged Heartless (λHtlKD-2xHA) and mutant 
versions of Dof bearing N-terminal FLAG epitope tags. Protein complexes were immunoprecipitated from the 
lysates using antibody against FLAG, and the precipitated proteins were detected on Western blots using 
anti-FLAG or anti-HA antibodies. The asterisk marks the heavy chain of the FLAG antibody used for IP. In 
addition to a protein of approximately the size predicted for each of the constructs, in each lane there is also 
a smaller fragment representing a breakdown product. Note that full length Dof had a weaker interaction with 
the mutant Heartless protein than the Dof construct lacking the last 200 amino acids (FLAG-Dof802). 
(B) Mutant Dof constructs lacking the DBB domain or bearing a point mutation in the DBB domain were co-
expressed with constitutively active (λ) or with kinase dead (KD) HA-tagged Heartless in S2 cells. Cell 
lysates were immunoprecipitated (IP) with anti-FLAG antibody. IPs were analysed by SDS-PAGE together 
with whole cell lysate. Western blots were probed for the tagged Heartless proteins by anti-HA antibody and 
the presence of tyrosine phosphorylated proteins in the IPs was detected by an antibody directed against 
phospho-tyrosine residues. The amount of precipitated mutant FLAG-Dof proteins on the Western blot is not 
shown here but was similar as in the experiment shown in panel A. Arrowhead marks phospho-protein bands 
with corresponding size of constitutively active Htl. Note that full length Dof interacted weaker with both forms 
of Heartless than the Dof construct lacking the last 200 amino acids (FLAG-Dof802). 
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mutation of this site by exchanging lysine 297 to an arginine in the context of Dof1-802 resulted in 
the complete elimination of interaction with the receptor in yeast (Battersby, 2001). This indicates 
that Lys 297 is critical in receptor binding. We tested the effect of this mutation in 
immunoprecipitation assay in the context of full length Dof as well as of Dof1-802 (Figure 17). 
Kinase dead version of the constitutively active Heartless construct was expressed with these 
mutant versions of FLAG-Dof in S2 cells. Both, full length and C-terminally truncated Dof 
constructs with the point mutation lysine to arginine at position 297 showed strongly reduced 
binding to the kinase dead receptor (Figure 17A). Their interaction affinity to Heartless was as weak 
as that of the Dof constructs lacking the DBB domain (Dof∆233-364). In addition, wild type Dof 
interacted much weaker with Heartless than the construct lacking the last 200 amino acids of Dof 
suggesting that this region might have an inhibitory effect on the binding of Dof to the FGF 
receptor. 
To reveal if lysine 297 plays also an essential role in the interaction with the activated receptor 
immunoprecipitation assay was extended to the constitutively active form of Heartless (Figure 
17B). K297R mutant Dof constructs showed as weak interaction with both receptor forms as the 
constructs lacking the DBB domain. Wild type Dof showed weak binding compared to the C-
terminally truncated Dof construct. Therefore the weak interaction of mutant Dof constructs 
containing the last 200 amino acids can not be interpreted as an effect of the mutations in the DBB 
region. However, the K297R point mutation caused significant reduction in receptor binding in the 
context of Dof[1-802]. Reduced receptor binding correlated with reduced tyrosine phosphorylation 
of the mutant Dof constructs (Figure 17B, bottom panel). Thus, these results indicate that Lys 297 
in Dof is required for efficient interaction with the FGF receptor Heartless in S2 cells. These results 
are consistent with earlier yeast data, including the fact that the presence of the C-terminal 200 
amino acids in Dof weakens interaction with the FGF receptors (Battersby, 2001). 
The fine-mapping of the interaction domain in Dof for receptor binding is summarised in Table 
2. In cell culture assays there was no difference in the behaviour of the constitutively active and the 
kinase-dead versions of Heartless indicating that ATP binding and phosphorylation of the receptor 
does not influence Dof interaction. No Dof deletion constructs were found that completely failed to 
interact with Heartless in S2 cells. Wild type Dof showed weaker interaction with Heartless than the 
truncated Dof form lacking the last 200 amino acids. Strongly reduced binding was observed in Dof 
constructs lacking regions including amino acids 233-364 as well as in Dof constructs bearing a 
point mutation at position 297. In yeast two hybrid experiments two FGF receptor fragments with 
different length were tested for interaction. Whereas the Dof construct with a 167 amino-acid N-
terminal truncation efficiently interacted with both receptor fragments, Dof ∆233-364 as well as 
constructs bearing the point mutation K297R or lacking the first 226 or 276 amino acids showed no 
or only weak interaction with the two receptor fragments, although a slight difference was observed 
in case of the two receptor fragments. These suggest that lysine 297 is an important residue in the 
interaction of Dof with Heartless but more N-terminal regions appeared also essential for receptor 
binding. Thus, the integrity of the region between amino acids 168 and 364 which spans the DBB 
domain is required for efficient receptor interaction. 
 
2.2.3 The effect of Dof binding on the activation level of Heartless in S2 cells 
 
Interaction of Dof with the FGF receptor could have the function to facilitate receptor activation. 
Dof could trigger receptor activation in vivo via two mechanisms: either by propagating the FGF 
receptors to the cell surface or by stabilising conformational changes for autophosphorylation. 
Observations that subcellular localisation of Heartless is not influenced by Dof would support the 
second way of action (Wilson et al., 2004). Alternatively or in parallel Dof could be involved in the 
transmission of the signal from the receptor. The phosphorylation of Dof in the presence of an 
RESULTS 
 40
Table 2. Interaction of the FGF receptor Heartless with mutant forms of Dof 
Yeast two hybrid assay Immunoprecipitation 
Dof constructs Htl 349-730 Htl 491-730 λHtl-2xHA λHtlkinase dead-2xHA 
Full length +/- +/- +/(+) +/(+) 
1-802 + +/- + + 
1-522 n.d. n.d. + + 
1-446 + + + + 
168-1012 + + + n.d. 
227-1012 - (+)/- n.d. n.d. 
277-1012 - +/- n.d. n.d. 
FL∆233-364 - (+)/- (+) (+) 
1-802∆233-364 n.d. n.d. (+) (+) 
FL∆233-449 n.d. n.d. (+) (+) 
1-802∆233-449 n.d. n.d. (+) (+) 
FL∆361-449 n.d. n.d. + + 
1-802∆361-449 n.d. n.d. + + 
FLK297R n.d. n.d. (+) (+) 
1-802K297R - - (+) (+) 
Mutant Dof constructs studied in the interaction assays are listed on the left. FL marks full length Dof protein. 
Numbers in the name mark either the position of the first and last amino acids present in the construct or 
beyond a “∆” sign the position of the first and last amino acids of an internal deletion. K297R labels a lysine 
to phenylalanine exchange at amino acid position 297 in the protein. 
Yeast two hybrid interaction data are summarised in the next two panels. Two fragments of the FGF receptor 
Heartless were analysed. Htl 349-730 lacks only the N-terminal first 12 amino acids of the intracellular 
domain of the receptor, Htl 491-730 lacks the N-terminal lobe of the kinase domain. Interactions were tested 
under two selection conditions. If yeast showed different growth behaviour under the two conditions, both 
results are represented in the table: first that of the less stringent than that of the more stringent selection 
separated by a slash. Note, the smaller receptor fragment showed weak interaction to a subset of Dof 
deletion constructs which failed completely to bind to the larger Htl fragment. 
Immunoprecipitation data are listed in the two right columns. Interactions were analysed with a constitutively 
active Heartless construct containing the entire intracellular part of the receptor (λHtl-2xHA) and with a 
kinase dead version of the first construct (λHtlkinase dead-2xHA). 
“+” marks strong, “(+)” weak and “-“ no interaction. “n.d.” marks no data. 
 
 
activated FGF receptor supports this model (Wilson et al., 2004). 
To see if the physical interaction of Dof with the FGF receptors influences the activation level of 
the receptors, phosphorylation state of constitutively active Heartless was monitored in S2 cells in 
the presence of Dof constructs bearing different affinity for receptor interaction (Figure 18). 
Receptor phosphorylation was slightly enhanced in the presence of Dof constructs showing high 
binding affinity for Heartless, indicating that Dof interaction might trigger receptor activation. 
However, these preliminary data require further precise quantitative analysis. This experiment did 
not reflect in vivo situation since the receptor molecules were artificially forced to dimerise by a 
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Figure 18. Effect of Dof on the phosphorylation/activation levels of the FGF receptor Heartless. Western 
blots of whole cell lyastes and immunoprecipitations (IP) from S2 cells expressing constitutively active HA-
tagged Heartless (λHtl-2xHA) alone or together with mutant Dof constructs. Protein complexes were 
immunoprecipitated from the lysates using antibody against HA, and the precipitated proteins were detected 
on the Western blots using antibodies directed against the HA epitope or phospho-tyrosine residues. 
Arrowhead marks phospho-protein bands with corresponding size of constitutively active Htl. 
 
heterologous domain, which might circumvent at least partially the need of other potential factors to 
facilitate activation and thus, might underscore the effect of such factors.  
 
2.2.4 Large Dof-FGF receptor complexes are present in S2 cells 
 
To determine the size of the protein complex Dof forms with an activated FGF receptor in S2 
cells gelfiltration experiments were performed. Whole cell lysates of stable transfectant Drosophila 
S2 cells overexpressing FLAG-Dof alone or together with a constitutively active FGF receptor were 
fractionated on a size exclusion chromatography column (Figure 19). Overexpressing FLAG-Dof 
alone the protein accumulated at a complex size of 600-750 kDa (fractions 13-14) and its 
continuous presence up to fraction 19 indicated that it was present in diverse smaller complexes 
(Figure 19B). Monomeric full length molecule would be expected in fractions 20-21 (calculated 
molecular weigth of Dof is 114 kDa). This indicates that Dof molecules without protein-protein 
association were not present in the lysate. Dof was able to interact with itself in S2 cells (see 
Chapter 2.1). This might propose that the detected complexes are Dof oligomers with different 
numbers of Dof units (tetramers or pentamers as maximum). Alternatively or in addition Dof might 
form a complex with diverse cellular components. The wide spectra of complex sizes might be 
either a reflection of independent complexes with different protein composition or the consequence 
of overexpression situation and therefore components of the complex which are expressed at lower 
levels in the cells were titrated out sequentially. 
Cell lines co-expressing FLAG-Dof and a constitutively active FGF receptor showed changes in 
the size of Dof complexes with slightly differences in the case of the two different Drosophila FGF 
receptors (Figure 19C, D). In the presence of activated Heartless Dof accumulated in fraction 16 
corresponding to a complex size of about 500 kDa, whereas in the presence of activated Breathless 
it accumulated in a somewhat larger complex with a size of about 550 kDa (fraction 15) with a 
remarkably broader distribution on the column. Both FGF receptors were detected in complexes,  
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Figure 19. The size of Dof complexes formed in S2 cells. (A) Western blots of whole cell lysate of S2 cell 
lines stably transformed as indicated above each lane with different combinations of the activated form of the 
FGF receptor Breathless (λ-Btl), the constitutively active HA-tagged Heartless (λ-Htl-2xHA), both under the 
control of a heat shock promoter and Dof with an N-terminal FLAG epitope tag under the control of the actin 
5C promoter (FLAG-Dof). The presence of the proteins following heat shock induction was monitored using 
antibodies directed against the FLAG and HA epitope tags and phospho-tyrosine residues. Black and white 
arrowheads mark phospho-tyrosine bands corresponding to the activated receptors and phosphorylated Dof 
respectively. (B-D) Size exclusion chromatography of whole cell lysates from stably transformed S2 cells 
expressing (B) FLAG-Dof, (C) FLAG-Dof and λ-Htl-2xHA or (D) FLAG-Dof and λ-Btl. Proteins from each 
fraction (fraction numbers are labelled above each lane) were collected and precipitated with trichloric acid, 
separated by SDS-PAGE and detected by Western blotting analysis using anti-FLAG antibody to detect Dof, 
anti-HA antibody for detecting λ-Htl and anti-phospho-tyrosine antibody to visualise λ-Btl as well as 
phosphorylated form of Dof, marked by black and white arrowheads on the blot respectively. Standard 
proteins were used to estimate the size of protein complexes collected in the fractions and calculated 
standard curve is given as a scale bar above the fraction numbers in B. 
 
which were 50-100 kDa larger in size compared to the major peak of FLAG-Dof complexes of the 
same lysate and so co-fractionated only partially with FLAG-Dof. Interestingly, the profile of 
tyrosine phosphorylated Dof also did not completely overlap with the general FLAG-Dof protein 
profile (Figure 19D). Its accumulation peak on the column was at about 50-100 kDa higher 
molecular weights than that of “bulk” FLAG-Dof detected via the FLAG epitope tag and thereby 
exactly co-fractionated with tyrosine phosphorylated activated Breathless. 
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These data show that activated FGF recepors co-fractionate preferentially with tyrosine 
phosphorylated Dof indicating that Dof phosphorylation might require complex formation with 
activated FGF receptors and not only their presence in the cells. The fact that non-phosphorylated 
Dof protein accumulated in fractions where FGF receptors were underrepresented suggests that Dof 
was present in receptor independent complexes. The expression level of FLAG-Dof relative to that 
of the activated receptors is not known therefore the stoichiometry of the complexes is not 
understood. Nor is understood if the FGF receptor-independent fraction of Dof is only due to 
different abundancy of the two proteins in the cells or might have physiological relevance. 
In summary, Dof is able to form high molecular weight complexes in resting cells. These 
complexes might be re-organised upon signalling, when Dof forms a complex with activated FGF 
receptors and becomes phosphorylated probably in this complex. This complex is large enough to 
contain two or more Dof molecules and probably other components in addition to the receptor 
dimer. 
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2.3 Tyrosine phosphorylation of Dof 
 
FGF receptors do not have the capability to directly bind Grb2, like other receptor tyrosine 
kinases (RTK). In order to activate the MAPK cascade they utilise adaptor molecules to bridge this 
gap. The adaptor molecule Dof forms a complex with both Drosophila FGF receptors and is 
tyrosine phosphorylated in the presence of activated FGF receptors. To see if Dof phosphorylation 
could contribute in transmitting the signal from the FGF receptor towards downstream effector 
cascades, like the MAPK pathway our first aim was to map the tyrosine phosphorylation sites in the 
molecule.  
This might then help to identify phosphorylation-dependent binding partners of Dof. 
 
2.3.1 Identification of tyrosine residues phosphorylated in Dof 
 
There are 19 tyrosines in the molecule (Figure 20A) and eight of them are located in conserved 
sequence motifs, which could serve as docking sites for the Drosophila homologues of signal 
transducer molecules Grb2, PI3K, SHP2, RasGAP or Crk in their tyrosine phosphorylated state 
(Vincent et al., 1998). We focused our attention on tyrosines of these consensus binding sites. We 
applied an indirect way to map phosphorylated tyrosines. Dof constructs bearing point mutations at 
positions of tyrosine residues were co-expressed with the constitutively active FGF receptor 
Heartless in S2 cells. The phosphorylation state of the mutant Dof proteins was monitored in cell 
lysates by an antibody specifically recognising phosphorylated tyrosine residues. Mutations that 
resulted the production of proteins containing phenylalanine residues in place of particular tyrosines 
or deleted parts of the molecule were analysed in different combinations. In vivo analysis of 
truncated forms of Dof indicated that the last 210 amino acids containing one potential RasGAP or 
Crk and four potential Grb2 docking sites (see breakpoint 802 in Figure 20) are not essential for the 
function of the molecule (Wilson et al., 2004). However, additional mutation of the three remaining 
consensus tyrosine residues at positions 97, 486 and 515 to phenylalanine resulted in a dramatic 
reduction in Dof activity in vivo suggesting that at least one of the three tyrosines is important for 
Dof function (Wilson et al., 2004). We found that the phosphorylation of this protein was not 
completely abolished in S2 cells (Figure 21B). This pointed out that tyrosines other than those lying 
within recognisable consensus binding sites for known adaptor molecules can also be 
phosphorylated. 
 
Figure 20. The distribution of tyrosine residues in Dof and a summary of tyrosine phosphorylation of mutant 
Dof constructs used in the phosphorylation assays. (A) Schematic representation of the Dof protein. Grey 
boxes and an oval label protein domains, the name of each domain is marked above the boxes/oval. DBB, 
Dof-BCAP-BANK domain; Ank., ankyrin repeats; c.c., coiled coil region; PEST, protein degradation motif. 
Each tyrosine in the protein is labelled with a coloured line+oval on the scheme; blue lines mark tyrosines not 
located in known consensus tyrosine motifs, red lines highlight tyrosine residues located in consensus 
tyrosine motifs. Signalling molecules for which these consensus tyrosine motifs could serve as binding sites 
if the tyrosine is phosphorylated are listed below each of the tyrosines. Amino acid position of these tyrosines 
is marked above each red line. Amino acid positions 446, 522 and 802 – breakpoints of Dof deletion 
constructs – are marked with grey dashed lines on the scheme. (B) Schematic representation of mutant Dof 
constructs used in the phosphorylation assays. Tyrosine residues of consensus motifs and non-consensus 
tyrosines which were mutated in some of the constructs are marked as red and blue lines respectively and 
their amino acid position is given above each line. The letters F stay for tyrosine to phenylalanine exchanges 
in the marked positions. The name of the constructs is listed on the left. Each name marks the position of the 
first and last amino acids present in the construct and the positions of the point mutations. FL labels full 
length Dof protein. Each construct was fused to the FLAG epitope tag on its N-terminus (green oval). Right 
column summarises the results of the phosphorylation assay of the mutant constructs. “+”, the construct was 
tyrosine phosphorylated, “(+)”, weak tyrosine phosphorylation, “-“, no tyrosine phosphorylation. 
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Figure 21. Comparison of the phosphorylation states of mutant Dof proteins in the presence of an activated 
FGF receptor. FLAG epitope-tagged mutant Dof constructs were expressed together with an activated form 
of HA-tagged Heartless (λHtl-2xHA) in S2 cells. Whole cell lysates were separated by SDS-PAGE, or used 
for immunoprecipitation with anti-Dof antibody. Western blots were probed using antibodies directed against 
FLAG or phospho-tyrosine residues. Black arrowheads mark the tyrosine phosphorylated protein bands 
corresponding to the activated Heartless construct. The asterisks mark the heavy chain of the Dof antibody 
used for IP. (A) With the exception of Dof[168-1012] all constructs are expressed at high levels and are 
precipitable with antibody against Dof. Note, the full length Dof protein is strongly phosphorylated, whereas 
the phospho-tyrosine signal is reduced in all of the mutants. The band for Dof[1-446] cannot be judged in this 
panel, as it might be obscured by the heavy chain of the Dof antibody. However, in the bottom panel, which 
is from a separate experiment, the signal of the heavy chain is very weak, but yet no signal for Dof[1-446] is 
visible. (B) Note, the C-terminally truncated version of Dof in which the tyrosines in the potential Grb2, PI3K 
and SHP2 consensus sites are mutated can still be phosphorylated. 
 
Analysis of further Dof deletion constructs indicated that tyrosine residues between amino acids 
446 and 802 are substrates for kinase activity (Figure 21A). Dof1-522 was the smallest N-terminal 
fragment that was efficiently phosphorylated whereas deletion of a further 76 amino acids 
(construct Dof1-446) abolished detectable phosphorylation. Since other protein bands were detected 
at the same molecular weight position on the Western blot as construct Dof1-446 we could not 
exclude its phosphorylation completely. Therefore we tested Dof1-522, which still contained the three 
consensus tyrosines for potential interaction with Grb2, PI3K and SHP2 to what extent the mutation 
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of these residues influences phosphorylation state of the molecule in S2 cells (Figure 22). All 
constructs containing different combinations of point mutations at the position of the three 
consensus tyrosines showed comparable expression levels. The introduced mutations did not 
influence the ability of the Dof constructs to interact with the constitutively active FGF receptor 
Heartless.  However, mutation of two tyrosines at the positions of the potential PI3K and SHP2 
binding sites was sufficient to abolish phosphorylation completely. Thus, this indicates that tyrosine 
residues at position 486 and 515 are substrates for phosphorylation in Dof. 
 
 
 
Figure 22. Mapping of phosphorylated tyrosine residues in the first 522 amino acids of the Dof protein. 
FLAG epitope-tagged Dof constructs containing the first 522 amino acids of Dof and different combinations 
of the tyrosine to phenylalanine point mutations at amino acid positions 97, 486 and 515, marked as (F__), 
(_F_) and (__F) respectively were expressed together with an activated form of HA-tagged Heartless (λHtl-
2xHA) in S2 cells. Protein complexes were immunoprecipitated from whole cell lysates using antibody 
against the FLAG epitope, and the precipitated proteins were detected on the Western blots using antibodies 
directed against FLAG, HA or phospho-tyrosine residues. Black arrowhead marks the tyrosine 
phosphorylated protein bands corresponding to the activated Heartless construct. The asterisk marks the 
heavy chain of the FLAG antibody used for IP. 
 
Since residues 486 and 515 were the only two tyrosines phosphorylated in the first 522 amino 
acids of Dof, the phosphorylated non-consensus tyrosine residue(s) observed in the Dof 1-802(FFF) 
construct might lie in the region between amino acids 522 and 802, which contains seven tyrosines. 
From earlier experiments we learned that the N-terminal 75 kDa Dof fragment was less strongly 
phosphorylated than the full length form (see Figure 14 in Chapter 2.2). Therefore we focused on 
five tyrosine residues at positions 592, 613, 629, 654 and 726, which are not present in the N-
terminal cleavage product of Dof (for details on Dof cleavage site see Chapter 2.5). Mutation of 
these five residues to phenylalanine in different combinations in a Dof1-802 context drew attention to 
three tyrosines at positions 592, 613 and 629, the simultaneous mutation of which caused dramatic 
reduction on the phosphorylation level of the protein (Figure 23A), indicating that they might be the 
major phosphorylation targets in the region between amino acids 522 and 802 in Dof. We aimed to 
see if all three of these tyrosines were involved in phosphorylation and if the residual 
phosphorylation observed in Dof [1-802]592F,613F,629F was due to the phosphorylation of the tyrosines 
at positions 486 and 515. Therefore, different combinations of additional point mutations were 
introduced at positions 592, 613 and 629 into the construct Dof [1-802]486F,515F and the 
phosphorylation state of the derived Dof proteins was monitored (Figure 23B). All constructs 
appeared stable in cells, albeit with slightly different expression levels, and retained their capacity  
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Figure 23. Mapping of phosphorylated tyrosine residues between amino acids 522 and 802 in the Dof 
protein. (A) FLAG epitope-tagged Dof constructs containing the first 802 amino acids of Dof and different 
combinations of the tyrosine to phenylalanine point mutations at amino acid positions 592, 613, 629, 654 and 
726 or (B) FLAG epitope tagged mutant Dof constructs containing the first 802 amino acids with tyrosine to 
phenylalanine point mutations at amino acid positions 486 and 515 and in addition different combinations of 
the tyrosine to phenylalanine point mutations at amino acid positions 592, 613 and 629 were expressed 
together with an activated form of HA-tagged Heartless (λHtl-2xHA) in S2 cells. Protein complexes were 
immunoprecipitated from whole cell lysates using antibody against the FLAG epitope, and the precipitated 
proteins were detected on Western blots using antibodies directed against the FLAG epitope or phospho-
tyrosine residues. As control for phosphorylation levels construct containing the first 802 amino acids of Dof 
without further mutations was used. Black arrowheads mark the tyrosine phosphorylated protein bands 
corresponding to the activated Heartless construct. 
 
to interact efficiently with Heartless. Increasing the number of mutated tyrosines resulted in 
stepwise reduction in the phosphorylation state of Dof leading to a complete abolishment of 
phosphorylation if all three tyrosines were exchanged. This indicates that the tyrosine residues at 
positions 592, 613 and 629 are substrates for phosphorylation. 
To test whether tyrosine residues of the last 210 amino acids of Dof contribute to the 
phosphorylation state of the protein, the five tyrosines identified as kinase substrates were 
exchanged to phenylalanine in full length Dof and the mutant construct was tested for the presence 
of phosphorylated tyrosines in the same assay as above (Figure 24). Despite the removal of the five 
potential phosphorylation sites the protein was phosphorylated at comparable levels with wild type 
Dof, suggesting that the C-terminal tail might contain multiple phosphorylation sites. The 
abundance of tyrosines within consensus binding sites for Grb2 (4 out of the 8 tyrosines of the 
region) enhances the probability that Grb2 binding sites are utilised for phosphorylation. Three of 
the other four tyrosines are in non-consensus positions and one is part of a potential RasGAP  or 
Crk docking site. 
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Figure 24. Tyrosine residues of the last 200 amino acids 
contribute to the phosphorylation of the Dof protein. Full 
length wild type Dof (FL) or full length Dof constructs with 
tyrosine to phenylalanine point mutations at amino acid 
positions 486 and 515 (FL 486F,515F) or in addition at amino 
acid positions 592, 613 and 629 (FLY5F) were expressed 
together with an activated form of HA-tagged Heartless 
(λHtl-2xHA) in S2 cells. Protein complexes were 
immunoprecipitated from whole cell lysates using antibody 
against the FLAG epitope, and the precipitated proteins 
were detected on Western blots using antibodies directed 
against the FLAG or HA epitopes or phospho-tyrosine 
residues. Black arrowhead marks the tyrosine 
phosphorylated protein bands corresponding to the 
activated Heartless construct. 
 
 
In summary, we identified five distinct tyrosine residues in Dof at positions 486, 515, 592, 613 
and 629 that might be phosphorylated in the presence of activated FGF receptors. In addition, we 
found that the C-terminal part of Dof between amino acids 802 and 1012 is also phosphorylated. 
Tyrosines 486 and 515 are located in consensus binding sites for PI3K and Corkscrew (Drosophila 
homologue of SHP2) respectively, whereas 592, 613 and 629 are not part of known motifs. Whether 
the consensus binding sites for RasGAP or Crk and Grb2 in the last 210 amino acids of Dof are 
targets of phosphorylation needs more detailed analysis. It similarly requires further studies to 
determine whether all of the tyrosines identified by site directed mutagenesis are in vivo kinase 
substrates in a wild type Dof molecule or phosphorylation was partially an artefact of kinase 
activity in the absence of endogenous substrate sites in the molecule. 
 
2.3.2 Conservation of Dof phosphorylation sites in Dof homologues 
 
Comparative sequence analysis of the identified phosphorylation sites in molecules homologous 
with Dof might help to reveal if these sites are evolutionarily conserved and so potentially might 
confer conserved functions. Dof is a fast-evolving gene as even its closest known homologue in 
Anopheles gambiae shows significantly lower similarity than the average degree of conservation 
between clear orthologs in the two insect genomes (Wilson et al., 2004). In vertebrates two proteins 
that function in B-cell signalling, BCAP and BANK share structural domains with Dof (Okada et 
al., 2000; Yokoyama et al., 2002). In all three homologues conservation is mainly restricted to the 
DBB domain, ankyrin repeats and coiled coil region (Wilson et al., 2004). Sequence analysis 
revealed that tyrosines located in consensus binding sites for Grb2, PI3K, SHP2 and RasGAP or 
Crk in Dof are also present in the homologues. Whereas the RasGAP or Crk binding site is 
restricted to Dof and its Anopheles homologue, potential SHP2 binding sites are present in all three 
related molecules. The PI3K docking site is lost in hBANK, but present abundantly in BCAP. 
Similarly, the Grb2 consensus binding site is lost only in hBANK (Figure 25A). Anopheles Dof is 
the closest known homologue of Drosophila Dof, and consistent with this we find the most reserved 
positioning of the consensus binding sites compared to Dof, although no data are available about the 
phosphorylation and the functional relevance of these motifs. While in both mBCAP and hBANK 
novel potential SHP2 consensus binding sites appeared at the N-terminus of the proteins, mBCAP 
still contains an SHP2 site in the middle of the molecule like Drosophila Dof. In addition a 
multiplication of the PI3K binding sites could be observed in mBCAP. This might be in correlation 
with the function of BCAP in PI3K activation in B-cell receptor signalling. However, the tyrosines 
of the four PI3K consensus binding sites contribute to the phosphorylation of BCAP and are 
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required for the recruitment and activation of PI3K in their phosphorylated state are not the 
exclusive sites of tyrosine phosphorylation in the molecule (Inabe and Kurosaki, 2002). In hBANK 
only SHP2 sites are conserved among the consensus binding sites Dof contains. Nevertheless it has 
been shown that not the N-terminal part, but the region between amino acids 367 and 653 with its 
eight tyrosines spanning between the conserved ankyrin repeats and coiled coil domain is required 
for phosphorylation of hBANK (Yokoyama et al., 2002). 
The three non-consensus tyrosines identified as phosphorylation targets in Dof are part of 
sequence patches which are highly conserved in Anopheles Dof (Figure 25B). While the conserved 
regions around the three tyrosines are in close proximity in Drosophila Dof they are interrupted 
with 11 and 16 amino acid long insertions in the Anopheles sequence indicating that they might 
represent three independent motifs in the molecule. Whereas Tyr592 is in a conserved but unique 
sequence environment the conserved amino acids around Tyr613 and Tyr629 show remarkable 
similarity to each other. This motif is found two more times in the C-terminal 200 amino acids in 
both molecules, one overlapping with the potential consensus RasGAP or Crk binding site (Figure 
25B). A minimal consensus profile derived from these eight conserved sites is depicted in (Figure 
25C). This motif is absent in BCAP, but interestingly, present in hBANK in the region between 
ankyrin repeats and coiled coil domain at amino acid position 458, which marks the position of the 
tyrosine (Figure 25D). Protein database search with this novel motif scored several known adapter 
and scaffolding molecules and tyrosine kinases both in Drosophila and higher vertebrates; a 
shortlist of examples from mouse and Drosophila is given in Figure 25E. These molecules are 
partially known to be tyrosine phosphorylated upon signalling, but tyrosine residues that are located 
in this motif were not object of molecular studies so far. 
 
 
Figure 25. Conservation of consensus tyrosine motifs among Dof homologues and the identification of two 
phosphorylation sites in Dof as novel consensus tyrosine motifs conserved in several signalling molecules. 
(A) Schematic representation of Drosophila Dof and related proteins Anopheles Dof, mouse BCAP and 
human BANK. Conserved protein domains of the four proteins and consensus tyrosine motifs are labelled on 
the scheme. White box, DBB domain; black box, ankyrin repeat and white oval, coiled coil region. Signalling 
molecules that could bind to the marked conserved tyrosine motifs if tyrosine is phosphorylated are listed 
above the position of each motif with the amino acid position of the tyrosine within the motif. Red stars mark 
the positions of a novel consensus tyrosine motif identified in Dof (see below). (B) Protein sequence 
alignment over the C-terminal half of Drosophila Dof ( DmDof) and Anopheles Dof (AgDof) starting from the 
end of the ankyrin repeats (accession numbers O96757 and Q8T5J9). Asterisks denote identical amino 
acids whereas dots mark similar amino acid residues. Black shaded sequence corresponds to the coiled coil 
region. Each tyrosine of both sequences is marked in red and tyrosine phosphorylation sites identified in Dof 
are labelled with a blue “P” above the particular residues. Consensus tyrosine motifs are underlined and 
shaded grey in both sequences. Positions of the novel tyrosine motif are shaded yellow and numbered 1-4 
above the sequence. Note that one consensus tyrosine motif is part of the third novel tyrosine motif in both 
sequences. CLUSTAL W alignment was modified by hand. (C) Alignment of the novel tyrosine motif in Dof, 
present four times in both the Drosophila and the Anopheles proteins. Numbering of the sequence patches is 
as in panel B. Residues with blue shading denote positions that are absolutely conserved. Four or more 
identical or similar residues shared by the sequences are shaded black and grey respectively. Consensus 
sequence is depicted below the alignment. Alignment was made using CLUSTAL W, and output file was 
formatted using BOXSHADE. (D) Alignment of Drosophila Dof and human BANK (accession number 
Q8WYN5) over the sequence patch of the novel tyrosine motif. Start and end positions of the sequences are 
marked on the alignment. Residues of the tyrosine motif are shaded yellow. (E) A conserved pattern of the 
eight tyrosine motifs in panel C was generated using Pratt (www.ebi.ac.uk/pratt). ScanProsite 
(www.expasy.org/tools/scanprosite) was used to find other proteins containing the conserved motif. Hits 
were sorted taxonomically and signalling molecules in mouse and Drosophila were short listed as example. 
The alignment over the novel consensus tyrosine motif of these proteins is shown here. Conserved residues 
are shaded blue. 3BP2, SH3 binding protein 2; Ap2a1, alpha-adaptin A; Ap2a2, alpha-adaptin C; ACK1, 
Activated CDC42 kinase 1; Ppp1r13b, Protein phosphatase 1 regulatory subunit 13B; CNK2, Connector 
enhancer of kinase suppressor of Ras 2; Dok1, p62(dok) adaptor; Dvl1-3, dishevelled 1-3 (homologue); Dsh, 
dishevelled (Drosophila); Dab, Disabled; Mm, Mus musculus; Dm, Drosophila melanogaster. 
 
RESULTS 
 51
 
 
B        P     P 
 DmDof     MYHYFKGVTPPGESCPKPSANVVIEAHPVKAGKTNKPPKELPTAEYMEMSSGSERENTPEVRTKTETLAISNLNYISVETE 521 
AgDof     MYHYFKGVSG------ASSDQVMIQPKQQQHGTG------LPLRTQNKTDAEKILSHVHALKQAEGYIDMSCAN--GSDQV 688 
          ********:        .* :*:*:.:  : *.       **     : .: .  .:.  ::     : :*  *  . :   
               P 
DmDof     DENLQASVAEKKVESEKKLPEAGNQPGPEKTTNELRINEPPYYQSKEQNQQPKELKNQSKSLDEVDAAPLYQTDKFSQECS 602 
AgDof     DGSSGASAINIHYLNDRPAGSELTPPGPPDEKDVCGENEDNFDVVRDTDRRCN--NGSLRSVESAERAAKY--DIFSNECS 767 
          * .  **. : :  .::   .  . *** . .:    **  :   :: ::: :  :.. :*::..: *. *  * **:*** 
         P   #1   P  #2 
DmDof     QLLENQLG-----------NDYVLQPSNVPVAQDD----------------GNYLFQPSNRPVEEPLRLNRCTNRQPGYGT 656 
AgDof     DLLENCEAGSTASAECVTNGDYMLQPSNAPFTPPTDRTPTPPPLPATAEPMGDYMIQPSNIPVHPYCNVPEVVPETGP--- 845 
          :****  .           .**:*****.*.:                   *:*::**** **.   .: . . .     
       coiled coil 
DmDof     LKRSASDASAASHTRSNADDELAEIMHDFKNNVLSIRDVEVLVERWKHRNDVQQSFREKQDQIDQLRREYERIQEQVKSHL 713 
AgDof     --TTEAASHVRSAEGRTVDDELLEIISDFKNNVFSIQEVEQLVTLWKNRNDVQKSFREKQDQLARMREHYEQIQRELKDKL 897 
             : : : . *    ..**** **: ******:**::** **  **:*****:********: ::*..**:**.::*.:* 
 
DmDof     KRETPFERIKKFFLRSKTP---------------GGNDSLLDETKSSIATSCSFKSAGGVSSSAG------AGRPISSLSL 773 
AgDof     KRPTPFERMRSFFSRTKPSPAGGKAAAAKQRAGNGSAGGASDPPGADVCDEIKFSMAGGGGSNGGYAVVRPQSLSLSMNSM 978 
          ** *****::.** *:*..               *. ..  * . :.:. . .*. *** .*..*       . .:*  *: 
             #3 
DmDof     QSVSSSSSSSGRLSTGSNCSGASLGDSGTHSDHEDRRFPHCR------MMDNYMVPPTPRPVFTPSSTP-GDERHQIVFPS 871 
AgDof     GSDNSEQSSGGRLSSGG---GPPVGTPTDGAPSEGRRLSHSKSWPKGTENENYMVPPSPRPVSEELHLVRGVRLGSGTLVG 1080 
           * .*..**.****:*.   *..:* .   :  *.**:.*.:        :******:****        * .  . .: .  
                 #4 
DmDof     PMSSCQR-LNTPTSPTGS-----------------------EHYQMFPSNIPVYGSQPLVGSQSSNYLNTIMEAKEQAETQ 928 
AgDof     ALNRCSNGSCSSTSSSHSNHSSHSSSSSNSAGSWAGMGKQESHYVMYPSNVPVF-----AG--GAEYMNV-----PAAVTH 1149 
          .:. *..   :.**.: *                       .** *:***:**:     .*  .::*:*        * *: 
 
DmDof     HYQNQNGVTLQPIKLNERSNIIYGKLTKSSSASGCSSFKPKQIPVPCPQVGSIEVQAEVYQNVGDVAPEKDSKAEEETPN  1008 
AgDof     HTKEDERMTARP------------KLGRTPSDTGG----------PTPHLVTFQSIMECNESADSVDSVT----------  1197 
          * :::: :* :*            ** ::.* :*           * *:: :::   *  :....* . . 
 
DmDof     YMNC 1012 
AgDof     ---- 1197 
           
C        E 
 DmDof_#1   DYVLQPSNVPV 
DmDof_#2   NYLFQPSNRPV 
DmDof_#3   NYMVPPTPRPV 
DmDof_#4   HYQMFPSNIPV 
AgDof-#1   DYMLQPSNAPF 
AgDof_#2   DYMIQPSNIPV 
AgDof_#3   NYMVPPSPRPV 
AgDof_#4   HYVMYPSNVPV 
consensus   YxxxPxxxP 
 
D 
DmDof   605 LENQLGNDYVLQPSNVPVAQDDGNYLF 631 
hBANK   450 SEDQYDDLYVFIPGADPENNSQEPLMS 476 
             *:* .: **: *.  *  :.:   :    
 
 
Dof_site#1_Dm   610 GNDYVLQPSNVPVAQ 625 
3BP2_Mm         201 PPAYPPPPVPVPRKP 215 
Ap2a1_Mm        173 LRLYKARPDITPELR 187 
Ap2a2_Mm        173 LRLYKASPDLVPMGE 187 
ACK1_site#1_Mm  483 DELYLGNPMDPPDLL 497 
ACK1_site#2_Mm  871 STHYYLLPERPPYLE 885 
Ppp1r13b_Mm     457 PPSYGHYPSSGPLGP 471 
CNK2_Mm         349 QDLYIPPPPAEPYIP 363 
Dok1_Mm         405 TDDYAVPPPRSPKPA 419 
Dvl1_site#1_Mm  343 PRSYFTIPRADPVRP 357 
Dvl1_site#2_Mm  539 PYQYPGPPPCFPPAY 553 
Dvl2_Mm         359 PQAYFTLPRNEPIQP 373 
Dvl3_Mm         535 AFPYGYPPPPHPYNP 549 
Dsh_Dm          344 PKGYFTIPRTEPVRP 358 
Dab_Dm         2041 VDSYEQTPTPTPRSN 2055 
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Thus, we postulate the sequence Y-[X]3-P-[X]3-P as a novel evolutionarily conserved motif for 
potential tyrosine phosphorylation and thereby probably serving as docking site for so far 
unidentified regulator(s) of tyrosine kinase activity-linked signalling. Functional analysis is required 
to confirm the biological role of these conserved tyrosine residues in Dof. These studies might help 
to identify new regulatory components of tyrosine kinase coupled signalling in general. 
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2.4 The role of sumoylation in Dof function 
 
Small ubiquitin-related modifier (SUMO) family proteins function by becoming covalently 
attached to and thereby modify the effect of other proteins. Not only SUMO itself but components 
of the whole conjugation pathway are closely related to the corresponding members of the 
ubiquitination machinery. SUMO modifies many proteins that participate in diverse cellular 
processes, including transcriptional regulation, maintenance of chromosomal integrity, nuclear 
transport and signal transduction. However, the functional consequences of sumoylation are 
different from ubiquitination. How sumoylation functions is not fully understood and might differ 
from substrate to substrate. In many cases it alters subcellular localisation or interaction of the 
substrate with other proteins or with DNA, but it acts also as inhibitor of proteosomal degradation 
by blocking ubiquitin binding sites (reviewed in (Johnson, 2004)). The majority of identified 
proteins modified by SUMO attachment is nuclear or becomes sumoylated upon entering the 
nucleus or assists at nuclear import. Thus, most known functions of this modification are linked to 
the nucleus. Nevertheless, there are some examples where SUMO modification is needed for 
cytoplasmic function. The MAPK kinase Mek1 becomes sumoylated after cAMP stimulus in 
Dictyostelium and the initially nuclear Mek1 relocates to the plasma membrane upon SUMO 
attachment where it probably activates membrane recruited MAPK. Strikingly, by 3 min after 
pathway activation Mek1 was desumoylated and disappeared from the plasma membrane (Sobko et 
al., 2002). This indicates a very dynamic regulation of SUMO modification at the plasma 
membrane which makes sumoylation a potent sensitive regulator of signal transduction but also 
challenges for a hard hunt to catch such events. Recent work showed that Drosophila Ulp1, the 
SUMO deconjugating enzyme localises to the nucleoplasmic face of the nuclear pore complex and 
prevents accumulation of cytoplasmic SUMO conjugates probably by inhibiting proteins from 
leaving the nucleus in a SUMO attached form (Smith et al., 2004). These indicate that the nucleus 
might be the major but not the exclusive permissive place in the cell for a sumoylated state and 
suggest a tight spatio-temporal regulation of cytoplasmic SUMO modification to prevent 
sumoylation of the many nuclear SUMO target proteins in the cytosol but allow temporary 
modification of cytosolic SUMO substrates. 
Most SUMO substrates contain at least one copy of the short SUMO attachment consensus 
sequence I/V/L-K-x-E, in which the lysine residue is the site for modification. However, the 
abundance of this sequence motif in proteins, together with the fact that proteins were identified 
with alternative SUMO attachment sites indicate that probably not all proteins with consensus 
sumoylation site are SUMO targets and that interactions other then those between the SUMO 
conjugating enzyme and the consensus motif are critical in determining SUMO modification in 
vivo. 
Dof contains four SUMO attachment consensus sites with lysine residues at amino acid positions 
3, 82, 297 and 737 respectively (see Figure 6 in Introduction). Yeast two hybrid data provided 
additional indication for potential SUMO modification of Dof. Ubc9, the E2 SUMO conjugating 
enzyme and dPIAS, the Drosophila homologue of the mammalian PIAS family E3 SUMO ligases 
interacted with Dof in yeast (Battersby et al., 2003) and Ubc9-Dof interaction was confirmed in co-
immunoprecipitation experiments in Drosophila S2 cells (see Chapter 2.1 for details). To test 
directly if Dof is able to become SUMO modified biochemical experiments were performed. 
 
2.4.1 Dof sumoylation assay in Drosophila S2 cells 
 
Ubc9 was shown to be sufficient to sumoylate substrates without additional E3 SUMO ligase 
activity under in vitro conditions and in cell culture overexpression studies (Bhaskar et al., 2000; 
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Lee et al., 1998). Therefore, we took the minimal critical components of SUMO modification 
including Ubc9 and SUMO itself to establish sumoylation assay in Drosophila S2 cells. Full length 
Dof with an N-terminal FLAG epitope tag was transiently co-expressed with an HA-tagged form of 
Ubc9 and with the activated form of Drosophila SUMO. Activated SUMO lacks the last two C-
terminal amino acids of the protein which have to be cleaved off by SUMO-cleaving enzymes to 
make the molecule active for binding with E1 enzmyes. The three proteins were overexpressed in 
different combinations in the cells. To analyse the sumoylation state of FLAG-Dof the protein was 
purified from whole cell lysates by immunoprecipitation using antibody against Dof followed by 
Western blot analysis using antibodies against the FLAG epitope tag and Drosophila SUMO 
protein. The FLAG antibody detected protein bands only in immunoprecipitates of cell lysates 
where FLAG-Dof was expressed (Figure 26, upper panel). In each of these protein fractions at least 
three bands were recognised by the FLAG antibody. They migrated at about 140 kDa, 100 kDa and 
72kDa which corresponde to the size of full length Dof and N-terminal fragments of FLAG-Dof 
respectively. In immunoprecipitates of cell lysates containing FLAG-Dof, Ubc9 and SUMO a weak 
fourth band was detected by the FLAG antibody, migrating with an appearent size of about 85 kDa. 
This band must represent an additional N-terminal fragment of Dof since the FLAG epitope tag was 
attached to the N-terminus of the protein. To assess the presence of sumoylated proteins in Dof 
immunoprecipitates SUMO antibody was used in Western blot analysis. A protein band migrating 
at about 85 kDa was recognised by the SUMO antibody specifically in Dof immunoprecipitates of 
cell lysates where FLAG-Dof, Ubc9 and SUMO were expressed simultaneously but not of other 
lysates that lacked at least one of the three proteins (Figure 26, lower panel). Considering that 
covalent attachment of SUMO to a substrate causes a shift of about 10 kDa in the migratory 
behaviour of that protein the most likely explanation might be that the detected protein band 
represents the sumoylated form of the 72 kDa N-terminal fragment of Dof. This is strongly 
supported by the presence of an N-terminal Dof fragment of similar size (ca. 85 kDa) specifically 
and exclusively in the same precipitate where the protein band was detected with the SUMO 
antibody. 
 
 
 
Figure 26. Sumoylation of Dof in Drosophila S2 cells. FLAG epitope-tagged full-length Dof, HA epitope-
tagged dUbc9 and the activated form of dSUMO with an N-terminal 6xHis epitope tag (His-SUMOGG) were 
transiently transfected in the labelled combinations in Drosophila S2 cells. Whole cell lysates of transfected 
cells were immunoprecipitated with Dof antibody and analysed on Western blots. Blots were stained with 
FLAG antibody to visualise Dof protein (upper panel) or with SUMO antibody raised against Drosophila 
SUMO to detect sumoylated proteins in Dof antibody immunoprecipitates (lower panel). Asterisks mark the 
heavy chain of Dof antibody used for immunoprecipitation. “cont.” marks contaminating protein bands 
detectable with SUMO antibody. Arrowheads indicate FLAG and SUMO antibody reactive bands at similar 
molecular weight positions. 
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Three SUMO attachment consensus sites with lysine residues at amino acid positions 3, 82 and 
297 are present in the 72 kDa N-terminal Dof fragment (for details of Dof processing see Chapter 
2.5). Strikingly, lysine to arginine exchange of amino acid 297 in the molecule leads to the 
complete loss of Dof function in vivo (R. Wilson personal communication) probably by abolishing 
effective interaction of the molecule with the FGF receptor (see Chapter 2.2). Important questions 
of future works are whether lysine 297 is the target for sumoylation in the N-terminal Dof fragment 
and whether sumoylation is involved in the interaction of Dof with the FGF receptors. No less 
importance has the analysis why only the N-terminal fragment of Dof became sumoylated in our 
assay but not the full length molecule. An effort to increase or stabilise the proportion of 
sumoylated Dof in S2 cells might be also useful for further experimental work. 
In summary, this result shows that Dof is able to become sumoylated in S2 cells but further work 
is required to identify the site of modification in the molecule and to analyse the functional 
relevance of SUMO attachment of Dof. 
 
2.4.2 Analysis of the role of the SUMO conjugation pathway in FGF dependent 
developmental processes 
 
If sumoylation plays a role in the regulation of Dof function in vivo the sumoylation machinery 
itself should be also involved in Dof-dependent developmental processes. To test this hypothesis, 
mutant alleles of the genes encoding Ubc9 and SUMO were analysed for genetic interaction with 
FGF signalling during embryogenesis. Our assays involved the monitoring of the formation of Eve-
positive clusters in the mesoderm and the development of the tracheal network. 
 
Ubc9 
 
First we studied the gene coding for ubc9, called lesswright (lwr) or semushi (semi) in 
Drosophila. Figure 27 shows the lwr locus in the Drosophila genome. Several P element insertion 
and excision alleles are located in this genomic region. The lwr alleles lwr5486 and its derivative 
lwr4-3 dominantly suppress the non-disjunction and cytological defects of female meiotic mutations 
that influence spindle formation (Apionishev et al., 2001). The lethal P element insertion semi2858 
and its derivative semi107 are located downstream to the coding region of both, the lwr and the 
distal neighbouring u-shaped genes. The semi alleles block nuclear import of Bicoid by affecting 
ubc9 rather than u-shaped function and as a consequence embryos have multiple defects in anterior 
segmentation (Epps and Tanda, 1998). Although each of these alleles is linked to ubc9 gene 
activity, they form two distinct complementation groups, that of the lwr alleles and that of the semi 
alleles. The different effects of the alleles and their relevance to Ubc9 function is not understood. 
Thus, the genetics of this genomic region is not worked out. 
Since the relationship of the two allele groups is not clear we decided to analyse mutant alleles of 
both complementation groups. Embryos homozygous for the mutant alleles lwr5486, lwr4-3 and 
semi2858 showed no detectable deviation from wild type in the formation of mesodermal Eve-
positive clusters and in the development of the tracheal network (data not shown). On the other 
hand semi107 embryos showed early segmentation defects with incomplete penetrance. These 
embryos showed reduced numbers of Eve-positive clusters and trachea metamers often combined 
with tracheal branching defects (Figure 28). A few embryos showed defects in germ band retraction 
occasionally combined with segmentation abnormalities and/or tracheal branching defects (Figure 
28G). Thus, it indicates that the semi107 allele has pleiotropic effects. Defects in FGF signalling 
dependent processes were considered as secondary effects since they were often combined with  
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Figure 27. Characterisation of lesswrite (lwr)/semushi (semi) mutations in the lwr genomic locus. The 
lwr/semi gene is located at cytological position 21C on the second chromosome. It has two exons (black 
boxes) separated by a short intron (black bar). The second exon contains the entire coding region (red 
rectangle). The gene is in the same orientation as the adjacent proximal gene shanti but reads in the 
opposite direction than the distal neighbouring gene u-shaped. The lethal P{PZ} insertion lwr5486 is located at 
nucleotide position 62 in the 5’UTR of lwr. lwr4-3, a lethal excision of lwr5486 contains 76 bp residual foreign 
sequence at the lwr5486 insertion site. The deficiency Df(2L)dUbc9-14 was generated by imprecise excision of 
lwr5486. lwr5 is an EMS induced lethal allele and contains a single R to H point mutation at amino acid position 
104 in the coding region of lwr. The lethal P{PZ} insertion semi2858 is positioned 3’ to the coding sequence of 
both genes, lwr and u-shaped with a distance to the putative poly-adenylation signals of 560 and 47 
nucleotides respectively. semi107 is a lethal excision of semi2858 without published molecular data (Epps and 
Tanda, 1998). Schematic map is modified from (Apionishev et al., 2001) and http\\:www.flybase.org. 
 
severe segmentation defects, consistent with the data that semi alleles cause reduced segment 
numbers (Epps and Tanda, 1998). Surprisingly and in contrast to earlier findings, semi2858 
embryos did not show detectable defects including segmentation defects, although homozygosity 
for this allele caused embryonic lethality (summarised in Table 3B). 
The lack of abnormal development in the analysed tissues of lwr5486, lwr4-3 and semi2858 
embryos might be due to the high lwr mRNA levels deposited in the eggs maternally. Although this 
maternal contribution is not sufficient for the embryo to develop to larval stages it can mask early 
requirement of Ubc9 and potential differences in Ubc9 expression levels needed in different tissues. 
To overcome this problem we generated germ line clones (GLC) of the lwr4-3 allele and as a 
control of the semi107 allele. Females with mutant germ line clones were crossed to lwr5486, lwr4-
3, semi2858 or semi107 heterozygous males. To control paternally rescued phenotypes females 
were also crossed to wild type males. lwr4-3 GLC females produced very few or practically no 
eggs. The 25 eggs laid in total by 1500 females were unfertilised and showed fused dorsal 
appendages (Figure 29A-C), summarised in Table 3A), indicating that the lwr gene is required 
during oogenesis. This is in agreement with the finding that lwr plays a role in female meiotic 
events (Apionishev et al., 2001). semi107 GLC females laid fertilised eggs with wild type 
morphology indicating that the semi107 mutation represents a hypomorphic allele, which does not 
interfere with oogenesis. One copy of a wild type or lwr5486 paternal chromosome completely 
rescued embryonic lethality consistent with the reports that lwr5486 and semi107 belong to separate 
complementation groups. The lwr4-3 allele failed to complement semi107 GLCs in our assay. 
Analysis of semi107 GLC embryos showed that only the homozygous semi107 allelic 
combination caused detectable defects on the formation of Eve-positive clusters and on the 
development of the tracheal network (summarised in Table 3A). These abnormalities were 
indistinguishable from the ones observed in zygotic mutant semi107 embryos (data not shown) and 
are probably secondary consequences of segmentation defects as discussed above. 
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In summary, this genetic approach did not indicate an obvious requirement of Ubc9 function in 
FGF signalling in vivo. Sorting out genetics of this gene is a prerequisite of future work. 
 
 
 
 
Figure 28. Homozygous mutant semi107 embryos show pleiotropic morphogenetic defects. (A-B) stage 11 
(A) wild type or (B) homozygous semi107 embryos were stained with Even-skipped antibody to visualise Eve-
positive cluster in the mesoderm. A’ and B’ show the same embryos as seen in A and B with Eve-positive 
cells of the central nervous system (CNS)  in the focus. Note the overlapping positions of the lack of 
mesodermal Eve-positive clusters with the patterning defects in the CNS. (C-F) stage 15 (C) wild type or (D-
F) homozygous semi107 embryos stained with 2A12 antibody to visualise the lumen of the trachea network. 
Note (D) the reduced number of tracheal units, (E) the complete failure of tracheal branching including dorsal 
trunk fusion or (F) the combination of these two abnormalities. Note segmentation defects of embryos on B,D 
and F and germ band retraction defect of the embryo on E. Anterior to the left. 
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Table 3. Studies on different lethal alleles in the lwr locus 
A                     Germ line clones B       Zygotic mutations 
 semi107 GLC 
paternal 
genotype 
lwr4-3 GLC 
embryonic 
lethality 
Eve-
clusters 
tracheae 
 
embryonic 
lethality 
Eve-
clusters 
tracheae 
 
lwr5486 9 eggs  
(fused dorsal 
appendages) 
> 90% 
hatched 
(339/352) 
not  affected not  affected 41% 
hatched 
(189/467) 
not  affected not  affected 
semi2858 9 eggs  
(fused dorsal 
appendages) 
66% 
hatched 
(162/246) 
not  affected not  affected 66% 
hatched 
(321/478) 
not  affected not  affected 
lwr4-3 no eggs  63.5% 
hatched 
(306/482) 
not  affected not  affected 51% 
hatched 
(211/418) 
not  affected not  affected 
semi107 7 eggs  
(fused dorsal 
appendages) 
55% 
hatched 
(166/300) 
42% (34/81) 
lower 
number of 
clusters in 
embryos 
lacking 
middle 
segments 
 
40% (45/113) 
reduced number 
of tracheal units 
in embryos with 
fewer segments 
occasionally 
branching 
defects 
45% 
hatched 
(180/402) 
24% (19/80) 
lower number 
of clusters in 
embryos 
lacking 
middle 
segments 
 
32% (38/120) 
reduced 
number of 
tracheal units 
in embryos 
with fewer 
segments 
 
wild type no eggs > 90% 
hatched 
(268/285) 
not  affected not  affected - - - 
 (A) females with germline homozygous for the lwr4-3 or semi107 alleles were crossed to males heterozygous 
for mutations listed on the left. For lwr4-3 GLC the total number of eggs produced by 300 females in 5 days is 
labelled in case of each cross. To asses the effect of paternal rescue in semi107 GLCs 250-500 eggs were 
scored for viability. Percentage of the hatching was calculated as a ratio of the number of larvae hatched 
over the total number of eggs analysed. Absolute numbers are given in brackets for each case. Overnight 
collection of embryos was stained with Even-skipped or 2A12 antibody to visualise mesodermal Eve-positive 
clusters or the lumen of the tracheal network respectively. Observed abnormalities are described and the 
calculated ratio of embryos with abnormalities noted. Not affected marks phenotypes indistinguishable from 
wild type. 
(B) Recessive lethal alleles listed on the left were tested for zygotic effects in their homozygous form. Their 
severity on embryonic lethality was assessed by calculating the ratio of hatched larvae over the total number 
of eggs analysed. Absolute numbers are shown in brackets. Effects on mesoderm and tracheal 
morphogenesis were analysed the same way as described for the GLCs. GLC, germ line clone. 
 
Smt3 
 
A single gene coding for SUMO is present in the Drosophila genome, called smt3. Two lethal P 
elements, l(2)k01211 and l(2)04493 are available which have independent origin but are mapped to 
the same position molecularly: about 10 base pairs upstream of the first exon of the smt3 gene 
(www.flybase.org). Consistent with this they do not complement each other. Work with these two 
alleles showed that smt3 interacts with ras1 in Drosophila eggshell patterning and morphogenesis. 
It is thought to act in EGF signalling downstream of the EGF receptor (Schnorr et al., 2001). EGF 
signalling occurs in follicule cells of somatic origin which surround the egg and produce the 
eggshell. 
Homozygous mutant embryos of both alleles were analysed and no abnormalities were found in 
mesoderm or tracheal development (data not shown). smt3 has a strong maternal contribution which 
might deliver sufficient protein for embryonic development. Thus, germ line clones were generated 
with the l(2)04493 allele. Three independent FRT l(2)04493 recombinant chromosomes were  
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Figure 29. Dorsal appendage morphology defects of eggs derived from lwr4-3 and smt3 mutant germ line 
clones (GLC). Eggshell preparation of eggs laid by (A) wild type females and by females with germ line 
clones homozygous (B,C) for the lwr4-3 allele or (D-F) for the lethal P-element insertion l(2)04493 in the smt3 
gene. B shows the weakest, C a representative example for the dorsal appendages fusion phenotype found 
among the lwr4-3 mutant GLC eggs. Note, that the eggs are unfertilised. (D-F) Phenotypic range of eggs laid 
by females with smt3 mutant GLC. (D) dorsal appendage material appeared as short trunk, (E) the two 
appendages were fused on their basis or (F) were identical to wild type structures. Note the egg in F was 
fertilised. Anterior to the left. Scale bar 100 µm. 
 
analysed. GLC females were crossed to males heterozygous for the appropriate FRT l(2)04493 
recombinant chromosome, the original l(2)04493 chromosome or the independent l(2)k01211 P 
insertion and to wild type males as a control for the paternally rescued phenotype. Eggs were 
produced in each cross. In each case they could be divided into three phenotypic classes: (i) eggs 
that showed fused dorsal appendages; in the most severe cases short trunks or bulbs labelled only 
the position of the appendages (Figure 29D-E). These eggs were rarely fertilised. (ii) eggs that had 
normal dorsal appendages (Figure 29F), but larvae did not hatch from them either because they 
were unfertilised or due to an arrest in embryonic development. (iii) eggs from which larvae 
hatched. The distributions of these phenotypes and the percentages of unfertilised eggs are shown in 
Figure 30 for each cross. The defects in eggshell morphology indicated a role of smt3 during 
oogenesis. Smt3 is reported to be required in the dorsal follicle cells for the formation of the dorsal 
appendages of the eggshell (Schnorr et al., 2001). The observed eggs with fused dorsal appendages 
are in concert with this. Based on the method how germline clones were induced and selected, eggs 
derived from GLCs are mutant for germ cells, but are derived from ovaries that can contain both 
mutant and wild type follicle cells. This might explain the two classes of eggs with fused or wild 
type dorsal appendages. Alternatively, the P insertions might represent hypomorphic alleles of smt3 
thereby causing various egg phenotypes. We also can not exclude the variable effect of perduration 
where SUMO protein stays due to long half life of the molecule and/or by recycling from 
sumoylated substrates for a sufficient period after mitotic recombination to drive mutant germ cells 
through oogenesis. 
The three recombinant lines showed a large difference in the severity of the observed phenotypes 
indicating that “background” interfering mutations of the original chromosomes were differentially 
inherited due to different recombination sites. Eggs obtained from crosses with males bearing the 
recombinant mutant chromosomes or the original l(2)04493 P insertion often showed more severe 
phenotype than those derived from males bearing the independent l(2)k01211 P insertion, possibly 
due to the additional effect of homozygous chromosomal background. Therefore we concentrated 
on the comparative analysis of the cross with males heterozygous for l(2)k01211 and of that with 
wild type males. In zygotically rescued emryos (wild type male cross) about 85-90% of the 
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fertilised eggs of line#1 and #3 hatched to larvae whereas in line#2 it was only about 20%. The high 
variation between the different lines indicates that it might be an effect independent of smt3. In 
crosses with l(2)k01211 heterozygous males where half of the progenies inherited wild type 
chromosome only 50-75 percent of the embryos developed to larvae. Thus, the presence of the 
zygotic mutation interfered with the embryonic development of eggs, which had successfully 
overcome oogenesis, albeit with a moderate penetrance. This supports a zygotic requirement of 
smt3. 
Embryos were collected and analysed from these GLC crosses. Many embryos showed a 
complete lack of tissue patterning and occasionally embryos were observed with tracheal defects 
but no abnormalities were detected in the mesoderm or in tracheal development at statistically 
relevant frequency (data not shown). Thus, we concluded that these smt3 alleles might not primarily 
influence FGF-dependent development in the flies. 
 
 
Figure 30. Germ line clone analysis of the smt3 mutant allele l(2)04493. (A-C) GLC analysis of three 
independent FRT40A l(2)04493 recombinant chromosomes. In each case females with homozygous 
l(2)04493 clones in the germ line were crossed to males bearing the same recombinant chromosome (FRT 
l(2)04493#1-3), to males with the original l(2)04493 P{PZ} insertion chromosome, to males bearing an 
independent P{lacW} insertion in identical genomic position as l(2)04493 (l(2)k01211) or to wild type males 
(wt). Eggs obtained from the crosses belonged to three different phenotypic classes: eggs, from which larvae 
hatched, non-hatched eggs with normal dorsal appendages or with fused dorsal appendages. The 
distributions of the three phenotypes among the 200-400 eggs analysed for each cross and taken as 100% 
is shown on the left column of each data series on the diagrams. The right columns of the data series show 
the percentage of unfertilised eggs in relation to the total number of eggs analysed. Colour code see in the 
legend next to the diagrams. 
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In summary, the phenotypes of mutants of the two genes Ubc9 and SUMO showed no 
similarities. Unlike in semi107 mutants we did not see early embryonic segmentation defects in 
smt3 mutants. Neither homozygous mutant lwr alleles nor smt3 alleles showed detectable 
embryonic defects in our assay. GLC of these alleles indicate that they are both involved in 
oogenesis. The few eggs laid by lwr4-3 GLC females were poorly developed in general but clearly 
showed fused dorsal appendages indicating that lwr might be involved in the formation of dorsal 
appendages but that it has an essential role in even earlier processes. Considering that the two genes 
encode obligatory components of the same pathway and there are no similar genes in the 
Drosophila genome lwr and smt3 mutations might demonstrate differences in allelic strength or 
perduration. In summary, we obtained no conclusive answer if Ubc9 is required in mesoderm and 
tracheal development and some weak indications that SUMO might not be essential in these 
processes. However, the major conclusion is that alternative approaches are needed to answer this 
question. 
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2.5 Identification of Dof as caspase substrate and analysis of the role 
of Dof cleavage 
 
2.5.1 Dof is cleaved in S2 cells 
 
Dof protein bearing a FLAG epitope tag on its N-terminus was expressed in Drosophila S2 cells 
in several experiments discussed so far. A typical pattern was always observed on Western blots of 
whole cell lysates visualising Dof via its N-terminal FLAG tag. Intact Dof was detected at about 
140 kDa on protein gels. In addition, one major degradation product at an apparent molecular 
weight of about 75 kDa and two minor degradation products with molecular weights of about 90 
and 110 kDa were usually observed. The presence and amount of the minor products varied in 
different experiments whereas the major degradation product always appeared. The ratio between 
the intact form and the major degradation product of Dof also varied in different experiments 
(compare earlier experiments). Protein sequence analysis of Dof highlighted a potential caspase-3 
cleavage site with the sequence DEVD at amino acid positions 584-587 in the molecule. The intact 
molecule has a predicted molecular weight of 113 kDa and cleavage at amino acid position 587 
would yield N-terminal and C-terminal cleavage products with predicted molecular weights of 66 
and 47 kDa respectively. In order to detect all cleavage products of Dof in S2 cells two different 
epitope tags were fused to the two ends of the protein; a FLAG tag to the N- and a 2xHA tag to the 
C-terminus (Figure 31A). Expressing this construct in S2 cells the described 140 kDa and 75 kDa 
protein bands were detected with FLAG antibody on Western blots of lysates corresponding to full 
length Dof and an N-terminal fragment of the molecule respectively (Figure 31B left panel). The 
antibody against the HA epitope detected bands with molecular weights of 140, 60, 50 and 35 kDa 
corresponding to full length Dof and additional C-terminal fragments of the protein respectively 
 
 
Figure 31. Detection of N- and C-terminal fragments of Dof in S2 cell lysate. (A) Schematic representation of 
the Dof construct bearing a FLAG epitope tag (blue oval) and a double HA epitope tag (green rhombus) 
fused to its N- and C-terminus respectively. Grey boxes and oval on the scheme denote protein domains 
DBB, ankyrin repeats and coiled coil respectively and serve for orientation. The protein sequence “DEVD” 
marks a potential consensus caspase cleavage site in Dof between ankyrin repeats and coiled coil region 
(black line). The exact amino acid position is given in brackets. 113 kDa marks the calculated molecular 
weight of the full length Dof molecule. Cleavage at this position would generate two separate Dof fragments 
with calculated molecular weights marked below the drawings. Note that full length Dof construct is 
detectable via both epitope tags whereas the N-terminal and C-terminal fragments would be detectable by 
only the FLAG tag or the HA tag respectively. (B) Western blot analysis of lysate from S2 cells expressing 
the Dof construct depicted in A using antibodies against FLAG (left panel) and HA (right panel). The two 
lanes on both panels are duplicates of the same lysate. Note that both blots show a protein band of similar 
size (full length Dof) and in addition smaller protein bands representing different N- and C-terminal fragments 
of Dof. Note the difference between the calculated molecular weight and running behaviour of Dof on protein 
gels. 
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 (Figure 31B right panel). Considering that intact Dof is detected at a higher molecular weight on 
protein gels than predicted, the major degradation product observed at about 75 kDa with the FLAG 
antibody might represent the N-terminal 66 kDa cleavage product whereas the 60 kDa protein band 
recognised by the HA antibody might correspond to the C-terminal 47 kDa cleavage product. We 
think that the additional smaller C-terminal fragments might be further degradation products of the 
60 kDa protein band from two reasons. First, no protein band was observed with FLAG antibody at 
a size that would be complementary to these bands (between 75 and 150 kDa) in the lysate; 
secondly, although the N-terminal 75 kDa Dof fragment was always detectable the presence of a 
precise band of the C-terminal 60 kDa fragment was less reliably detected in many experiments 
indicating that the C-terminal cleavage product might be less stable. 
 
2.5.2 Cleavage of Dof depends on caspase activity 
 
To see if caspases are responsible for the cleavage of Dof in S2 cells we used different ways to 
block caspase activity. First, to distinguish whether degradation of Dof occurs after lysis, or the 
protein is already processed in the cells, a pancaspase inhibitor drug was added to the lysis buffer or 
alternatively, cells were incubated with the same drug prior lysis. No difference was observed in the 
degradation pattern of FLAG-Dof on Western blots of whole cell lysates using lysis buffer with or 
without caspase inhibitor (Figure 32A, lanes 1 and 2). On the other hand, if cells were treated with 
different concentrations of the same caspase inhibitor for 2 hours before harvest, the amount of full 
length FLAG-Dof increased significantly in the lysate compared to untreated cells (Figure 32, lanes 
6 and 7). This result indicates that Dof processing is sensitive to caspase inhibitor drugs. 
Furthermore it shows that cleavage occurs in the cells, before lysis. The partial effect of the caspase 
inhibitor Z-VAD on Dof cleavage might be an issue of concentration and timing the drug was used. 
Indeed we observed a dose dependent action of Z-VAD on cleavage (compare lines 6 and 7 on 
Figure 32). Since cells were treated with the drug only 22 hours after Dof expression was induced 
cleavage products might have already accumulated by that time. 
To see if Dof processing could be completely abolished by blocking caspase activity the 
baculoviral caspase inhibitor p35 was constitutively expressed in the cells prior the induction of Dof 
expression. p35 blocked Dof cleavage completely (Figure 32A, lane3). In addition, the amount of 
intact FLAG-Dof in the lysate correlated with the amount of the transfected p35 construct (Figure 
32A, compare lanes 3-5). Transfection and induction by copper causes enormous stress to the cells, 
which might serve as pro-apoptotic signal. Since p35 was continuously expressed in the cells after 
transfection (unlike FLAG-Dof, the expression of which had to be induced), more p35 might have 
provided higher probability for survival resulting more living cells which expressed Dof. 
Nevertheless, we cannot exclude the possibility that p35 affects Dof expression levels in a dose 
dependent manner. 
The experiments above serve with strong evidence to conclude that cleavage of the Dof protein 
is mediated directly or indirectly by caspases in Drosophila S2 cells. 
To reveal which caspase might be responsible for the cleavage of Dof the expression level of 
individual caspases was knocked down by RNA interference in S2 cells. Drosophila has seven 
different caspases three of them - Dcp-1, Drice and Dronc - are definitely expressed in S2 cells (P. 
Meier personal communication). We targeted these three caspases by RNAi and monitored the 
cleavage pattern of FLAG-Dof in whole cell lysates (Figure 32B). Decreased Dcp-1 levels in the 
cells resulted in a partial decrease of the N-terminal cleavage product of Dof whilst abolishing 
Drice had no effect on Dof cleavage. Depletion of Dronc eliminated Dof cleavage completely. 
Efficiency of the RNA interference was tested on overexpressed epitope-tagged forms of the 
caspases in S2 cells (Figure 32C). Dcp-1 and Drice proteins were eliminated by RNAi to  
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Figure 32. Effect of caspase inhibition on the cleavage of Dof in S2 cells. (A) Western blot of whole cell 
lysates from S2 cells expressing N-terminally FLAG-tagged Dof (FLAG-Dof) (lanes 1, 2, 6 and 7) or co-
expressing FLAG-Dof and different amounts of p35 (lanes 3, 4 and 5). The relative amount of p35 plasmid 
DNA to that of the FLAG-Dof plasmid DNA used for transient transfection is marked above each lane. In 
lysates of lane 1 and 2 cells derived from the same transfection, were split during harvest and one half was 
lysed in a lysis buffer supplemented in addition with 20 µM Z-VAD. Cells that gave the lysates of lane 6 and 
7 were incubated with the marked concentration of Z-VAD for 2 hours prior lysis. Full length Dof and the 
presence of N-terminal fragments were detected using anibody against the FLAG tag. Lower panel shows 
the same blot after longer exposure. Arrowheads denote the protein bands of full length Dof in lane 1 and 2 
not detectable at shorter exposure. (B) Dcp-1, drice and dronc RNAi on S2 cells expressing FLAG-Dof. “+” 
marks addition of the corresponding dsRNA, lanes with “-“ are mock treated. Western blots of whole cell 
lysates from these cells were probed with antibody against FLAG to detect full length Dof and the presence 
of the N-terminal Dof fragment. To control the amount of the lysates loaded in each lane Western blots were 
probed with antibody against β-tubulin. (C) Western blot of whole cell lysates from S2 cells expressing 
FLAG-tagged Dcp-1, FLAG-tagged Drice or His-tagged Dronc. Prior the transfection of the dcp-1, drice or 
dronc constructs half of the cells were incubated with dcp-1, drice or dronc dsRNA respectively. The 
presence of tagged Dcp-1, Drice or Dronc proteins was monitored using antibodies against FLAG or His 
epitope tags. To control the amount of the lysates loaded in each lane Western blots were probed with 
antibody against β-tubulin. (D) Western blot of whole cell lysates from S2 cells expressing FLAG-Dof alone 
following mock treatment (marked with “-“) or dronc RNAi, or co-expressing FLAG-Dof with HA epitope-
tagged DIAP1 or DIAP2. Full length Dof and the presence of N-terminal Dof fragments were detected using 
anibody against the FLAG tag. dronc RNAi on S2 cells expressing FLAG-Dof was a separate experiment 
from the one shown in panel B. 
 
undetectable levels. The inefficient knock down of the overexpressed Dronc protein might be due to 
the fact that this construct was under the control of an inducible promoter that might have 
overwhelmed the RNAi machinery. The strong effect of Dronc depletion on Dof cleavage indicates 
that endogenous levels of Dronc might be efficiently eliminated by RNAi. Thus, Dof cleavage in S2 
cells is absolutely dependent on Dronc activity and Dcp-1 is also required for efficient cleavage. 
Dronc is considered to be the major initiator caspase in Drosophila and is the only known 
caspase in flies which is insensitive to the inhibitory effect of p35 (Jabbour et al., 2002; Meier et al., 
2000). Hence, these data indicate that Dronc regulates the cleavage of Dof in S2 cells not by 
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directly acting on it but by regulating the activity of other caspases, probably of Dcp-1, which than 
process Dof. 
Finally, we aimed to block caspase activity by the overexpression of IAP (inhibitor of apaptosis) 
proteins, factors that bind to and inhibit caspases (Salvesen and Abrams, 2004). DIAP1and DIAP2, 
the two known IAPs in Drosophila were co-expressed with FLAG-Dof in S2 cells. The 
overexpression of DIAP1 caused a significant decrease of the 75 kDa N-terminal cleavage product 
of Dof, albeit not as strong as that upon dronc RNAi (Figure 32D). DIAP2 had no effect on Dof 
cleavage. This is consistent with the finding that DIAP1 regulates Dronc activity (Meier et al., 
2000). 
In summary, we showed by four independent approaches that Dof cleavage is caspase mediated 
in S2 cells. We found that the initiator caspase Dronc plays an essential role in this process in S2 
cells. 
 
2.5.3 Cleavage of Dof requires an intact caspase cleavage site in the molecule 
 
To see if the predicted caspase cleavage site DEVD at amino acid positions 584-587 in Dof is 
utilized for cleavage the consensus site was destroyed by mutating the aspartate to a glutamate at 
position 587 in the molecule. This Asp at the P1 position in the caspase cleavage site is essential in 
substrate recognition and cleavage for the most known caspases (Hawkins et al., 2000). To test the 
effect of this point mutation on Dof cleavage wild type Dof bearing a FLAG or an HA epitope tag 
on its N-terminus and caspase site mutant DofD587E with an N-terminal FLAG epitope tag were 
expressed alone or in different combinations in Drosophila S2 cells (Figure 33). Both, wild type 
FLAG-Dof and wild type HA-Dof were cleaved in the cells giving rise to the characteristic 75 kDa 
N-terminal Dof cleavage product. Co-expression of the two differently tagged wild type Dof 
proteins did not alter the cleavage pattern. On the other hand FLAG-DofD587E was not cleaved in the 
cells; furthermore, it had a strong inhibitory effect on the cleavage of wild type HA-Dof if the two 
proteins were co-expressed. This result shows that the caspase cleavage site DEVD in Dof is 
essential for the cleavage of the molecule. The molecular weights of the cleavage products would be 
also consistent with a cleavage at this position. Thus, we propose that the sequence motif DEVD at 
amino acid position 584-587 is a functional caspase cleavage site in Dof. 
 
 
Figure 33. Effect of a point mutation in the potential caspase cleavage site in Dof on the cleavage of the 
protein. Western blot analysis of whole cell lysates from S2 cells expressing, as indicated above each lane, 
different combinations of N-terminally FLAG- or HA-tagged wild type Dof and FLAG-tagged Dof with the point 
mutation D to E at amino acid position 587. Each lysate is present in duplicate on the blot. Full length Dof 
and the presence of N-terminal Dof fragments were detected using anibody against the FLAG and HA tags. 
 
 
RESULTS 
 66
2.5.4 Searching for the molecular role of caspase cleavage in Dof function 
 
What might be the physiological relevance of the caspase-dependent cleavage of Dof during 
development? Dof might be cleavaed off to downregulate FGF signalling in the cells and so acting 
as a survival signal to maintain signalling capacity of the cells which often antagonises with 
apoptosis induction. However, deletion analysis of Dof showed that the first 522 amino acids of the 
molecule have high biological activity, indicating that cleavage at position 587 might not be 
sufficient to eliminate signalling activity of Dof (Wilson et al., 2004). Thus, we analysed 
possibilities where Dof cleavage might have an active role in the function of the molecule. 
So far we had no direct evidence if full length unprocessed Dof has the capacity to interact with 
the FGF receptor. Dof is able to form a complex with Heartless in S2 cells. Both, full length Dof 
protein and the N-terminal cleavage product of Dof co-immunoprecipitate with the FGF receptor. 
The first 445 amino acids of Dof are sufficient to interact with the FGF receptor Heratless (see 
Chapter 2.2) as well as to dimerise with the full length Dof protein (Battersby et al., 2003). Thus, 
these data do not distinguish if full length Dof was present in a Dof-Htl complex due to a direct 
interaction with the receptor or only due to Dof self-association. 
To see if the presence of the N-terminal cleavage product is required for efficient receptor 
binding of Dof, caspase cleavage site mutant FLAG-DofD587E was co-expressed with constitutively 
active Heartless in S2 cells and interaction of the two proteins was analysed by 
immunoprecipitation (Figure 34). FLAG-DofD587E showed as efficient interaction with Heartless as 
wild type FLAG-Dof and both proteins were phosphorylated on tyrosine residues at comparable 
levels, indicating that caspase cleavage of Dof is neither required for interaction with the FGF 
receptor nor for efficient phosphorylation of the molecule. 
 
 
Figure 34. The effect of the point mutation D587E on the interaction of Dof with an activated FGF receptor. 
Western blots of immunoprecipitations (IP) from S2 cells expressing a constitutively active form of HA 
epitope-tagged Heartless (λHtl-2xHA) and mutant Dof constructs bearing a FLAG epitope tag fused to their 
N-terminus. Protein complexes were immunoprecipitated from the lysates using antibody against FLAG, and 
the precipitated proteins were detected on Western blots using anti-FLAG anti-phospho-tyrosine or anti-HA 
antibodies. Arrowhead marks the the tyrosine phosphorylated band corresponding to the constitutively active 
form of Heartless. 
 
To see if cleavage influences tyrosine phosphorylation of Dof, phosphorylation state of full 
length Dof and both, N- and C-terminal cleavage products were analysed. From earlier experiments 
we learned that the N-terminal cleavage product of Dof was less strongly phosphorylated than the  
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Figure 35. Analysis of the phosphorylation state of Dof cleavage products in the presence of an activated 
FGF receptor in S2 cells. Western blots of immunoprecipitations (IP) from lysates of S2 cells (A) expressing 
Dof bearing a FLAG tag on its N- and an HA tag on its C-terminus alone or in the presence of a constitutively 
active form of Heartless with or without an HA epitope tag (λHtl-2xHA and λHtl respectively) or a kinase dead 
version of the constitutively active form of Heartless (λHtlKD-2xHA); or (B) expressing Dof bearing a FLAG tag 
on its N-terminus and an HA tag on its C-terminus alone or in the presence of HA-tagged wild type Heartless 
(HtlFL-2xHA). Protein complexes were immunoprecipitated from the lysates using antibody against Dof, and 
the precipitated proteins were detected on the Western blots using anti-FLAG, anti-HA or anti-phospho-
tyrosine antibodies. Asterisk mark the heavy chains of the Dof antibody used for IP. Arrowheads mark the 
position of the different Heartless proteins on the blots probed with antibody against HA or phospho-tyrosine 
residues. Note the different size of the protein bands corresponding to the constitutively active form of 
Heartless or to wild type Heartless. In panel B black line marks weak tyrosine phosphorylated protein bands 
corresponding the size of N- and C-terminal Dof fragments. 
 
full length form (see also Figure 14 in Chapter 2.2). We also found that sites of tyrosine 
phosphorylation are more abundant C-terminal to the caspase cleavage site; which might explain 
this difference in the phosphorylation level. Alternatively, full length Dof might be a better 
substrate for phosphorylation. To test this, we took advantage of the Dof construct bearing different 
epitope tags fused the two ends of the molecule (FLAG-Dof-2xHA) and co-expressed it with 
activated Heartless in S2 cells. A polyclonal antibody directed against Dof efficiently precipitated 
N- and C-terminal fragments of Dof as well as the full length protein from cell lysates (Figure 35A). 
Full length Dof was efficiently tyrosine phosphorylated but there was no sign of phosphorylated 
cleavage products in the same immunoprecipitate. The protein band at about 80 kDa detected via 
the antibody directed against phospho-tyrosine corresponds to the activated FGF receptor that co-
precipitated with Dof. To eliminate eventual masking of protein bands of the phosphorylated 
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cleavage products by overlapping receptor bands the experiment was repeated with wild type 
Heartless protein, which appears at higher molecular weight on protein gels (Figure 35B). Wild type 
Heartless was auto-activated under these expression conditions in S2 cells. It was as effective as 
constitutively active Heartless to interact with Dof, and full length Dof was also efficiently 
phosphorylated (see also Figure 14 in Chapter 2.2). However, consistent with the results above, we 
detected only very weak phosphorylated protein bands with corresponding sizes to the N- and C-
terminal cleavage products. This shows that the weak phosphorylation level of the N-terminal 
cleavage product is not a consequence of the split-off of the phosphorylated tyrosine residues of full 
length Dof among the cleavage products. This rather indicates that caspase cleavage products of 
Dof might be preferentially in a non-phosphorylated state in S2 cells. In summary, this is the first 
indication for the existence of a regulatory crosstalk between caspase cleavage and phosphorylation 
of Dof in S2 cells. In future experiments, the use of phosphatase inhibitors in living cells might help 
to distinguish whether Dof is protected from cleavage in its tyrosine phosphorylated state or caspase 
cleavage products of Dof are immediate substrates of phosphatases. 
 
2.5.5 Analysis of the in vivo function of Dof cleavage and caspase activity in FGF 
signalling 
 
We do not have data whether Dof is cleaved in vivo. Thus, we tested genetically if the mutation 
of the caspase cleavage site influences in vivo function of Dof. Transgenic flies were generated 
bearing full length Dof with the same point mutation in the caspase cleavage site as described 
above. Cell culture experiments indicated that caspase cleavage site mutant Dof inhibits the 
cleavage of wild type Dof. To analyse this potential dominant effect in vivo, the mutant DofD587E 
transgene was overexpressed in the mesoderm and in the tracheae of wild type embryos. The 
formation of Eve-positive cells in the mesoderm and the development of the tracheal network were 
assayed. No alterations were observed in these developmental processes upon overexpression of the 
transgene (data not shown). Next, we tested the capability of the mutant molecule to rescue dof loss 
of function phenotypes in the same tissues. The caspase cleavage site mutant Dof transgene was as 
efficient as a wild type Dof construct to reconstitute Eve-positive cell clusters in the mesoderm or a 
fully developed tracheal network (data not shown), indicating that caspase cleavage might not be 
essential for Dof function in vivo. Since the correlation of the expression levels of transgenic Dof 
constructs to endogenous Dof protein levels is not known, dose dependent effects of caspase 
cleavage cannot be excluded in Dof function. Similarly cannot be excluded that caspase cleavage of 
Dof affects other Dof-dependent morphogenetic processes which were not assayed here. 
An alternative way to test if caspase cleavage of Dof has physiological relevance is to analyse 
the requirement of caspase activity in developmental processes in which Dof is involved. Cleavage 
of Dof was sensitive to the caspase inhibitor p35 in S2 cells. Therefore we tested the effect of p35 
on tracheal development by ectopically expressing UAS-p35 transgene with the tissue specific 
btlGal4 driver. p35 had no apparent effect on the development of the tracheal network in embryos 
(data not shown). This indicates that caspase activity might not be essential for tracheal 
development in embryos. Alternatively, unlike in S2 cells, Dof cleavage might be under the direct 
control of the p35-insensitive caspase Dronc. It also cannot be excluded that the level and/or the 
timing of p35 expression might not be sufficient to inhibit caspase activity during the time window 
of embryonic development of this tissue. 
Loss of function analysis of caspase genes might discriminate these possibilities. There are seven 
different caspases in Drosophila each encoded by a single gene but the only caspase with recorded 
mutant alleles is dcp-1. A lethal P insertion l(2)k05606 located in the dcp-1 gene was originally 
described as a dcp-1 allele causing “fragile tracheae” phenotype among many other defects in 
homozygous mutant larvae (Song et al., 1997). Genetic analysis of the locus revealed that the P 
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insertion affects the function of the pita gene and not of dcp-1, which is inserted in the first intron of 
pita, since independent mutant alleles of pita caused similar phenotypes as the P element insertion 
((Laundrie et al., 2003) and personal communication to K. McCall). Imprecise excision of this P 
element generated null alleles of dcp-1 (Laundrie et al., 2003). These flies are homozygous viable 
and can be maintained as a stable stock indicating that dcp-1 function is not essential in Drosophila. 
As expected these flies showed normal tracheal development during embryogenesis and a 
sensitised, heterozygous dof mutant genetic background did not alter this phenotype (data not 
shown). 
Loss of function phenotype of dronc was analysed using the deficiency Df(3L)AC1. This 
chromosomal deletion removes a genomic region between the cytological breakpoints 67A2 and 
67D11-13, which includes the dronc locus. Based on available complementation analysis and the 
genomic sequence the deleted region spans 133 annotated genes having Rdl as the first distal and 
can as the first proximal gene that are definitely not removed (www.flybase.org). Homozygous 
Df(3L)AC1 embryos showed significant defects in tracheal development (Figure 36). Dorsal trunks 
failed to form and visceral branches did not develop properly. Interestingly, dorsal branches 
appeared always normal and also the anterior and posterior lateral branches were only weakly 
affected with some fusion problems. The severity of the phenotype varied but at least half of the 
dorsal trunks failed to fuse or form and most of the visceral branches were misguided or not formed 
in the embryos. This phenotype indicates that the general motility of tracheal cells might be 
maintained but regional differentiation or migratory guiding information might be affected. No 
other overlapping deficiencies exist in this region which could narrow down the number of potential 
genes causing this phenotype, and genes of this region have not been directly shown to be involved 
in tracheal development. The genes Gap1 and shc code for signalling molecules and are also located 
in the deleted region. Gap1 is GTPase activating protein specific for Ras. Shc is an adaptor protein 
utilised by several RTKs. Shc was reported to be involved in Drosophila EGF signalling (Lai et al., 
1995; Luschnig et al., 2000). EGF plays a role in the regional differentiation of tracheal cells and 
mutations in components of the cascade like rhomboid, DER and spitz cause specific loss of dorsal 
trunks and visceral branches during tracheal development, reminiscent to the phenotype of 
Df(3L)AC1 mutant embryos. 
Thus, this result shows that the deficiency Df(3L)AC1 removes a gene which is essential for 
tracheal development but the identity of this gene is not known. Shc is a potential candidate for this 
function but further analysis of mutant shc alleles is required to clarify this as well as to reveal if 
loss of dronc function contributes to the phenotype. 
 
 
Figure 36. Analysis of tracheal development in embryos homozygous for the deficiency Df(3L)AC1. Stage 
15 (A) wild type embryo or (B) an embryo homozygous for the deficiency Df(3L)AC1 stained with 2A12 
antibody to visualise the lumen of the tracheal network. Note the gaps in the dorsal trunk and the missing or 
stalled visceral branches. 
 
As an alternative approach to eliminate Dronc activity in the tracheae mutant forms of the 
molecule with dominant negative effects were expressed using btlGal4. Overexpression of the 
caspase dead version of full length Dronc or an N-terminal fragment bearing only the CARD 
domain of the molecule has been shown to inhibit Dronc activity efficiently in the developing 
Drosophila eye (Meier et al., 2000). Embryos expressing these constructs in their tracheae showed 
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no significant differences compared to wild type (data not shown). However, 2-3 % of the embryos 
showed aberrations in tracheal branching. Similarly, if constitutively active forms of Dronc were 
overexpressed in the tracheae branching defects were rarely observed but few embryos showed 
abnormalities in their tracheae (data not shown). Thus, it suggests that if Dronc has any role in 
tracheal development its activity might require a tight balancing. However, no significant ratio of 
affected embryos was detected, indicating that overexpression of different mutant Dronc proteins in 
the tracheae did not interfere with the normal embryonic developmental program of this tissue. It 
cannot be excluded that the concentration and timing of the expressed transgenes was not sufficient 
to influence endogenous processes. 
In summary, the genetic analysis for the involvement of Dronc in tracheal development was not 
completed. Future work on loss of function analysis of the gene and in situ detection of Dronc 
activity by specific antibodies directed against activated forms of Dronc as well as genetic studies 
on components of the caspase activating cascade might help to reveal if Dronc is involved in the 
regulation of FGF signalling. 
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2.6 Indications for the translational control of Dof protein levels in S2 
cells 
 
In vivo analysis of the caspase cleavage site mutant form of Dof did not support a physiological 
role of caspase cleavage in the function of the molecule. One explanation might be that dose 
dependent effects of Dof processing are masked due to high levels of transgenic expressions. This 
would than indicate that regulation of Dof protein levels might be an important issue in 
development. This possibility seemed to be interesting to follow up from two reasons. First, 
significant difference was always observed in the expression levels of different Dof constructs 
transiently transfected in S2 cells. Secondly, a ribosomal protein, rpS10 was found to be a yeast two 
hybrid interactor of Dof (Battersby et al., 2003) and this interaction was confirmed in co-
immunoprecipitation assay (see Figure 13C in Chapter 2.1). Two hints that Dof protein expression 
might be controlled in S2 cells and translation might be involved in this control. 
The construct Dof[1-522]  showed much higher protein levels in the cells than all the other Dof 
constructs (Figure 37). Thus, the expression level of the construct Dof[1-446] which had a further 
truncation of 76 amino acids was similar to the ones that contained the C-terminal part. This 
indicated that both the lack of the C-terminal part of Dof as well as the presence of the particular 76 
amino acids might be required for higher protein levels. This difference was specific for Dof 
protein, since co-transfected constitutively active Heartless was expressed at comparable levels in 
all transfections. 
 
 
Figure 37. Expression level of different Dof constructs in S2 cells. Western blots of whole cell lyastes and 
immunoprecipitation (IP) from S2 cells expressing mutant versions of Dof bearing N-terminal FLAG epitope 
tags and a constitutively active form of HA epitope-tagged Heartless (λHtl-2xHA). This figure is an outlet of 
the experiment presented in Figure 16 in Chapter 2.2. For details refer to that. 
 
The first question was from where this elevated protein level derives. Each of these Dof 
constructs was cloned into the same expression vector and transfected into S2 cells using equal 
amounts of DNAs. Protein expression was under the control of the copper inducible metallothionein 
promoter and induction was performed simultaneously in all cells. These argue that differences in 
transcription levels of the different Dof constructs should not be expected. To test this hypothesis 
directly dof mRNA levels of S2 cells transiently transfected with different Dof constructs were 
compared using quantitative real-time RT-PCR on total RNAs isolated from these cells. mRNA 
levels of FLAG-Dof[1-522], FLAG-Dof[1-446] and as controls of FLAG-Dof and FLAG-DofD587E 
were calculated (for details see Materials and Methods). Figure 38A shows the fold mRNA 
expression of these constructs relative to that of the wild type FLAG-Dof. FLAG-Dof[1-522] 
showed a slight increase in transcription levels compared to wild type Dof (ca. 1.3 fold) and FLAG-
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Dof[1-446] mRNA levels were comparable to these values, albeit with high deviation depending on 
the approach reverse transcription was performed. FLAG-DofD587E produced lower amounts of 
mRNA (ca. 0.4-0.5 fold). Thus, the C-terminally truncated Dof constructs did not show significant 
difference in mRNA levels compared to each other or to the wild type Dof construct indicating that 
they are transcribed at comparable levels in S2 cells. The lower transcription levels of FLAG-
DofD587E are not understood. It has to be remarked that FLAG-DofD587E was the only construct with 
a different polyadenylation signal (see Materials and Methods). 
Despite of the similar mRNA levels the protein levels of the different Dof constructs showed 
significant differences on Western blot analysis of the cell lysates of the same transfections which 
were used for RNA isolation (Figure 38B). Equal amounts of cell lysates contained about ten times 
more FLAG-Dof[1-522] than FLAG-Dof[1-446] protein estimated from dilution series of the two 
proteins on Western blots (data not shown). Protein levels of the two full length constructs were 
comparable to that of FLAG-Dof[1-446], although in case of the wild type construct it was hard to 
estimate due to its cleavage in the cells. 
 
 
 
Figure 38. Analysis of the difference in expression levels of mutant Dof proteins in S2 cells. (A) Quantitative 
analysis of the amount of mutant Dof mRNAs transiently expressed in S2 cells by real-time RT-PCR. Bars on 
the diagram show the fold mRNA expression of the mutant Dof constructs marked below each bar relative to 
wild type Dof mRNA levels. Black and grey bars denote two experimental results on the same isolated RNAs 
using random hexamers or dof specific primers for reverse transcription respectively. (B) Western blot of 
whole cell lysates from S2 cells expressing mutant versions of Dof bearing N-terminal FLAG epitope tags, 
and from which RNA was isolated for real-time RT-PCR. Expression level of mutant Dof proteins was 
detected using antibody directed against the FLAG tag. (C-D) Western blot analysis of whole cell lysates 
form S2 cells expressing N-terminally FLAG-tagged wild type and mutant Dof proteins. Cells were lysed after 
different hours as labelled above each lane following the addition of cycloheximide. The amount of Dof 
proteins was monitored by probing the blots with antibody against the FLAG tag. (C) Note, the expression 
level of FLAG-Dof[1-522] at the time point cycloheximide was added (lane “0”) was about sixteen times 
higher than that of FLAG-Dof[1-446]. (D) Note that whole cell lysate from S2 cells expressing FLAG-DofD587E 
also contained N-terminal fragments of Dof after eight hours of incubation with cycloheximide (lane “8”). 
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In summary, elevated protein levels of the construct containing the first 522 amino acids of Dof 
was not combined with significantly increased mRNA levels compared to other Dof forms, 
indicating that the difference might be restricted to protein levels. However, further numbers of 
independent experiments might be optional to confirm these data statistically. 
To test whether the accumulation of higher protein levels of FLAG-Dof[1-522] was due to 
higher stability of the protein the half life of different mutant Dof proteins was monitored in S2 
cells after blocking de novo protein synthesis with 20 µM cycloheximide. Metabolic labelling of the 
cells with [35S]-methionine confirmed that this concentration of the drug was sufficient to block 
translational activity of S2 cells completely (data not shown). Both C-terminally truncated Dof 
proteins showed high stability, FLAG-Dof[1-446] appeared as stable as FLAG-Dof[1-522] (Figure 
38C). The stability of full length wild type Dof could not be determined because it was processed in 
the cells (Figure 38D). However, the simultaneous increase in the level of the N-terminal cleavage 
product with the disappearance of the intact Dof form indicated that full length Dof was not 
degraded in the cells but only processed into the cleaved form. This is supported by the observation 
that the caspase site mutant Dof protein which was not cleaved appeared also stable in the cells. 
However, at eight hours after the addition of cycloheximide even the caspase site mutant Dof 
molecule was processed to some extent in the cells. This result suggests that the introduced point 
mutation at amino acid position 587 in Dof did not completely eliminated being a substrate for 
caspases. Translational block induces programmed cell death, which activates caspases in the cell. 
In consistence with this about 40 % of the cells were apoptotic after incubation with cycloheximide 
for eight hours compared to the 5-8 % at the time point when the drug was added (data not shown). 
Thus, the cleavage of DofD587E might be an issue of higher caspase concentrations but it can not be 
similarly excluded that proteases including caspases cleaved DofD587E which were not present in S2 
cells under the conditions the effect of the point mutation was verified. This phenomenon was not 
analysed further. 
In summary, no significant differences were detected in the stability of the two C-teminally 
truncated forms of Dof. They both showed also comparable mRNA levels in the cells suggesting 
that the elevated protein levels of the construct FLAG-Dof[1-522] might derive from an increased 
level of translation. 
 
How can cause a 76 amino acid long stretch such a high difference in translation levels? 
Theoretically two mechanisms are possible: this region could play a regulatory role as RNA giving 
a secondary structure to the mRNA that can be more efficiently transcribed than the mRNA coding 
for the shorter Dof construct. Alternatively the 76 amino acid region could be responsible for a 
regulatory protein-protein/-RNA interaction which than through an unknown mechanism could 
increase the translation rate of the own mRNA. The ribosomal protein S10 (rpS10) belonged to the 
potential interacting partners of Dof identified in a yeast two hybrid screen and this interaction was 
confirmed in co-immunoprecipitation experiments with full length Dof in S2 cells (see Figure 13C 
in Chapter 2.1). Since protein translation is linked to ribosomes, rpS10 seemed to be a good 
candidate to contribute in the translational regulation of Dof. 
The region in the Dof protein responsible for rpS10 binding was mapped by 
immunoprecipitation using different deletion constructs of Dof. The Dof construct lacking the last 
200 amino acids as well as constructs with inner deletions which remove the DBB domain or/and 
the Ankyrin repeats interacted with rpS10 as efficiently as wild type Dof (Figure 39 and data not 
shown). The construct FLAG-Dof[1-522] co-immunoprecipitated  also efficiently with the 
ribosomal protein whereas FLAG-Dof[1-446] failed to interact with rpS10 (Figure 39). Thus, the 
amino acid region 447-522 was identified as a binding site for the ribosomal protein S10 in Dof. 
Strikingly, this region is responsible for the increased translation level of the construct FLAG-
Dof[1-522]. Hence, the capability of FLAG-Dof[1-522] to interact with rpS10 correlated with an  
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Figure 39. Interaction of the ribosomal protein S10 with mutant forms of Dof. Western blots of whole cell 
lyastes and immunoprecipitations (IP) from S2 cells expressing HA epitope-tagged ribosomal protein S10 
(rpS10, identical to the i-clone i14) and mutant versions of Dof bearing N-terminal FLAG epitope tags. 
Protein complexes were immunoprecipitated from the lysates using antibody against HA, and the 
precipitated proteins were detected on the Western blots using anti-FLAG or anti-HA antibodies. The asterisk 
marks the heavy chain of the HA antibody used for IP. Note that protein content of the lysate was improperly 
denaturated before SDS-PAGE (“smeary” lanes on the Western blot probed with anti-FLAG antibody). 
 
 
elevated translation of the molecule, suggesting that rpS10 might contribute to the translational 
regulation of Dof. 
To test if the presence of FLAG-Dof[1-522] in the cells could “inherit” translational upregulation 
to other dof transcripts it was co-expressed with wild type Dof or full length Dof bearing a point 
mutation in the caspase cleavage site in S2 cells. FLAG-Dof[1-522] did not influence the 
expression levels of the two other Dof constructs (data not shown). This indicates that the process 
utilised by FLAG-Dof[1-522] can not be generalised for Dof transcripts as such. Further analysis is 
required to see if translational regulation of FLAG-Dof[1-522] is relevant for wild type Dof and if 
yes what the minimal requirements are for the upregulation of wild type Dof protein levels. This 
might help to understand the mechanism and the potential physiological relevance of the 
translational regulation of Dof.  
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2.7 The role of Ras effectors in FGF signalling in Drosophila  
 
FGF signalling provokes complex cellular responses involving cell migration and differentiation. 
Migration is based on the quick and dynamic remodelling of the cytoskeleton while differentiation 
is manifested in reprogrammed gene expression. How the different effectors are activated during 
FGF signalling in flies is not understood. Dof is essential in FGF signalling and has diverse 
interaction partners (Battersby et al., 2003; Imam et al., 1999; Michelson et al., 1998; Vincent et al., 
1998). Thus, Dof might have the capacity to activate different molecules and serve as a branching 
point in FGF signal transduction. In addition, downstream signalling cascades might diverge at a 
different point; a possible point is Ras. Constitutively active Ras efficiently overcome defects of dof 
loss of function mutation if specifically overexpressed in the affected tissues, indicating that Ras 
might play a central role in transmitting the FGF signal towards downstream effectors (Imam et al., 
1999; Michelson et al., 1998; Vincent et al., 1998). Ras can activate several known effectors in a 
GTP-dependent manner. One known essential Ras effector pathway of FGF signalling is the 
activation of the Raf-Mek-MAPK cascade. However, activated Raf has less stronger capacity to 
rescue dof mutant phenotypes than Ras. This raises the question whether Ras effector pathways 
other than MAPK activation are utilised in FGF signalling. So far the only evidence for the 
involvement of Ras protein in FGF-dependent developmental processes during Drosophila 
embryogenesis comes from expression studies of constitutively active Ras (Gisselbrecht et al., 
1996; Imam et al., 1999; Michelson et al., 1998; Michelson et al., 1998; Reichman-Fried et al., 
1994; Vincent et al., 1998). This bypasses the need of activation by endogenous factors. Several 
Ras effectors can be activated also by the Ras related small GTPase Rap1. In endogenous situations 
these two GTPases are regulated independently but in overexpression studies they might take over 
functions of each other. It raises the other question, to what extent Ras is the endogenous transmitter 
of the FGF signal during Drosophila embryogenesis. 
At present there are six known GTP-dependent Ras effectors: Raf, the MAPK inhibitors IMP and 
RIN, PI3K, the Ral specific guanine nucleotide exchange factor RalGDS and AF6/Canoe (see 
Introduction). Ras proteins containing point mutations in the Ras effector loop were tested for 
binding affinity towards the three best studied effectors Raf, PI3Kand RalGDS in mammalian cell 
culture systems (Rodriguez-Viciana et al., 1997; White et al., 1995). Amino acid position 35 in Ras 
proved to be essential for PI3K and RalGDS but not for Raf binding, since mutation of it led to 
specific Raf interaction but loss of PI3K and RalGDS interaction. Mutation of amino acid 37 
generated specific binding for RalGDS whereas mutation at amino acid position 40 resulted in 
exclusive PI3K binding of Ras. IMP showed binding only with the effector loop mutant 
Ras1V12,G37 (Matheny et al., 2004). There are no data how these point mutations affect the 
binding of other effectors to Ras. Mammalian Ras1 constructs bearing the described point mutations 
in the effector loop in the background of a point mutation at amino acid position 12 (V12), which 
results in constitutive GTP binding and therefore constitutive activity are available in transgenic 
flies. Several studies verified the specific and distinguishable activities of these constructs 
(Bergmann et al., 1998; Halfar et al., 2001; Karim and Rubin, 1998; Mirey et al., 2003; Therrien et 
al., 1999). In the original mammalian cell culture studies the RasS35 effector loop mutant showed a 
weakened (ca. 30%) affinity to Raf compared with the wild type effector loop form (Rodriguez-
Viciana et al., 1997), whereas in Drosophila systems they had comparable activity (Karim and 
Rubin, 1998). 
Ras itself as well as components of the different downstream effector pathways including Raf, 
Mek, MAPK, PI3K, DRal and the two fly homologues of RalGDS Rgl1 and Rgl2 are maternally 
deposited in Drosophila eggs. Effects of zygotic mutations in their respective genes might show 
little or no effect because of the high maternal contribution. Germline clone analysis could 
overcome this problem. However, since these effectors play general roles in many different 
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signalling events germline clone analysis might be suitable to study early developmental processes 
but becomes less interpretable in the time course of development with the accumulation of 
secondary defects. Therefore to obtain insight into their loss of function and gain of function effects 
in FGF-dependent processes we analysed the consequences of tissue specific expression of 
dominant negative and constitutively active versions of the different molecules. We also took 
advantage of the available effector loop mutant Ras alleles. Mesoderm differentiation and tracheal 
development were chosen as two FGF dependent processes to study the signalling pathway 
downstream of dof. 
FGF signalling has a biphasic role during mesoderm formation (Michelson et al., 1998). First, it 
is essential in the initial contact formation with the ectoderm. This early event is ras independent 
(Wilson, 2004). However, expression of constitutively active Ras (UAS-RasV12) with the 
mesoderm specific driver twiGal4 can improve dorsal migration of mesodermal cells in dof mutant 
embryos to some extent (Michelson et al., 1998; Vincent et al., 1998) indicating that subsequent 
migration processes might use Ras-dependent molecular mechanisms. Nevertheless some cells of 
the collapsed mesodermal tube can eventually reach the competence zone for dorsal mesoderm 
differentiation even without active migration (Schumacher et al., 2004; Smallhorn et al., 2004). 
Subsequently, FGF signalling is involved in the cell fate specification of a subset of dorsal 
mesodermal cells which is manifested in the specific expression of Even-skipped (Michelson et al., 
1998). The formation of pericardial progenitors depends on FGF signalling-induced MAPK 
activation, whereas DA1 muscle progenitors get a dual input from FGF and EGF signalling to the 
common Ras-MAPK cascade (reviewed in (Michelson et al., 1998)). Progenitors are singled out 
from the initial competence cluster of equivalent cells by Notch mediated lateral inhibition that 
antagonises with the Ras/MAPK cascade (Carmena et al., 2002).  
 
2.7.1 The capacity of effector loop mutant Ras transgenes to rescue dof mutant 
phenotypes 
 
Rescue of mesoderm development 
 
Expression of RasV12 in the mesoderm of dof mutant embryos rescues the formation of Eve-
positive clusters in the mesoderm and Even-skipped is expressed within the whole competence 
cluster - similarly as in wild type embryos expressing RasV12  ((Michelson et al., 1998) and Figure 
40C). This shows that constitutive high levels of Ras activity in the cluster overcome the 
antagonising effects of Notch signalling in all cells and thus, progenitors fail to single out from the 
cluster. Furthermore, it shows that wild type cells and dof mutant mesodermal cells in the “dorsal 
fate” competence zone behaved similarly upon overexpression of constitutively active Ras. dof 
mutant embryos expressing RasV12 showed a nearly wild type number and an overall coordinated 
appearance of Eve-clusters. This effect could be due to the simultaneous rescue of migration and 
“dorsal” FGF signalling. However we do not have direct evidence that dof mutant mesodermal cells 
were not able to contact ectodermal regions with Dpp levels sufficient for dorsal fate induction in a 
regular manner. 
The constitutively active effector loop mutant Ras constructs, RasV12,S35 and RasV12,G37 both 
showed a strong rescue of Eve-positive cells in dof mutant embryos (Figure 40D,E). RasV12,G37 
was comparable in its rescue capacity with RasV12 in reconstituting the number of hemisegments 
with Eve-positive cells (summarised in Figure 44). On the other hand, the size of rescued Eve-
positive clusters appeared smaller with the effector loop mutant Ras constructs than with RasV12. 
Elevated expression levels of these alleles through the combination of a maternal Gal4 driver with 
twiGal4 increased the size of Eve-positive clusters comparable to the size observed with RasV12  
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Figure 40. Capability of different mutant Ras proteins to rescue dof mutant phenotype in the mesoderm. 
Stage 11 embryos expressing different mutant UAS-Ras constructs under the control of the twistGal4 driver 
are stained with Even-skipped antibody to visualise Eve-positive pericardial progenitor cells. (A) wildtype 
embryo, (B-H) dof mutant embryos (B) without or (C-H) with ectopic expression of (C) Ras1V12, (D) 
Ras1V12,S35, (E) Ras1V12,G37 and (F) Ras1C40 and with combined expression of (G) Ras1S35 and Ras1C40 or (H) 
Ras1V12 and DRal25N. Note the variation in the size as well as in the number of Eve-positive clusters between 
the different genotypes. Anterior to the left. 
 
(data not shown), indicating a dose dependent behaviour. This could be due to a lower activity of 
these alleles compared to RasV12 or due to different expression levels of the transgenes. In 
consistence with their similar rescue capacity, both mutant Ras molecules induced comparable 
levels of activated MAPK in the Eve-positive clusters (data not shown). RasV12,G37 was reported 
to have some residual Raf interaction capacity (ca. 10% of RasV12,S35) (Rodriguez-Viciana et al., 
1997). An interesting question is whether this residual Raf binding capacity of RasV12,G37 is 
sufficient to activate MAPK and rescue Eve-positive cells as efficiently as RasV12,S35, which has 
about ten times higher affinity for Raf. It points out the possibility that these point mutations 
differentially affect a Ras induced, Raf independent regulation of MAPK activity. It would be 
consistent with the fact that the Ras effector IMP which regulates MAPK activity at the level of 
Mek activation can specifically interact with RasV12,G37 but not with RasV12,S35 (Matheny et 
al., 2004). 
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The residual Raf binding capacity of RasV12,G37 did not allow to discriminate whether the 
RalGDS binding capacity of RasV12,G37 had an input on the rescue of Eve-positive clusters. To 
test the contribution of Ral GTPase in Ras dependent effects on mesoderm development 
constitutively active Ras was expressed in combination with the dominant negative form of 
Drosophila Ral (DRal25N) under the control of twiGal4 in dof mutant embryos. This simultaneous 
expression caused a less reliable rescue with high variability in the number, size and position of 
Eve-positive cells compared to the one of RasV12 alone (Figure 40H, and summarised in Figure 
44). Interestingly, expression of DRal25N via twiGal4 in wild type embryos had no effect on the 
formation of Eve-clusters (data not shown, summarised in Table 4). Dominant negative constructs 
need a certain latency period to accumulate high concentrations to be able to interfere with 
endogenous components. In the co-expression situation constitutively active Ras accumulated with 
the same timing as the antagonising DRal25N in the cells. It might be that in the wild type situation 
activated Ras starts to accumulate prior the expression of DRal25N and the sensitive period is 
already passed by the time of high dominant negative DRal concentrations. A relevant example is 
the twiGal4 driven expression of the dominant negative form of Heartless, the mesoderm specific 
FGFR in Drosophila (DNHtl). It does not affect mesoderm migration, cells are able to reach dorsal 
most positions in the presence of DNHtl, but it affects Eve-positive cluster formation, indicating 
that sufficient inhibitory levels of the dominant negative molecule accumulated only by the second 
phase of FGF signalling (Michelson et al., 1998). This suggests that DRal might be involved in the 
first, migratory phase of mesoderm development. 
A clearly distinct phenotype was observed by the expression of RasV12,C40 in dof mutant 
embryos, which failed to rescue Eve-positive cells in the mesoderm (Figure 40F, summarised in 
Figure 44). This effector loop mutant represents a “PI3K specific Ras” molecule with no detectable 
affinity towards Raf (Rodriguez-Viciana et al., 1997). Consistent with this no MAPK activation was 
observed in the mesoderm (data not shown). This is in accordance with the fact that MAPK activity 
is required to induce Eve expression (Carmena et al., 1998). To distinguish the possibilities of PI3K 
activity not being required or being involved but alone not being sufficient for mesoderm 
development, RasV12,C40 was expressed together with RasV12,S35 in dof mutant embryos. In the 
first case no improvement in Eve-cluster formation was expected whereas the second case would 
have a synergistic effect on the rescue of Eve-positive cells. The simultaneous expression of the two 
mutant Ras constructs led to a reduction in the number of Eve-positive clusters compared to the 
experiment where RasV12,S35 was expressed alone (Figure 40G, summarised in Figure 44), 
indicating that PI3K activity might be not required for the formation of Eve-clusters. Furthermore 
RasV12,C40 seems to have a dominant negative effect perhaps through its inability to bind Raf by 
probably diluting out the local concentration of Ras-Raf complexes at the plasma membrane or 
titrating out other Ras interacting factors. 
 
Rescue of tracheal development 
 
The same mutant Ras transgenes were tested for their capacity to rescue dof mutant phenotypes 
in the tracheae. Ras constructs were expressed by btlGal4 in dof mutant embryos and their rescue 
capacity was quantified by counting the number of reconstituted dorsal trunk fusions (summarised 
in Figure 44). Tracheal network was visualised via the lumen specific antibody 2A12, therefore in 
our assay, successful fusion meant continuous lumen formation between adjacent dorsal trunks. The 
expression of constitutively active Ras partially rescued dof mutant tracheal defects ((Imam et al., 
1999; Vincent et al., 1998) and Figure 41C). It appeared very potent to reconstitute dorsal trunk 
junctions but several missing or misdirected branches could be observed. RasV12,S35 provided a 
significantly weaker rescue (Figure 41D). In further contrast to the mesodermal data RasV12,G37 
behaved very differently from RasV12,S35 in the tracheal system. It rescued migration in the sense  
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Figure 41. Capability of different mutant Ras proteins to rescue dof mutant phenotype in the trachea. Stage 
15 embryos expressing different mutant UAS-Ras constructs under the control of the btlGal4 driver are 
stained with 2A12 antibody to visualise the lumen of the tracheal network. (A) wildtype embryo, (B-F) dof 
mutant embryos (B) without or (C-F) with ectopic expression of (C) Ras1V12, (D) Ras1V12,S35, (E) Ras1V12,G37 
and (F) Ras1C40. Anterior to the left. Scale bar represents 100 µm. 
 
that branches grew out from the tracheal trunk but dorsal trunk fusion impaired remarkably and 
showed a wide variation in the embryos (Figure 41E, summarised in Figure 44). This weak rescue 
might be explainable with the residual Raf binding activity of RasV12,G37. To test independently 
whether Ral GTPase activity contributes to tracheal development, dominant negative DRal was 
overexpressed by btlGal4. No tracheal defects could be observed even at increased expression 
levels by using two copies of btlGal4 (data not shown). As discussed above certain driver lines turn 
on gene expression early enough to enable manipulations with active molecules in tissue specific 
manner but too late to show effects with dominant negative constructs in the same developmental 
process due to the required lag/accumulation phase of this type of molecules. To circumvent this 
potential problem we took advantage of an available heat shock inducible dominant negative 
mammalian RalA construct (hs-RalA28N). Heat shock induced expression of RalA28N in wild type 
embryos prior to tracheal pit formation interfered with later tracheal development (Figure 41G). 
Control embryos subjected to the same heat shock conditions did not show tracheal fusion defects 
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(data not shown). Nevertheless it cannot be excluded that RalA28N acted on the tracheae in a non-
autonomous manner or its effect was only a secondary consequence of defects in unrelated 
developmental processes. In summary, we have no direct evidence that the RasV12,G37 induced 
tracheal branching in dof mutant embryos is a consequence of RalGDS activation. 
The effector loop mutant RasV12,C40 showed identical behaviour in the tracheae as observed in 
the mesoderm. It could not rescue any aspects of tracheal branching or fusion (Figure 41F). This 
further indicates that Raf binding capacity of Ras might be essential to induce tracheal branching. 
 
2.7.2 Capacity of known downstream effectors of Ras to rescue dof mutant 
phenotypes 
 
Analysis of effector loop mutant Ras constructs indicated that the Raf binding affinity of Ras is 
essential for its rescue capacity in dof mutant embryos. However these experiments also suggested a 
role of Ras for Raf-independent MAPK regulation and for Ral GTPase activation. To test to what 
extent Raf activation can overcome dof mutant phenotype in the developing mesoderm and 
tracheae, a constitutively active Raf transgene (actRaf) was expressed under the control of twiGal4 
and btlGal4 respectively. Surprisingly, constitutively active Raf was completely unable to rescue 
Eve-positive cells in the mesoderm (Figure 42A). 
 
 
 
Figure 42. Constitutively active forms of different Ras effectors have weak if any capacity to rescue dof 
mutant phenotypes. dof mutant embryos expressing (A,B) UAS-actRaf, (C,D) UAS-Rgl2CAAX or (E,F) UAS-
DRal20V (A,C,E) in the mesoderm under the control of twiGal4 or (B,D,F) in the tracheae driven by btlGal4. 
(A,C,E) Stage 11 embryos are stained for Even-skipped to visualise Eve-positive cell clusters in the 
mesoderm. Note the lack of signal in the mesoderm; the signal out of focus derives from Eve-positive cells of 
the CNS. (B,D,F) Stage 15 embryos are stained with the trachea lumen specific 2A12 antibody. Anterior to 
the left. 
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To distinguish between the different possibilities why actRaf failed to induce dorsal mesodermal 
fate we monitored the presence of activated MAPK in the mesoderm during the period of Eve-
positive cell fate determination. Activated MAPK accumulated in cells at positions of the Eve-
positive competence clusters (Figure 43D-F). Thus, mesodermal cells must have reached dorsal 
positions and constitutively active Raf was able to activate MAPK. There are three different 
explanations why actRaf was not able to turn on Even-skipped expression in dorsal mesodermal 
cells: (i) activated MAPK levels were not sufficient to induce Eve expression, (ii) Ras might have 
Raf independent regulatory role on MAPK activation or (iii) Ras dependent regulation of additional 
factors might be required to turn on Even-skipped expression. Future work is required to 
discriminate these possibilities. 
 
 
Figure 43. Constitutively active Raf and DRal are able to induce MAPK activation in the mesoderm. (A-I) 
Single optical sections showing the posterior one third of stage 11 embryos stained for (A,D,G) Even-skipped  
and for (B,E,H) phosphorylated MAPK (dpErk).(C,F,I) shows an overlay of the to signals (Eve red, dpErk 
blue). In (A-C) wild type embryos Even-skipped colocalises with dpErk accumulation. (D-I) dof mutant 
embryos expressing (D-F) UAS-actRaf or (G-I) UAS-DRal20V under the control of twiGal4 show dpErk 
accumulation but no Even-skipped expression in the mesoderm. Arrowheads indicate examples of dpErk 
positive cells in the mesoderm; tp marks trachea pits with high accumulation of dpErk induced by EGF 
signalling. Dorsal up, anterior to the left. Scale bar 50µm. 
 
In the tracheae actRaf behaved differently. It was able to rescue tracheal cell branching in dof 
mutant embryos, albeit at a much weaker level than RasV12 or RasV12,S35 ((Vincent et al., 1998), 
Figure 42B and summarised in Figure 44). Tracheal branches had an uncoordinated appearance, 
more than half of the dorsal trunks failed to fuse and formation of ectopic secondary branches could 
be observed. On the other hand the same Raf construct was reported to be able to turn on the MAPK 
target gene DSRF (Drosophila Serum Response Factor) in the tracheae of dof mutant embryos with 
similar efficiency as RasV12, indicating that it induced MAPK activation and subsequent 
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transcriptional activation efficiently (Vincent et al., 1998). Thus, the higher capacity of the “Raf 
specific” effector loop mutant RasV12,S35 to rescue tracheal migration might be independent of its 
MAPK activating function and other downstream effectors might be responsible for it. However, 
we cannot exclude differences in the strength and expression level of the different transgenic 
constructs. 
 
 
 
Figure 44. Capacity of mutant forms of different signalling molecules to rescue dof mutant phenotypes in the 
embryo.  Mutant signalling molecules tested in in vivo assays are listed on the left. All represent UAS 
transgenic constructs. See text for details of the mutations. To achieve a comparison for the ability of the 
transgenes to rescue mesoderm development the number of Eve-positive clusters formed on one lateral side 
of stage 11 embryos was determined following twiGal4 (black bars) or both twiGal4 and a maternal Gal4 
(grey bars) driven expression of the constructs. To assess the ability of a transgene to rescue tracheal 
development, transgene expression was driven by btlGal4 followed by counting the junctions formed by the 
dorsal trunk on one lateral side of stage 15 embryos. The diagrams show the average number and standard 
deviation of the counted structures. Number of embryos analysed in each experiment is depicted on the 
diagram. Both lateral sides of each embryo were counted and taken as independent values. 
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Next, components of the RalGDS effector cascade were analysed. Drosophila has a single 
RalGDS family RalGEF homologue encoded by the rgl gene (Mirey et al., 2003). It has two 
isoforms, Rgl1 and Rgl2. To achieve constitutively active Rgl molecules, a CAAX lipid 
modifications signal was introduced into the protein (Mirey et al., 2003). Rgl1CAAX, Rgl2CAAX 
or the constitutively active form of Drosophila Ral GTPase (DRal20V) were expressed in dof 
mutant embryos under the control of twiGal4 or btlGal4. The observed phenotype was identical in 
all cases: complete failure to rescue Eve-positive clusters or tracheal branching (Figure 42C-F and 
data not shown). Surprisingly, constitutively active Rgl1, Rgl2 and Ral were able to induce 
activated MAPK accumulation at positions of Eve-positive competence clusters in the mesoderm 
(data not shown and Figure 42G-I). Thus, the “RalGDS specific” RasV12,G37 might not 
(exclusively) rely on its residual Raf binding capacity to activate MAPK but might do it in a Ral 
dependent manner. This might explain the observed comparable efficiency of RasV12,S35 and 
RasV12,G37 to accumulate phosphorylated MAPK and to rescue the formation of Eve-positive 
cells. It is not understood at present what mechanism might lie behind Ral-mediated MAPK 
activation. 
Cell culture studies showed that Raf and RalGDS have a synergistic effect in cell transformation 
and differentiation (Okazaki, 1997). Effector loop mutant Ras proteins might still utilise cooperative 
action of Raf and Ral due to their residual binding properties, which might explain their rescue 
capacity and the lack of rescue potential of the single effectors. To test if simultaneous action of Raf 
and Ral is sufficient for efficient rescue of dof mutant phenotypes, constitutively active Raf was 
expressed together with Rgl1CAAX, Rgl2CAAX or DRal20V in the mesoderm and in the tracheae 
of dof mutant embryos. These embryos showed indistinguishable phenotypes from the one obtained 
by the expression of actRaf alone; thus, no Eve-positive clusters in the mesoderm and weak 
branching capacity of tracheal cells (data not shown). This indicates the requirement of additional 
Ras function(s) for efficient signal transmission during these processes. This Ras function could 
have a direct role in the spatio-temporal coordination of Raf and Ral activity or could be 
independent of these effectors. 
 
2.7.3 Dominant effects of constitutively active Ras effectors 
 
Constitutively active Ras induces Eve-positive clusters with supernumerary cells in the 
mesoderm and ectopic secondary branches in the tracheae upon ectopic expression in the 
corresponding tissue (Imam et al., 1999; Michelson et al., 1998; Vincent et al., 1998). We analysed 
this effect with the different effector loop mutant forms of Ras. In these overexpression studies 
mutant Ras proteins reflected the activity they showed in the rescue experiments. RasV12,S35 and 
RasV12,G37 were able to form larger Eve-clusters in the mesoderm as well as secondary branches 
at ectopic positions in the tracheae, whereas overexpression of RasV12,C40 did not influence these 
developmental processes at a detectable level (data not shown and Figure 45A). This indicates that 
the phenotypes caused by RasV12 overexpression depend on Raf and RalGDS but not on PI3K 
mediated processes. To confirm this, constitutively active forms of Raf, Rgl1, Rgl2 and DRal were 
overexpressed by twiGal4 and btlGal4. Both, Raf and the three RalGDS effector pathway 
components formed ectopic secondary branches in the tracheae upon overexpression (data not 
shown and Figure 45B-D). Their appearance was variable ranging from small “papilloma-like” 
protrusions of the lumen to multiple-branch structures. The different rescue capability of 
consitutively active Raf and Rgl/DRal suggests that the formation of these secondary branches is 
mediated through different mechanisms. ActRaf was able to induce secondary branching even in 
dof mutant embryos indicating that activation of the MAPK pathway might be sufficient to induce 
secondary branches. DRal20V on the other hand was able to act on secondary branch formation  
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Figure 45. Ectopic secondary branches are formed by the overexpression of constitutively active signalling 
molecules in the trachea. Stage 15 embryos expressing (A) UAS-Ras1V12,G37, (B) UAS-Rgl1CAAX, (C) 
UAS-Rgl2CAAX or (D) UAS-DRal20V under the control of btlGal4 are stained with 2A12 antibody to visualise 
the lumen of the trachea network. A’, B’, C’ and D’ are magnifications of areas marked with black boxes on 
A, B, C and D respectively. Anterior to the left. 
 
only in wild type embryos but failed to induce any branching in dof mutants suggesting that its 
activity might require endogenous FGF signalling activity. The observation, that simultaneous 
expression of actRaf and constitutively active Rgl/DRal in dof mutant embryos failed to improve 
rescued levels of tracheal branching obtained by actRaf expression alone, indicates that the FGF 
dependent additional activity required for DRal action is not Raf dependent and so probably 
different from the MAPK cascade. The partial capacity of RasV12,G37 to induce branching in the 
tracheae of dof mutant embryos suggests that this required additional activity might be Ras 
activation dependent. However as mentioned earlier, we cannot exclude the possibility that the 
tracheal branching induced by RasV12,G37 is primarily due to its residual Raf binding capacity. 
In contrast to their effect in the tracheae, no detectable alteration was observed in Eve-cluster 
formation by the ectopic expression of RalGDS effector pathway components in the mesoderm 
(data not shown). Constitutively active Raf was not tested in this assay (data summarised in Table 
4). The fact that MAPK activating capacity of RasV12,G37 in the presumptive Eve-positive 
competence cluster manifested in ectopic Even-skipped expression - but that of 
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DRal20V/RglCAAX did not - suggests that additional Ras dependent functions are required for 
Even-skipped expression. 
 
2.7.4 Ras and/or Rap? – searching for the in vivo players in FGF signalling 
 
To reveal the in vivo function of Ras in FGF signalling we tried to mimic Ras loss of function 
situations in the mesoderm and the tracheae. Mutational analysis was not the tool of choice because 
of reasons discussed above (high maternal contribution, broad developmental function from early 
on). Two strategies were applied to decrease Ras activity in a tissue specific manner: (i) expression 
of dominant negative forms of Drosophila or mammalian Ras proteins or (ii) expression of the Ras 
specific GTPase activating protein Gap1 under the control of twiGal4 and btlGal4. Although all 
three transgenic constructs were efficiently used in different studies (Alvarez et al., 2003; Duchek 
and Rorth, 2001; Lee et al., 1996; Powe et al., 1999), no comparative analysis was available about 
the strength of these transgenes to inhibit Ras activity. Therefore we first tested them in the 
developing Drosophila eyes using the strong GMRGal4 as well as the weaker, R7 cell specific 
SevenlessGal4 driver line (Figure 46). All three constructs caused a rough eye phenotype, albeit 
with very different severity. Ras85DN17, the dominant negative form of Drosophila Ras and Gap1 
had weaker effect. Ras1N17, the dominant negative form of mammalian Ras1 appeared as far the 
most efficient construct to inhibit Ras activity. The same ranking was obtained in the Ras inhibiting 
capacity of the three transgenes with both driver lines (Ras1N17>>Gap1=Ras85DN17), and the 
range of severity in the phenotype correlated with the strength of the drivers. 
Next, the effects of these constructs were analysed in the mesoderm. No detectable alteration in 
the appearance of Eve-positive cells was observed when Ras85DN17 or Gap1 were overexpressed. 
 
 
Figure 46. Comparative analysis of different transgenes in their strength to inhibit Ras activity in the eye. 
Whole-eye views of (A) wild type fly and flies expressing (B,E) UAS-Ras85DN17, (C,F) UAS-Gap1 or (D,G) 
UAS-Ras1N17 under the control of (B,C,D) GMRGal4 or (E,F,G) SevGal4. Note the differences in the 
roughening and size of the eyes. Anterior to the left. 
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Ras1N17 expression by twiGal4 led to the loss of Eve-positive DA1 muscle progenitors with an 
incomplete penetrance but did not influence the formation of Eve-positive pericardial progenitor 
cells (EPCs). The read-out of this at later developmental stages was the lack of DA1 muscle fibers 
in some hemisegments without the loss of EPCs (Figure 47B). It was consistent with the finding of 
other studies, in which the same transgenic combination induced a strong decrease in Eve-positive 
DA1s (greater than 50%), but rarely a loss of Eve-pericardial cells (James B. Skeath personal 
communication). In contrast to this, DN Heartless was able to block both DA1 progenitor and EPC 
formation in a non-selective fashion (Carmena et al., 1998; Michelson et al., 1998). DA1 muscle 
progenitor formation requires the dual input of FGF and EGF signals whereas EPCs rely only on 
FGF signalling. The phenotype we observed was reminiscent of those caused by ectopic expression 
of DN-EGFR or by loss of function mutations of components of the EGF signalling cascade (Buff 
et al., 1998; Carmena et al., 1998). However, it is possible that EPC formation is also Ras 
dependent but that it is not sensitive to this level of Ras1N17. 
 
 
Figure 47. Ectopic expression of dominant negative Ras1 causes loss of DA1 muscles in the mesoderm. 
Stage 14 embryos are stained with Even-skipped antibody to visualise Eve-positive cells in the mesoderm. 
(A) wild type embryo contains two EPCs and a multinuclear DA1 muscle fibre in each hemisegment at this 
stage (magnified on A’). (B) Embryo expressing UAS-Ras1N17 under the control of twiGal4 looses DA1 
muscle fibres in some hemisegments. Note the unaltered number of EPCs (magnified on B’). Anterior to the 
left. EPC, Eve-positive pericardial cell; DA1, dorsal acute 1. Scale bar 50 µm for A’ and B’. 
 
In tracheal expression studies using btlGal4 the three transgenic constructs behaved identically, 
in that they had no effect on any aspects of tracheal network formation detectable with the lumen 
specific 2A12 antibody (data not shown). The use of two copies of btlGal4 did not alter the 
observed phenotype. EGF signalling is involved also in tracheal development; it initiates the 
invagination of tracheal pits and plays a role in the regional differentiation of tracheal branches 
(Llimargas and Casanova, 1999; Wappner et al., 1997). EGF signals through Ras; thus, it was 
surprising that we failed to detect any defects in tracheal morphogenesis upon expression of 
dominant negative Ras. Our earlier experiments with dominant negative DRal as well as other 
studies on embryonic tracheae with dominant negative forms of Rho-family GTPases indicated that 
tracheal development might be insensitive to the level of dominant negative molecules which 
accumulate with the btlGal4 driver line (Wolf et al., 2002). There are no studies on the tracheae 
using dominant negative forms of the EGF receptor or the FGF receptor Breathless under the 
control of the btlGal4 driver. These would be important controls to test whether our observations 
are specific for Ras or EGF and FGF signalling events are insensitive in general to the levels and 
timing of dominant negative factors accumulated by btlGal4 during the time window of our assay. 
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 The only indication for the efficient expression of Ras1N17 by btlGal4 was that it caused 
lethality at late larval/pupal stages (summarised in Table 4). Even assuming that the observation is 
specific for Ras it could not be excluded completely that this is only an issue of critical 
concentrations of the dominant negative construct. However, one possible explanation might be that 
other factors are involved in the transmission of the signal from the FGF (and EGF in the tracheae) 
receptors towards downstream effectors. The small Ras-related GTPase Rap1 is able to activate 
several known Ras effectors. 
To test the potential involvement of Rap1 in tracheal development, a dominant negative form of 
Rap1 (Rap1N17) was expressed under the control of btlGal4. This approach was chosen based on 
the same consideration as in the case of Ras. In contrast to Ras1N17, Rap1N17 expression caused 
significant defects in the formation of the tracheae (Figure 48A,B). Remarkably, this was the only 
dominant negative construct in our assays that caused tracheal defects upon expression with 
btlGal4. The phenotype was variable but general in the sense that it affected all the different 
branches of the tracheal network. The formation and proper directionality of visceral branches was 
frequently affected, lateral branches were missing which often led to defects in lateral trunk fusion. 
Dorsal branches stalled occasionally or were misled and in the most severe cases several gaps were 
observed in the dorsal trunk, indicating a role of Rap1 in tracheal development. 
To test if Rap1 might be sufficient to transmit FGF signal during tracheal development, a 
constitutively active version of the protein (Rap1V12) was expressed with btlGal4 in dof mutant 
embryos. It had a weak, but significant capacity to induce tracheal branching and to induce the 
 
 
Figure 48. Effects of mutant forms of Rap1 in in vivo assays. (A-D) stage 15 embryos stained with 2A12 
antibody to visualise the lumen of the tracheal network. (E,F) stage 11 embryos stained with Even-skipped 
antibody to visualise Eve-positive clusters in the mesoderm. (A,B) embryos expressing the UAS-Rap1N17 
transgene (A and B two independent insertion lines) under the control of btlGal4. (C,E) control wildtype 
embryos. (D,F) dof mutant embryos expressing UAS-Rap1V12 driven by (D) btlGal4 or (F) twiGal4. In A and 
B arrowheads, black asterisks and red asterisks indicate gaps in the dorsal trunk, missing ganglionic 
branches and missing or misleaded visceral branches respectively. Anterior to the left. 
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formation of dorsal trunk fusion occasionally (Figure 48D). Thus, constitutively ative Rap1 was not 
able to efficiently take over the function of constitutively active Ras in the tracheae indicating that 
they might have differences in affinity towards downstream effectors. We have to remark the 
possibility for differences in the expression levels of the two transgenes. All these data suggest that 
both Ras and Rap1 might have in vivo functions in tracheal development probably acting in parallel. 
In mesodermal expression constitutively active Rap1 could partially circumvent the dof mutant 
phenotype, showed higher activity then in the tracheae but remained less efficient compared to 
constitutively active Ras (Figure 48F, summarised in Figure 44). Further loss of function studies are 
required to confirm the role of Rap1 in FGF dependent developmental processes in the mesoderm. 
 
Table 4. Effects of tissue specific expression of different mutant signalling molecules on 
the development of Drosophila 
 Tissue morphology Survival rate 
 Mesoderm 
Effect on Eve positive 
clusters 
Tracheae 
Effect on tracheal network 
formation 
flies emerged x 100 
flies expected 
 twiGal4 btlGal4 twiGal4 btlGal4 
UAS-RasV12 bigger clusters ectopic secondary branches 0% 0%
UAS-RasV12,S35 bigger clusters ectopic secondary branches 3% 0%
UAS-RasV12,G37 bigger clusters ectopic secondary branches 104% 16%
UAS-RasV12,C40 no effect no effect 93% 93%
UAS-actRaf n.d. ectopic secondary branches 0% 0%
UAS-Rgl1CAAX no effect ectopic secondary branches 1% 0%
UAS-Rgl2CAAX no effect ectopic secondary branches 2% 0%
UAS-DRal20V no effect ectopic secondary branches 1% 11%
UAS-Rap1V12 n.d. n.d. 34% n.d. 
UAS-Ras85DN17 no effect no effect 95% 123%
UAS-Gap1 no effect no effect 95% 38%
UAS-Ras1N17 missing DA1 muscle 
progenitors, no effect on 
pericardial cells 
no effect 0% 1%
UAS-DRal25N no effect no effect 107% 0%
hs-RalA28N n.d. missing lateral and dorsal  
branches, fusion defects 
number of dorsal trunk 
fusions: 6.25+1.48 
n.d. n.d. 
UAS-Rap1N17 n.d. missing lateral, dorsal and 
visceral branches 
fusion defects 
99% 
101% 
25%
34%
Mutant signalling molecules tested in in vivo assays are listed on the left. They represent UAS transgenes 
with the exception of RalA28N, which is under the control of a heat shock promoter. Transgenes with 
described constitutive activity (top) are separated with a dashed line from transgenes which showed 
dominant negative effects in other studies (bottom). UAS transgenes were expressed under the control of 
twiGal4 and btlGal4 followed by descriptive analysis of Eve-positive clusters and tracheal network formation 
respectively. To test how UAS transgenes effect vitality by tissue specific expression flies heterozygous / 
hemizygous either for the UAS transgene or for the driver line were crossed to each other. Thus, the number 
of emerged flies with and without transgenic expression was expected to be equal. Survival rate was 
calculated by dividing the number of emerged flies with transgene expression (=flies emerged) through the 
number of emerged flies without transgene expression (=flies expected). To follow chromosome segregation 
balancer chromosomes or sex determination were used. The way of calculation could not take attention 
about the effects of balancer chromosomes or transgene function independent effects of transgenic 
chromosomes (some UAS transgene insertions are homozygous lethal) on vitality. 
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3. Discussion 
 
The FGF signal transducer molecule Dof is essential in all known aspects of FGF signalling in 
Drosophila. It has been shown to act upstream of the conserved Ras-MAPK pathway and has been 
proposed to serve as an adaptor molecule transmitting the signal from the FGF receptor to the 
MAPK cascade and probably to other effectors. Dof does not share sequence similarity with factors 
involved in FGF signalling in vertebrates. Its vertebrate homologues BCAP and BANK are 
involved in B-cell receptor signalling which indicates that the ancestor gene lost its role in FGF 
signalling but gained an adaptor function in a novel signalling cascade during vertebrate evolution. 
However, the downstream effector cascades utilised in FGF signalling are conserved from worms to 
humans. How and to what extent Dof can activate these conserved pathways and what different 
roles it might have compared to its vertebrate functional relatives is not known. In this project Dof 
mediated interactions were characterised especially the interaction of Dof with the FGF receptor to 
obtain an insight into the mechanism of Dof function. Furthermore, potential post-translational 
modifications of the protein were analysed with respect on their physiological relevance in the 
function of Dof. In the last part of this work the role of downstream effector pathways of the FGF 
signalling cascade was investigated. 
 
3.1 Interaction of Dof with yeast two hybrid interactors 
 
Selected candidates of an earlier yeast two hybrid screen using Dof as bait were analysed for 
their interaction with Dof in Drosophila S2 cells by immunoprecipitation assay. The selection was 
based first of all on structural and functional characteristics of the yeast interactors and did not 
considered classical criteria used at the verification of yeast two hybrid interactions, e.g. different 
growth behaviours under different selection conditions, the reading frame of the identified clones or 
the number of identified clones representing the same interactor. In fact, immunoprecipitation data 
showed, that these criteria are not necessary valid for discrimination of interactions. Interactors 
identified as single clones growing only under less stringent selection conditions (e.g. i188 and i25 
coding for CG11275 and gustavus respectively) or the interactor i14 (coding the ribosomal protein 
S10), the clones of which were out of frame with the Gal4 activation domain sequence appeared as 
strong interactors in our immunoprecipitation assay, indicating that they represented equally potent 
interaction candidates. In general, the yeast two hybrid screen appeared as a reliable pre-selection 
for proteins that were able to form a complex with Dof in Drosophila cell culture assay. 
Dof interacted in the immunoprecipitation assay with itself, with the FGF receptor Heartless, 
with the SUMO conjugating enzyme Ubc9 and with the ribosomal protein S10. In this work the 
functional relevance of these interactions was investigated in more detail and will be discussed 
latter. The immunoprecipitation experiments also confirmed that Dof might bind and directly 
transduce the FGF signal to potential regulators of actin cytoskeleton (i19 - CDEP) and membrane 
trafficking (i52 - GAP69C). It also might be involved in the establishment and maintenance of 
epithelial integrity (i8 - sinuous). The signal dependent recruitment of the regulatory subunit of the 
protein phosphatase PP2A was reported to regulate the activation of the MAPK cascade (Ory et al., 
2003). Thus, the interaction of Dof with a regulatory subunit of the protein phsphatase PP2A (i234) 
indicates a potential function in the Ras-MAPK signal transduction cascade. The clone i188 coding 
the predicted gene CG11275 interacted also efficiently with Dof in S2 cells. It is a cytoplasmic BTB 
domain containing protein without known function. BTB domain proteins are substrate-specific 
adaptors in an SCF-like modular ubiquitine ligase complex (Pintard et al., 2004). Interesting 
question of further studies might be if CG11275 might play a role in the degradation of Dof.  
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Surprisingly, Dof showed weak interaction also with the nuclear protein Bap60 (i133) in a way 
that might conclude that Bap60 was able to interact only with a C-terminal fragment of Dof (see 
Chapter 2.1 for details). How does it fit to the yeast data? First, it is not known if Dof is processed 
in yeast cells. Even so, a C-terminal fragment of Dof would not give positive interaction results, 
since the Gal4 DNA binding domain, which was N-terminally fused to Dof, would have been 
cleaved off from the molecule. Nevertheless, yeast interaction data bypass the effects of different 
compartmentalisation behaviour of molecules by targeting both fusion proteins to the nucleus. It 
might be possible, that in the Drosophila S2 cell culture assay Bap60 did not bind full length 
FLAG-Dof, because the two molecules were not in the same cellular compartment, and only the C-
terminal fragment of FLAG-Dof entered the nucleus, whereas in yeast the C-terminal interacting 
site was available in the full length form of Dof. Bap60 grouped to Dof interactors, the binding site 
of which mapped either to the N-terminus or to a region within or in the vicinity of the coiled coil 
motif (Battersby et al., 2003). Although it is pure speculation, our immunoprecipitation data with 
Bap60 would be the first hint, that C-terminal fragment of FLAG-Dof has distinguishable features 
from the full length molecule. Further experiments are required including mapping of the 
interaction domain for Bap60 binding in Dof, confirming immunoprecipitation with C-terminally 
tagged Dof constructs and high resolution localisation studies of Dof with different N- and C-
terminal epitope tags in cells in the presence/absence of Bap60 to analyse this hypothesis. 
 
These interaction results indicate that Dof is able to interact with molecules representing diverse 
cellular functions and so give a broad field of interesting processes for further investigation. 
 
3.2 Conclusions from subcellular localisations of Dof 
 
Cellular localisation studies were performed with some of the yeast interactors. Beside the fact 
that Dof showed different levels of co-localisation with them, an interesting observation was that 
the co-expression of different factors influenced the cellular distribution of Dof, ranging from 
membrane enrichment to diffuse appearance (see Figure 11). In addition, localisation studies in 
Drosophila embryos ectopically expressing mutant Dof proteins showed that loss of protein 
domains alters subcellular localisation (Wilson et al., 2004). These indicate that Dof might have 
interacting partners located in different cellular compartments and the loose of interacting domains 
for the one partner might allow interaction with other partners. These data derived from non-
signalling cells in which not all the components are necessarily present that determine Dof 
localisation. Nevertheless, these data indicate that Dof might recruit differentially localised 
molecules to cortical regions of the cytoplasma. Alternatively, Dof itself might have a very dynamic 
re-localisation during signalling which would require dynamic changes in binding affinity towards 
the different interacting partners.  Two ways how this could be achieved are conformational 
changes and post-translational modifications of the molecule. Interaction behaviour of a panel of 
yeast interactors with different Dof deletion construct indicated that Dof might exist in different 
conformations. Based on the self-interaction capacity of the different deletion constructs a “closed” 
and an “open” structure has been proposed in which intramolecular interaction between the N-
terminal DBB domain and the C-terminal part of the molecule provide the force for a “closed” 
conformation (Battersby et al., 2003). The results of this project show that Dof indeed utilises 
different modifications potentiating the molecule to dynamic interactions. 
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3.3 Interaction of Dof with the FGF receptor 
 
In consistence with earlier yeast data Dof interacted with the FGF receptor Heartless in S2 cells. 
Dof was able to bind a constitutively active as well as the kinase dead form of the receptor. Thus, 
the interaction was independent from the phosphorylation state of Heartless, indicating that Dof 
might bind to FGF receptors in a constitutive, signalling-independent manner. However, our data 
cannot exclude the potential role of receptor dimerisation in this interaction. The interaction domain 
for FGF receptor binding is mapped to the DBB domain which is in agreement with yeast two 
hybrid data. The mutation of a single lysine at amino acid position 297 in the DBB domain 
eliminates interaction of Dof with the FGF receptor in yeast. This was also confirmed in our 
immunoprecipitation assay. Transgenic Dof constructs lacking amino acids 233-364 or bearing the 
point mutation K297R do not have the capacity to rescue the dof mutant phenotype in flies pointing 
out the essential function of the DBB domain and the pivotal role of lysine 297 within this region 
((Wilson et al., 2004) and R. Wilson personal communication). Our immunoprecipitation results 
highly suggest that this region and lysine 297 within this region are required for efficient FGF 
receptor binding. However, DBB domain might play a role also in other critical interactions during 
FGF signalling. 
Similarly to yeast data, the presence of the C-terminal 200 amino acids in Dof weakened the 
interaction of Dof with Heartless, indicating an inhibitory function of the C-terminal part. This 
suggests that an “open” conformation of Dof might be the active form during signalling. 
On the side of all these confirming results a general remarkable difference was detected between 
yeast interaction and immunoprecipitation data. In S2 cells each Dof construct showed some 
interaction with different forms of Heartless although this was strongly reduced in the constructs 
lacking the DBB domain, like Dof∆233-364. What might be the difference in the interaction of Dof 
with Heartless in yeast in contrast to that in S2 cells resulting the residual binding of Dof∆233-364 to 
the FGF receptor in S2 cells? The cell culture Heartless construct containes additional 12 amino 
acids of the juxtamembrane region, which are not present in the yeast constructs. However in yeast, 
the smaller receptor fragment lacking in addition the N-terminal lobe of the kinase domain showed 
a weak interaction at lower restriction selection conditions with Dof constructs lacking parts of the 
DBB domain but the larger receptor fragment did not bind to this constructs at all. Results of the S2 
cell interaction assay resembled that of the small and not of the large receptor fragment of the yeast 
assay indicating that the 12 amino acids in the juxtamembrane region of Heartless might be 
irrelevant in the interaction with Dof. An additional difference, that the residual Dof-interaction of 
Heartless might cause, is the dimeric versus monomeric state of the receptor molecules in the two 
assays. Dimerisation of FGF receptors leads to conformational changes (Mohammadi et al., 1996). 
Therefore, the weak interaction might be a reflection of a difference in binding affinity of Dof for 
the activated and non-activated receptor. Remaining parts of the DBB domain might be sufficient 
for residual binding to the activated receptor dimer. Petit et al. reported that different Dof deletion 
mutant versions retained the ability to form a complex with activated Breathless in S2 cells, but 
constructs lacking the entire region of amino acids 168-364 were not tested in their study neither 
(Petit et al., 2004). Alternatively, receptor dimerisation might generate novel interaction surfaces for 
Dof domains independent from the DBB domain. Concluded from our deletion studies a DBB 
independent interaction domain might span between amino acids 446 and 802. Interestingly there 
are tyrosine residues within this stretch that are phosphorylated in the presence of an activated FGF 
receptor (see Chapter 2.3). However, C-terminal parts of the Dof protein lacking the first 485 or 600 
amino acids are not able to interact with an activated FGF receptor in Drosophila S2 cells (Petit et 
al., 2004) indicating that the amino acid region 485-802 is not utilised for the interaction. Amino 
acids 446-485 were not studied independently from the DBB domain for receptor interaction. 
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3.4 The role of lysine 297 in the interaction of Dof with the FGF receptor 
 
The lysine at position 297 in the DBB domain is essential for efficient interaction of Dof with the 
receptor both in yeast and in S2 cells. Importantly, this point mutation did not altered the interaction 
of Dof with any other candidates of the yeast two hybrid screen which showed DBB domain 
dependent binding (Battersby, 2001). This indicates that the mutation did not cause structural 
distortion in the molecule and that the FGF receptors require a different interaction surface in the 
DBB domain than other binding partners. This lysine is located within a consensus SUMO 
attachment site. The mutation of this residue destroys the site for sumoylation since the lysine side 
chain is the site of SUMO attachment. This gives raise to two possibilities. First, lysine 297 might 
be required as an essential residue in the interaction surface of Dof towards the FGF receptor. 
Secondly, the lysine might be required as a site of SUMO attachment and thus, SUMO modification 
might be essential for the interaction of Dof with the FGF receptor. Considering that the consensus 
site of sumoylation and the mechanism of sumoylation are evolutionarily conserved the probability 
of Dof sumoylation in yeast might be possible. In future work, one way to distinguish these two 
possibilities might be to analyse FGF receptor binding capacity of Dof in cells in which the 
sumoylation machinery is affected. RNA interference against essential components of this cascade, 
like SUMO or Ubc9 might be an efficient tool to generate such a situation. 
All Dof homologues share the conserved DBB domain. However, lysine 297 is conserved only 
in the closest known homologue of Dof, in the Anopheles Dof molecule, in which it is similarly part 
of a consensus sumoylation site. Vertebrate relatives of Dof lost lysine at this position and neither 
have consensus sumoylation sites in other parts of their sequence. This indicates that a potential 
sumoylation of the DBB domain is not conserved and that the DBB domain might have other 
essential functions beside receptor binding. 
 
3.5 Sumoylation of Dof 
 
Dof interacts with components of the sumoylation machinery in yeast (Battersby et al., 2003). In 
this work immunoprecipitation experiments confirmed the interaction of Dof with the SUMO 
conjugating enzyme Ubc9. 
Dof is sumoylated in S2 cells upon co-expressing Ubc9 and SUMO. However, the interpretation 
of this result is not that simple. Dof is processed in S2 cells. In our sumoylation assay only the N-
terminal Dof fragment becomes SUMO modified but not the full length molecule. The N-terminal 
fragment of Dof contains three consensus sumoylation sites including the one with the lysine at 
position 297 in the DBB domain. It is an important question of further studies which of these sites 
are targets for sumoylation. 
Why is only the N-terminal fragment sumoylated in the S2 cell assay? Yeast two hybrid data 
indicate that Dof is able to form a “closed” conformation by intramolecular interaction of the N-
terminal DBB domain with the C-terminal part of the molecule (Battersby et al., 2003). This 
conformation might inhibit SUMO attachment to the N-terminal part. Cleaving off the C-terminus 
might liberate the N-terminal fragment for SUMO conjugation. Important point is to clarify if the 
full length Dof molecule can be a substrate of sumoylation. For this, further experiments might be 
optional to try to increase the proportion of sumoylated Dof in S2 cells. The depletion of Ulp1 
expression levels might be a successful tool, since Ulp1 RNAi increases the sumoylation of certain 
substrates in Drosophila S2 cells (Bhaskar et al., 2002; Smith et al., 2004). It might be an 
interesting point to test if Dof interacting partners that bind to the DBB domain and thereby might 
“attack” the “closed” conformation of Dof could promote sumoylation of full length Dof. 
It has been shown for some proteins that binding interactions with other macromolecules 
enhanced their sumoylation (Chen, 2003; Hardeland, 2002). Co-expression of the FGF receptor as a 
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potential sumoylation-dependent interaction partner of Dof might therefore promote/stabilise 
SUMO attachment of Dof. 
If sumoylation of Dof is essential for interaction with the FGF receptor it might need the 
reconsideration of the signalling dependence of this interaction. The example of the cAMP 
stimulation-dependent sumoylation of Mek1 in Dictyostelium shows, that cytosolic sumoylation 
might be a very temporary event and tightly regulated (Sobko et al., 2002). Thus, an interesting 
point of further investigation is if sumoylation of Dof is regulated by FGF signalling in vivo.  
Our genetic studies on Ubc9 and SUMO for their involvement in mesoderm and tracheal 
development during embryogenesis were not conclusive. Zygotic mutants of the genes do not show 
mesoderm or tracheal specific defects which might be due to a high maternal contribution of the 
genes. Germ line clone analysis indicated in consistence with earlier findings that they might be 
required during oogenesis. Alternative genetic approaches like clonal analysis might help to reveal 
if these genes play a role in FGF signalling. However, sorting out the genetics of the Ubc9 gene is 
the most important prerequisite of any further work. 
 
3.6 Phosphorylation sites in Dof 
 
It has been shown that Dof is phosphorylated in the presence of an activated FGF receptor 
(Wilson et al., 2004). In this work gelfiltration experiments showed that Dof is present in a complex 
with the FGF receptor preferentially in a phosphorylated form and non-phosphorylated form of Dof 
do not co-fractionates with the receptor. This indicates that Dof might become phosphorylated in 
complex with the FGF receptor probably the FGF receptor itself. 
The sites of tyrosine phosphorylation were analysed in Dof. Phosphorylation sites were mapped 
by mutational analysis to the consensus tyrosine motifs for PI3K and Corkscrew binding at amino 
acid positions 486 and 515 respectively. Tyrosine at position 515 has been shown to be required for 
the binding of Corkscrew in an activated receptor-dependent manner (Petit et al., 2004), supporting 
that tyrosine 515 might be real target of phosphorylation. In addition, three tyrosine residues were 
identified as phosphorylation targets at positions 592, 613 and 629, which do not belong to known 
conserved tyrosine motifs. Their sequence environment is conserved in Anopheles Dof. Amino acid 
insertions between the conserved sequence patches in Anopheles indicate that the three tyrosine 
sites might represent three independent moduls in Dof. Two of these motifs are very similar and the 
same sequence motif is present two more times in the C-terminus of both Drosophila and 
Anopheles Dof. Protein database search with the consensus sequence motif generated from these 
eight related sites shows that this motif is present in other phosphorylated signalling molecules also 
in vertebrates. The Drosophila adaptor Disabled and the planar polarity protein Dishevelled were 
also found among the molecules bearing this motif. Both become tyrosine phosphorylated upon 
receptor tyrosine kinase signalling however, the phosphorylation sites of them are not fully 
characterised (Inobe et al., 1999; Le and Simon, 1998). Interestingly, the Dof homologue human 
BANK protein also shares this motif. It might be an interesting point whether this tyrosine motif 
represents a conserved consensus phosphorylation site. No less interesting is the question whether 
the phosphorylation of this site is utilised for protein-protein interaction and if so, which signalling 
molecules might interact with this motif. 
The C-terminal part of Dof is also phosphorylated. It contains several Grb2 consensus binding 
sites; the novel motif is present two times, once overlapping with a consensus site for RasGAP or 
Crk binding. The identification which of these tyrosines is phosphorylated might provide further 
insight into signalling dependent interactions of Dof. 
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3.7 Functional relevance of the identified phosphorylation sites 
 
Detailed structural-functional analysis of Dof was performed in two independent works (Petit et 
al., 2004; Wilson et al., 2004). Findings of the two works are summarised here briefly. Both have 
shown that the first 522 amino acids of Dof have significant biological activity. This Dof form is 
able to activate MAPK and induce tracheal migration. The mutation of the tyrosine of the consensus 
Corkscrew binding site in this Dof construct results a dead molecule, indicating that the binding of 
Corkscrew might be essential for Dof to activate MAPK. Mutation of the PI3K binding site has no 
effect on the function of this construct. However, introducing the point mutation of the Corkscrew 
binding site in full length Dof or introducing an internal small deletion which removes the PI3K and 
Corkscrew sites has little effect on the activity of the molecule. On the other hand, if the point 
mutation of the Corkscrew site is present in a Dof construct lacking the last 200 amino acids this 
form shows a strong reduction in its capacity to rescue tracheal branching and its activity in the 
mesoderm appears even more affected. Nevertheless, it still shows some activity. The C-terminal 
part of Dof contains multiple Grb2 binding sites, which might be also utilised in Dof to activate the 
MAPK cascade. The lost importance of the Corkscrew binding site in the full length molecule 
might indicate a redundancy in the use of the Grb2 and Corkscrew interactions by Dof to activate 
the MAPK cascade. This is further supported by the strongly reduced activity of Dof upon the 
additional deletion of the potential Grb2 binding sites. The fact that the mutation of the Corkscrew 
binding site in a Dof molecule containing the first 600 amino acids is sufficient to eliminate the 
activity of the molecule completely but the same mutation in the context of the first 802 amino 
acids (along with two additional tyrosine point mutations in the PI3K and N-terminal Grb2 
consensus binding sites) results a molecule with a weak but significant activity points out a role of 
the region between amino acids 600 and 802 in Dof. This region contains the coiled coil domain but 
the deletion of this domain does not alter the activity of full length Dof. However, it has not been 
tested in combination with other mutations. Interestingly, this region contains three tyrosines 
identified as phosphorylation targets. Interesting question is for further analysis if the 
phosphorylation of these tyrosines is responsible for the remaining activity of the described mutant 
Dof construct. An important question is not addressed so far in these studies, namely whether this 
mutant construct maintains some capacity to activate MAPK or the residual activity of the molecule 
is MAPK independent. This might help narrow down the function of the 600-802 region of Dof and 
thus probably the function of the phosphorylated tyrosine residues. 
These structural-functional studies also point out that these three tyrosines are not absolutely 
essential in the molecule, since the first 522 amino acids are the minimal requirement for biological 
activity. This might indicate a redundant function or other functions which might gain importance 
in the context of the full length molecule. 
 
3.8 Phosphorylation as a landmark of full length Dof 
 
During the investigation of the consequences of Dof cleavage in S2 cells we found striking 
differences in the phosphorylation state of Dof and its cleavage derivatives. Whilst the full length 
form of Dof is efficiently phosphorylated in the presence of an activated receptor both the N- and 
C-terminal fragments of Dof show only very weak if any phosphorylation. This raises the 
possibility that phosphorylation might be a landmark of signalling activity of Dof and prevents the 
cleavage of Dof by caspases. Alternatively, Dof cleavage products might be an immediate substrate 
of phosphatases which might allow generating a new subpopulation of Dof in signalling cells with 
distinct interaction properties. Further analysis using phosphatase inhibitors might help to 
distinguish these two possibilities. This is the first indication for a potential crossregulation of the 
phosphorylation state and the caspase-mediated cleavage of Dof. 
DISCUSSION 
 95
Interestingly, the one identified phosphorylation site in Dof is mapped to the tyrosine residue at 
position 592 which is only 5 amino acids apart from the caspase cleavage site in Dof (amino acid 
position 587) and thus, the phosphorylation of this site might have an allosteric inhibitory effect on 
the cleavage of the molecule. However, no significant differences can be observed in the 
accumulation of cleavage products of Dof in the presence and absence of an activated FGF receptor 
in S2 cells, which would support such a function of this phosphorylation. 
 
3.9 Dof is a substrate for caspases in S2 cells – and in flies? 
 
Dof is cleaved in S2 cells. This project revealed that the cleavage is caspase dependent. Dronc 
activity is essential for this cleavage. However, the sensitivity of the cleavage against the caspase 
inhibitor protein p35, which cannot inhibit Dronc, indicates that Dronc might act indirectly on Dof 
by activating downstream effector caspases. A potential candidate might be Dcp-1, since dcp-1 
RNA interference reduced Dof processing in S2 cells. Mutational analysis indicates that the 
consensus caspase cleavage site at position 584-587 in Dof might be utilised for cleavage. It might 
be an important point to analyse if Dof is processed in vivo. 
What might be the in vivo relevance of caspase cleavage of Dof? Signalling molecules often 
serve as survival signals by maintaining the signalling capacity of the cells. Signalling is an 
inhibitor of apoptosis (Gorski and Marra, 2002; Meier et al., 2000). Thus, cleavage of Dof might be 
a potent tool to downregulate FGF signalling. Dof function has been investigated in early mesoderm 
development and in tracheal morphogenesis. Apoptosis has not been described as essential part of 
the developmental program of these tissues. However, recent findings indicate that apoptosis might 
be involved in the proper shaping of the developing tracheae (A. Bilstein, personal communication) 
and it was also reported that upon Rac hyperactivation cells delaminate from the tracheal epithelium 
and undergo apoptosis (Chihara et al., 2003). Thus, Dof cleavage might be essential to allow 
apoptosis induction in tracheal cells. However, a Dof construct bearing only the first 522 amino 
acids has significant biological activity, indicating that a potential cleavage of Dof at position 587 
might not be efficient to downregulate Dof activity. Growing body of evidence emerges that 
regulated caspase activity is also required in non-apoptotic developmental processes (Geisbrecht 
and Montell, 2004; Huh et al., 2004; Huh et al., 2004), although molecular targets of these caspase 
activities are not uncovered yet. In in vivo functional analysis the caspase cleavage site-mutant Dof 
transgene had comparable capacity to wild type Dof transgenes to rescue mesoderm and tracheal 
development, indicating that processing of Dof might not be required for Dof function. These 
observations on Dof function together would fit neither to an apoptotic nor to a non-apoptotic role 
of Dof cleavage. It cannot be excluded that Dof cleavage has a function which is masked due to the 
overexpression of the transgenes or that cleavage is required in other developmental processes 
which were not analysed in this work. Further genetic analysis of caspases and regulators of caspase 
activation as well as monitoring in situ caspase activiy also in other dof-dependent developmental 
processes might help to circumvent this problem and allow an insight into the physiological role of 
Dof cleavage. Nevertheless, in the next chapter a potential role of caspase cleavage in the 
translational control of Dof is discussed. This might fit to our observations in the sense that such a 
function could not have been revealed by the functional studies performed so far. 
 
3.10  Potential translational regulation of Dof and its relationship to 
caspase cleavage 
 
The ribosomal protein S10 was found as an out-of-frame interactor of Dof in a yeast two hybrid 
screen. In this work immunoprecipitation experiments verified it as a real Dof interactor. The 
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interaction site for rpS10 is mapped to the region between amino acids 446 and 522. Strikingly, in 
Dof deletion mutants which lack C-terminal parts of the molecule the presence of this region 
correlates with a strong increase of Dof protein levels in S2 cells. This difference in protein levels is 
neither due to different transcription levels nor due to different stability of the mutant Dof proteins, 
since both mRNA abundance and protein half life are comparable in case of these constructs. This 
indicates that the presence of the rpS10 binding site in these constructs correlates with a higher 
translational rate of the construct. This might indicate a potential contribution of rpS10 in the 
translational regulation of Dof. 
What might be the reason that wild type Dof and other mutant Dof constructs bearing the rpS10 
binding sites but also containing C-terminal parts of the molecule do not show such an elevated 
protein levels? One possible explanation might be that the C-terminal half of Dof has an inhibitory 
effect on rpS10 binding. This might indicate a potential role of caspase cleavage in liberating the N-
terminal part of the molecule for the interaction with the ribosomal protein. Thus, full length Dof 
might have to be processed first to be able to interact with rpS10 which might explain lower 
translation levels compared to the deletion construct with “free” rpS10 binding site on its C-
terminal end. Based on this hypothesis a decrease in Dof protein levels would be expected upon the 
inhibition of caspase activity in the cells. In caspase RNA interference and DIAP1 overexpression 
experiments we have indications for such an effect but further comparative quantitative analysis is 
required to test the significance of this phenomenon. The analysis of the caspase site mutant Dof 
construct does not support a difference in protein levels compared to wild type Dof. However, 
potential differences in mRNA and protein levels derived from different vectorial background 
cannot be excluded. 
This 70 amino acid region contains also the PI3K and Corkscrew binding sites which are targets 
for phosphorylation. An additional interesting question might be whether and how phosphorylation 
influences the interaction of Dof with rpS10. Further experimental work is required to narrow down 
the palette of potential interconnections of phosphorylation, caspase cleavage and translational 
regulation of Dof. 
What mechanism might be responsible for such a translational regulation? Several studies 
indicate that ribosomal proteins can have additional functions in the cell besides acting as structural 
components of the ribosome (Bhat et al., 2004). The ribosomal protein L13a acts as a transcript-
specific translational repressor of ceruloplasmin upon a regulated release from the 60S ribosomal 
subunit, proposing a model in which the ribosome functions not only as protein synthesis machine, 
but also as a depot for regulatory proteins that modulate translation (Mazumder et al., 2003). For 
transcript-specific translational regulation some specific recognition motif is necessary within the 
mRNA which distinguishes it from other transcripts. L13a for instance binds to a specific motif in 
the 3’ UTR region of ceruloplasmin. However, in the Dof expression constructs only the protein 
coding sequence is present. Certainly, the identified interaction between rpS10 and Dof cannot be 
sufficient to explain transcription-specific translational regulation of Dof. Thus, interesting further 
questions are if Dof itself or rpS10 are able to bind to the coding part of dof mRNA or to other 
mRNA-binding proteins. No less interesting question is if Dof binds rpS10 as part of the ribosome 
or a ribosomal release of S10 is required for the interaction. An additional point is to the complexity 
that the Drosophila genom encodes two rpS10 genes. The identified yeast interactor clones 
represented only the one gene, rpS10b. Although the two gene products are highly similar it might 
be an interesting question if both S10 proteins can interact with Dof. 
Not much known about rpS10, which would indicate a function in transcript-specific 
translational regulation. It is unique for eukaryots, considered as one of the four core components of 
the S40 ribosomal subunit (Malygin et al., 2000) and involved in the formation of the binding 
surface for the translation iniciation factor eIF-3 (Westermann and Nygard, 1983). Besides these 
structural studies rpS10 was reported to be transcriptionally upregulated in certain diseases and 
cancer cells (Frigerio et al., 1995; Maak et al., 2001) and its transcription is differentially regulated 
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during different developmental stages in Dictyostelium (Tapparo et al., 1998). The only indication 
for a potential additional role of rpS10 might be that it interacts with human securin/PTTG. Human 
rpS10 binds to the C-terminal 70 amino acids of securin/PTTG (Pei, 1999). Interestingly, an 
interaction of securin with the human homologue of the DnaJ chaperon mapped to the same amino 
acid residues in the molecule. Although no functional relevance is known of these interactions it 
might be an interesting question to address whether this shared interaction region mutually excludes 
simultaneous binding of the two interactors. This would help to reveal wether the accessibility of an 
rpS10 binding surface in securin might be regulated by chaperons. On the analogy of this we could 
imagine a hypothetic model in which C-terminal parts of Dof might inhibit rpS10 interaction and 
accessibility of this binding site might be regulated by the caspase-mediated cleavage of the 
molecule. 
 
3.11 The role of different Ras effector pathways in FGF signalling 
 
The Ras-MAPK pathway is essential in FGF-dependent developmental processes. However, it 
cannot be responsible for the diverse cellular responses. It is essential to reprogram gene expression 
patterns which determine cell fates but rapid and dynamic cytoskeletal rearrangements which give 
raise to changes in cell shape, cell adhesion and cell motility might require other FGF-dependent 
effectors. Multiple factors has been described which contribute to these processes, like E-cadherin 
and Rac in cell adhesion regulation or Rho and Cdc42 and their regulators in filopodia formation 
and migration (Chihara et al., 2003; Lee and Kolodziej, 2002; Schumacher et al., 2004; Smallhorn 
et al., 2004; Wolf et al., 2002). Some of them act in parallel to FGF signalling and others are 
regulated in an FGF-dependent manner, but how FGF receptor transmits the signal towards these 
efectors is not known. Ras has several known effectors which might serve a link to these processes; 
thus, we took an approach and investigated which other Ras-induced pathways might be utilised. 
Constitutively active effector loop mutant Ras proteins, constitutively active forms of components 
of the Raf and Ral effector pathways were tested for their capacity alone or in different 
combinations to rescue dof mutant phenotypes or to cause any dominant effects in mesoderm and 
tracheal development. In addition, dominant negative forms of the same signalling molecules were 
tested for their effect on these processes. 
 
3.11.1 Mesodermal studies of Ras effectors 
 
Studies on the formation of Eve-positive clusters in the mesoderm are a read-out of to 
independent action of FGF signalling: dorsal migration of mesodermal cells and cell fate 
differentiation. This work and earlier studies showed that mesodermal cells of dof mutant embryos 
reached dorsal regions and were able to express high levels of activated MAPK upon the expression 
of constitutively active forms of Ras, Raf or Ral (Vincent et al., 1998; Wilson, 2004). An important 
issue of further analysis is whether these constructs play an active role in the “migratory” phase of 
FGF signalling or their effect is restricted to cell differentiation. Analysis of pebble mutant embryos 
that affect mesoderm migration in an FGF signal-independent manner and thus, do not interfere 
with FGF-dependent cell differentiation showed that some cells of the collapsing epithelial tube 
occasionally can reach dorsal positions and differentiate into Eve-positive cell clusters; albeit in a 
very uncoordinated fashion. Since the expression of the listed transgenes led to a coordinated 
appearance of dorsal mesodermal clusters marked by Eve or activated MAPK, it raises two 
possibilities. Either loss of function mutation of dof leads to a much less several migration defect 
than that of pebble or these transgenes have a positive input on dorsal migration of the mesoderm. 
Markers of dorsal mesodermal cell fate, the expression of which depends only on Wingless and Dpp 
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signalling and thus, are a sole read-out of the efficiency of mesoderm migration might be a useful 
tool to discriminate these possibilities. Since this is not clarified yet, from here on I will focus on 
the aspects of FGF-dependent cell fate differentiation in the mesoderm. 
Although all three constitutively active transgenic constructs, Ras, Raf and Ral can activate 
MAPK in the presumptive Eve-cluster, only activated Ras is able to turn on Even-skipped 
expression. Not even the simultaneous expression of activated Raf and Ral can result Eve-positive 
cells, indicating that additional Ras-dependent factor(s) is required to turn on Eve. This factor might 
act either on the level of MAPK activation in a Raf-independent manner or on the regulation of 
MAPK dependent gene activation or on a crossregulatory level of FGF and Dpp, Wg or Notch 
signalling. Constitutively active Ras effector loop mutants, which are able to activate MAPK 
(RasV12,S35 and RasV12,G37, the “Raf- and Ral-specific” Ras forms respectively) can also induce 
Eve expression in the mesoderm, indicating that the binding of the additional factor is not affected 
by these point mutations. Thus, the requirement of PI3K can be excluded. The failure of 
RasV12,C40, the “PI3K specific” Ras effector loop mutant, to turn on Eve expression might be 
either due to the fact that this unknown factor cannot bind to this Ras form or it might require basal 
level of MAPK activity for its action. The identity of this factor is not known at present. It cannot 
also be excluded completely that the observed differences are due to differences in the strength of 
the transgenes to activate MAPK. Finally, expression of dominant negative Ral construct indicated 
that Ral might play a role in early phases of mesoderm development. Considering the regulatory 
role of this GTPase in filopodia formation it might be an interesting question to re-address, after the 
unclear aspects of mesoderm spreading in dof mutants (see above) had been resolved. 
 
3.11.2 Studies of Ras effectors in the tracheae 
 
The same set of mutant signalling molecules behaved differently in the tracheae of dof mutant 
embryos compared to the mesoderm. However, the assay was also different, since we concentrated 
on the capability of the constructs to induce tracheal branching and thus, cell migration. 
Constitutively active Ras is effective to induce migration and “Raf specific” RasV12,S35 does so 
too, although with a remarkably less efficiency. It cannot be excluded that the two alleles have 
different affinity for Raf binding as reported in mammalian studies (Rodriguez-Viciana et al., 
1997), however same transgenic insertions were found to have comparable activity to each other in 
flies (Therrien et al., 1999). In contrast to the mesoderm, the “Ral specific” RasV12,G37 has a 
strongly reduced capacity to induce tracheal branching. In further contrast to the mesoderm, 
activated Raf has also the capacity to induce branching, albeit in a very reduced and uncoordinated 
fashion. The fact that activated components of the Ral effector pathway cannot rescue tracheal 
branching in dof mutant embryos and they do not synergise with activated Raf in the induction of 
tracheal migration indicates that the branching activity of RasV12,G37 might not be due to its Ral 
activating capacity but maybe due to a residual Raf binding. This suggests also that the moderate 
rescue capacity of RasV12,S35 compared to RasV12 might not be due to the lack of Ral activating 
capacity. Nevertheless, activated components of the Ral pathway are able to induce ectopic 
branching upon overexpression in wild type tracheae, indicating that Ral might be involved in 
tracheal migration but it might rely on the activity of an FGF-dependent factor independent from 
Raf and maybe activated by Ras. To this latter statement it is a critical point of further analysis to 
test if RasV12G37 has the capacity to activate MAPK in the tracheae, which would be an indication 
for residual Raf binding. It might be an interesting object of further studies to test if Ral activity is 
able to induce filopodia formation in tracheal cells defective in FGF signalling and the lack of 
branching is only because these extensions are abortive and cells fail to migrate out or if the 
capacity of activated Ral to induce cell outgrowth relies obligatorily on an unknown FGF-
dependent factor. 
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The analysis of the “PI3K specific” effector loop mutant RasV12C40 showed that PI3K 
activation is not sufficient to induce tracheal branching. Interestingly, effector loop mutants 
RasV12,S35 and RasV12,G37 which lost the capacity of PI3K binding showed both a significantly 
reduced capacity to induce tracheal migration. Thus, it is an interesting point to test if PI3K activity 
might contribute to effective migration. It has to be noted, that zygotic mutants for different 
subunits of PI3K do not show tracheal defects (R.Wilson, personal communication). However, the 
high maternal contribution of the gene might be sufficient to overcome zygotic requirement of the 
gene. 
 
3.11.3 Implications for a role of Rap1 
 
An unexpected result of our genetic analysis on the role of Ras in FGF signalling is that 
dominant negative form of the molecule fails to affect FGF signalling in the mesoderm and in the 
tracheae. It significantly inhibits EGF dependent processes in the mesoderm (formation of DA1 
muscles), which validates the functionality of the construct. However, this might be only an issue of 
differencies in the threshold levels of MAPK activity to induce cellular differentiation. The 
possibility of different thresholds might derive from the fact that DA1 progenitors require a dual 
input of EGF and FGF signalling for differentiation which might result higher Ras activation levels 
whereas EPCs require only FGF dependent Ras activation which might provide only lower 
activated Ras levels. 
In the tracheae dominant negative Ras had neither effects on FGF nor on EGF signalling. An 
important question might be to distinguish whether this phenomenon is specific for Ras or other 
dominant negative molecules as DN-FGF and -EGF receptors might also fail to interfere with 
endogenous signalling, indicating that levels of the tissue specific expression might not be 
sufficient. 
Based on this non-conclusive results and on the fact that so far only overexpression studies with 
the constitutively active protein indicated an essential role for Ras in FGF signalling in flies we 
addressed the question to what extent Ras might be the endogenous transducer of the FGF signal. 
Emerging number of studies indicate that the closely related Ras family GPTase Rap1 acts through 
the similar set of effector pathways as Ras. The potential role of Rap1 was tested by analysing the 
effect of dominant negative and constitutively active forms of the protein on mesoderm and tracheal 
development in wild type and dof mutant embryos respectively. One conclusion of our results is that 
Ras might have essential functions since activated Rap1 shows significant differences to Ras in its 
capacity to rescue FGF-dependent developmental processes; first of all it has in the tracheae a weak 
activity. In addition, our results indicate that Rap1 might be involved in both developmental 
processes although maybe to different extent. It might be an object of further studies what effectors 
are utilised by Rap1 and how Ras and Rap1 might interact to concert downstream events of FGF 
signalling. 
As a last interesting remark, Dof contains also a consensus binding site for the adaptor Crk 
which can specifically activate Rap1 through its binding to the Rap1GEF C3G. This site is located 
in the C-terminal part of the molecule where also the consensus Grb2 binding sites are present, 
interaction sites for potential Ras activation. However, the C-terminal tail of Dof is not essential; 
thus, these binding sites are essential neither. As discussed above, Corkscrew might be involved to 
transduce the signal from Dof to Ras. Interesting subject of future projects might be to reveal what 
mechanisms might be used to activate Rap1 in FGF signalling.  
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4. Materials and Methods 
 
DNA constructs 
 
 Expression vectors 
The metallothionein inducible pRmHA-3 vector (Bunch et al., 1988) (kindly provided by M. 
Reth) was used for protein expression in Drosophila S2 cells with the exception of the construct 
pAC-HisSUMOGG (a gift from F. Schweisguth). The pmetHA vector was generated by introducing 
an oligonucleotide cassette coding for the HA epitope tag with the DNA sequence 
AATTCGACCATGGCTTACCCATACGATGTTCCAGATTACGCTAGCCCATGGTAC between 
the EcoRI and KpnI sites of the pRmHA-3 vector. The pRmHA-3-RI vector was a derivative of 
pRmHA with a unique XbaI site in the multi-cloning region by destroying the second XbaI site in 
the vector (kindly provided by R. Wilson). For transgenic expression in flies cDNAs were cloned 
into the pUAST vector (Brand and Perrimon, 1993). 
 Dof constructs for S2 cell expression 
Mutant dof constructs pRm-FLAGDof[168-1012], pRm-FLAGDof[1-446], pRm-FLAGDof[1-
522], pRm-FLAGDof[1-802], pRm-FLAGDof∆233-449, pRm-FLAGDof∆361-449, pRm-
FLAGDof∆233-364, pRm-FLAGDofPI3K, pRm-FLAGDofcsw, pRm-FLAGDofPI3K,csw, pRm-
FLAGDofdrk, pRm-FLAGDofdrk,PI3K,csw, pRm-FLAGDof[1-802]PI3K, pRm-FLAGDof[1-802]csw, 
pRm-FLAGDof[1-802]PI3K,csw, pRm-FLAGDof[1-802]drk, pRm-FLAGDof[1-802]drk,PI3K,csw, 
pAlterFLAGDof, pAlterFLAGDofPI3K, pAlterFLAGDofcsw and pAlterFLAGDofPI3K,csw were 
generated as described (Wilson et al., 2004) and kindly provided by R. Wilson. 
pRm-FLAGDof and pRm-HADof were generated by inserting the EcoRI/SpeI fragments of 
epitope-tagged Dof constructs 5’FLAG-Dof.pNB40 and 5’HA-Dof.pNB40 (provided by R. Wilson) 
into the EcoRI/XbaI partially digested pRmHA-3 vector. 
pRm-FLAG:Dof:2xHA was generated by inserting the NcoI/XbaI dof fragment of RW471 
(provided by R. Wilson) between the same sites of the pRmHA-3-RI vector. 
pRm-FLAGDof K297R was generated by cloning the EcoRV/SacI dof fragment of 
pAlterFLAGDof SUMO K.O..#3 (A288 in (Battersby, 2001) and provided by A. Battersby) into pRm-
FLAG:Dof:2xHA digested by EcoRV/SacI. 
pRm-FLAGDof[1-802]∆233-449, pRm-FLAGDof[1-802]∆361-449, pRm-FLAGDof[1-
802]∆233-364 and pRm-FLAGDof[1-802]K297R were constructed by inserting the EcoRV/SacI 
dof fragment from pRm-FLAGDof∆233-449, pRm-FLAGDof∆361-449, pRm-FLAGDof∆233-364 
and pRm-FLAGDofK297R into the EcoRV/SacI digested pRm-FLAGDof[1-802] vector 
respectively. 
Mutant dof constructs bearing point mutations of different amino acid residues were generated 
by in vitro mutagenesis applying  the pAlter system (Promega), with the exception that the 
Escherichia coli strains JM109 and ES455 were used. The presence of the desired mutation was 
confirmed by DNA sequence analysis. The following mutagenesis primers were used: 
STOPXbaI: ACCGAGGACTAAAATCTAGAGGCTTCCGTGG 
592F:   GCCACTCTTTCAGACCGACAAATTCAG 
613F:   TGGGCAATGACTTTGTGCTGCAGCCCTC 
629F:   TGATGGCAACTTTTTGTTCCAGCCATCG 
  654F:   AGACAGCCCGGATTTGGAACACTGAAGC 
  726F:   CGACGCGAGTTCGAGCGGATCCAGGAGC 
  D587E:   GACGAAGTGGAAGCGGCGCCACTC 
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pRm-FLAGDof[1-522]PI3K, pRm-FLAGDof[1-522]csw and pRm-FLAGDof[1-522]PI3K,csw were 
generated by mutagenesing pAlterFLAGDofPI3K, pAlterFLAGDofcsw and pAlterFLAGDofPI3K,csw 
with the STOPXbaI primer followed by EcoRV/XbaI digestion and ligation of the 1.0 kb fragments 
into the pRm-FLAGDof[1-522] vector cut with the same enzymes. 
pRm-FLAGDof[1-522]drk and pRm-FLAGDof[1-522]drk,csw were created by the ligation of the 
0.6 kb EcoRI/EcoRV fragment of pRm-FLAGDofdrk with the EcoRI/EcoRV digested pRm-
FLAGDof[1-522] and pRm-FLAGDof[1-522]csw vectors respectively. 
pRm-FLAGDof[1-522]drk,PI3K was generated by the one-step ligation of the 0.6 kb EcoRI/EcoRV 
fragment from pRm-FLAGDofdrk and the 1.0 kb EcoRV/XbaI fragment from 
pAlterFLAGDofPI3K,STOPXbaI into the EcoRI/XbaI digested pRmHA-3-RI vector. pRm-FLAGDof[1-
522]drk,PI3K,csw was cloned the same way with the exception that the1.0 kb EcoRV/XbaI fragment of 
the pAlterFLAGDofPI3K,csw,STOPXbaI construct was used. 
pRmFLAGDof[1-802] constructs with pointmutations 592F; 613F; 629F; 654F,726F and 
592F,613F,629F were generated by mutagenesing pAlterFLAGDof with the appropriate primers 
followed by SfiI/SacI digestion and ligation each of the 2.3 kb fragments into the pRm-
FLAGDof[1-802] vector digested with SfiI/SacI. 
pRmFLAGDof[1-802]PI3K,csw constructs with mutations 592F; 613F; 629F; 592F,613F; 
592F,629F; 613F,629F and 592F,613F,629F were generated by the mutagenesis of 
pAlterFLAGDofPI3K,csw with the appropriate primers followed by StuI/SacI digestion and ligation 
each of the 2.3 kb fragments into the pRm-FLAGDof[1-802] vector digested with StuI/SacI. 
pRmFLAGDofPI3K,csw,592F,613F,629F was generated by the insertion of the 1.5 kb StuI/SacI fragment 
of pAlterFLAGDofPI3K,csw,592F,613F,629F into the pRm-FLAGDof vector digested with the same 
enzymes. 
pRm-FLAGDofD587E was generated by in vitro mutagenesis of pAlterFLAGDof with the 
mutagenesis primer D587E followed by EcoRV/XhoI digestion and ligation of the 1.8 kb fragment 
into the EcoRI/XhoI cut pRm-FLAGDof vector. 
 pUAS-FLAGDofD587E 
A 2.4 kb EcoRI/XhoI fragment was isolated from the pAlterFLAGDofD587E plasmid and inserted 
into the pUAS-FLAGDof vector (obtained from R. Wilson) digested with the same enzymes. 
 i-clones for S2 cell expression 
Dof yeast two hybrid interacting clones i6, i8in frame (A308), i14, i19, i25, i51, i77, i133, i163, 
i184, i188, i234 and i249 were described previously (Battersby, 2001) and generously provided by 
A. Battersby. To put the i-clone i14 in the same reading frame as the upstream Gal4 activating 
domain in the pAct2 vector a one nucleotide frame shift was generated by linearising the plasmid 
with BamHI followed by relegation after filling up the 5’ overhangs by T4 DNA polymerase. The 
derived form was called i14in frame. 
Clones i6, i8in frame, i14in frame, i19, i25, i51, i77, i133, i163, i184, i188 and i234 were cut from the 
pAct2 vector with NheI/XhoI and inserted into the NheI/SalI digested pmetHA vector. To achieve a 
two nucleotide frameshift i249 was cloned into pmetHA by inserting the SmaI/XhoI i249 fragment 
into the SmaI/SalI vector. 
pmetHA-CG11275 was generated by PCR amplification of CG11275 from the cDNA clone 
RH28808 with the primers ACGGTACCAAACCATGAGCATCTCGGCGGTGG and 
CGGGTACCAAGTGGCTACACCAGGTTGGC having each a KpnI site in the overhang 
sequence. After KpnI digestion of the PCR product it was inserted into the KpnI linearised pmetHA 
vector. Sequence fidelity was confirmed by DNA sequence analysis. 
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 Heartless constructs for S2 cell expression 
pRm-HtlFL-2xHA was generated as following: RW433 contained the sequence coding for the 
cytoplasmic part of Htl fused to a double HA epitope tag on its C-terminus (kindly provided by R. 
Wilson). The htl cDNA clone pSP73 (kindly provided by A. Michelson) was digested with 
BglII/BstXI and the 1.65 kb fragment was inserted into the vector RW433 cut with BglII/BstXI. The 
2.3 kb EcoRI/XbaI fragment of the derived construct was ligated into the pRmHA-3-RI vector 
digested with the same enzymes. 
pRm-λHtl-2xHA and pRm-λHtlK.D.-2xHA  were generated as described (Wilson et al., 2004; 
Wilson, 2004) and provided by R. Wilson. 
 
Cell culture, transient transfection, immunoprecipitation and Western blot analysis 
 
Stable transfectant Drosophila S2 cell lines expressing N-terminally FLAG-tagged Dof under the 
control of the actin 5C promoter (actin::FLAG-Dof) alone or together with a constitutively active 
form of Breathless or Heartless under the control of a heat shock inducible promoter (hs:: λ-Btl  and 
hs:: λ-Htl-2xHA respectively) were generated and cultured as described previously (Wilson et al., 
2004).  
Drosophila S2 cells were cultured and transiently transfected as described (Rolli et al., 2002). 
106 cells were used for a transfection. The expression of the pRmHA-3 vector derived constructs 
was induced by the addition of CuSO4 to a final concentration of 1 mM. After 24 hours the cells 
were harvested, washed once in ice-cold phosphate buffered saline and lysed in 0.5 ml PLC-TX0.5 
buffer (10% (v/v) glycerol, 50 mM HEPES (pH 7.5), 150 mM NaCl, 0.5% (v/v) Triton X-100, 1.5 
mM MgCl2, 1mM EGTA, 200 µM Na3VO4, 10 mM NaF supplemented with Protease inhibitor 
Cocktail (Sigma)) for 45 minutes followed by centrifugation at 22,160g for 20 minutes at 4 °C. For 
SDS-PAGE, supernatants were boiled in 1 x SDS-PAGE loading buffer and volumes corresponding 
to 7.5 µl of the lysate were loaded into the lanes. For immunoprecipitation, 90 µl of lysates were 
incubated overnight at 4 °C with anti-FLAG M5 (Sigma), anti-HA 12CA5 (Boehringer Mannheim) 
or anti-Dof (Vincent et al., 1998) antibodies. Protein G sepharose beads (Amersham Pharmacia), 
that had been incubated in 5% (w/v) BSA in PLC-TX0.5 were added to the samples and incubated 
together for a further two hours at 4 °C followed by three washes, five minutes per wash, in 0.5 ml 
of PLC-TX0.5. Beads were boiled in 30 µl 2 x SDS-PAGE loading buffer and the supernatants were 
fractionated by SDS-PAGE (10% (w/v) polyacrylamide gel) loading 10 µl of the sample into one 
lane followed by Western blotting according to standard methods (Hybond ECL nitrocellulose 
membrane and ECL detection kit from Amersham Pharmacia) using anti-FLAG M5 (1:4000), anti-
HA 3F10 (1:3000) (Boehringer Mannheim), anti-His6 (1:500) (Roche), anti-phosphoTyrosine 4G10 
(1:4) (courtesy of F. Sprenger) and anti-SUMO (1:1000) (kindly provided by F. Schweisguth) 
primary antibodies and appropriate horse radish peroxidase conjugated secondary antibodies 
(Jackson ImmunoResearch Laboratories, Inc.) 
 
Size exclusion chromatography 
 
10 ml confluent culture of stable transfectant S2 cells expressing actin::FLAG-Dof, 
actin::FLAG-Dof and hs::λ-Btl or actin::FLAG-Dof and hs::λ-Htl-2xHA were incubated at 37 °C 
for 30 minutes to induce expression of the proteins under the control of a heat shock promoter and 
allowed to recover for 4 hours at 22 °C before lysis. Cells were harvested and lysed in 150 µl PLC 
buffer (10% (v/v) glycerol, 50 mM HEPES (pH 7.5), 150 mM NaCl, 1% (v/v) Triton X-100, 1.5 
mM MgCl2, 1mM EGTA, 200 µM Na3VO4, 10 mM NaF supplemented with Protease inhibitor 
Cocktail (Sigma)) for 30 minutes followed by centrifugation at 22,160g for 15 minutes at 4 °C. 
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Supernatant was taken and re-centrifugated at 45,000rpm for 30 minutes at 4 °C. ÄKTAexplorer 
chromatography system was used with a Superose 6 HR 10/30 column (Amersham Pharmacia 
Biotech) for size exclusion chromatography of the lysate. Column was equilibrated with PLC buffer 
containing only 0.05% (v/v) Triton X-100 and calibrated with standards: thyroglobulin, 669kDa; 
apoferritin, 440 kDa and alcohol-dehydrogenase, 150 kDa. 100 µl of prepared lysate was applied to 
the column and was eluted with the same buffer as used for equilibration at a flow rate of 0.2 
ml/min. 0.5 ml fractions were collected and proteins were precipitated by the addition of 100 µl of 
72% trichloric acid. Pellet was washed twice in ice cold acetone and re-dissolved in 25 µl 2x SDS-
PAGE loading buffer. Samples were boiled and separated by SDS-PAGE. The position of FLAG-
Dof, λ-Htl-2xHA and λ-Btl in the elution profile was determined by Western blot analysis using 
antibodies against FLAG, HA and phospho-tyrosine residues respectively. 
 
RNAi in Drosophila S2 cells 
 
dsRNAs were prepared as described (Worby, 2001). Nucleotides 152-937 of the dcp-1 ORF, 84-
763 of the drice ORF and 1-765 of the dronc ORF were PCR amplified with sequence specific 
primers each containing overhangs with T7 RNA polymerise binding site 
(TTAATACGACTCACTATAGGGAGA) using the plasmid constructs pacFLAG-Dcp-1(C-A), 
pacFLAG-Drice(C-A) and pMT-V5/HisDronc (kindly provided by P. Meier) respectively. 
Primer sequences following the T7 RNA polymerase binding site: 
dcp-1_5’: -GCCCCTTGCCGGCCAACAAGTTTG 
dcp-1_3’: -AGCGCAGTATGCGCGTCAGCATGGA 
drice_5’: -TGCCCTGGGCTCCGTGGGATCCG 
drice_3’: -ATCCAGGAACCGTCGAGTAGGCG 
dronc_5’: -ATGCAGCCGCCGGAGCTCGAGATTGG 
dronc_3’: -CGAGGAGGTCACCATTGTCAGAAG 
For in vitro transcription MEGAscript T7 kit (Ambion) was used. 15 µg of dsRNA was added to 
2x106 cells in 1ml serum free Drosophila S2 media (Gibco) after removing culture media 
supplemented with 5% FCS and washing the cells once with serum free Drosophila S2 media. Cells 
were incubated for 1 hour, medium was removed and transient transfection was directly applied to 
the cells as described above. Cells were harvested 72 hours after dsRNA treatment. Control mock 
RNAi was performed the same way without adding dsRNA to the solution. 
 
Caspase inhibition in transiently transfected Drosophila S2 cells 
 
Cells were transiently transfected as described above. 2 hours prior harvest cells were incubated 
with the drug Z-VAD dissolved in DMSO (Sigma) in a final concentration of 20 µM or 50 µM. As 
a control same volume of DMSO was added to the cells. Cells were harvested and lysed in PLC-
TX0.5 buffer. Alternatively Z-VAD was added to the lyses buffer in a final concentration of 20 µM. 
pIE1-4-p35 (kindly provided by G. Jones) construct was transiently transfected to S2 cells in equal 
(300ng), in double or in four times higher amount than the co-transfected pRm-FLAGDof. 
 
Metabolic [35S]-methionin radioactive labelling of Drosophila S2 cells 
 
Cycloheximide was added to 0.5 ml cultures of Drosophila S2 cells (106 cells/ml) in a final 
concentration of 0, 5, 10, 20, 50 and 100 mM. After 1 hour incubation time 15 µCi [35S]-methionin 
was supplied to each sample and incubation was continued for further 4 hours. Cells were harvested 
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and directly boiled in 2 x SDS-PAGE loading buffer. SDS-PAGE was carried out and 
autoradiogram of vacuum dried polyacrylamide gel was developed. 
 
Dof protein stability analysis in Drosophila S2 cells 
 
S2 cells were transiently transfected with different mutant Dof constructs. At time point of 
induction cells were split into six parts each of a volume of 0.5 ml in 24-well plates. 24 hours after 
induction cycloheximide (CHX) was added to each well in a final concentration of 20 mM. Cells of 
individual wells were harvested and lysed in 83 µl PLC-TX0.5 buffer at time points 0, 1, 2, 4, 8 and 
24 hours after CHX addition. SDS-PAGE of whole cell lysates was performed followed by Western 
blot analysis. 
 
Real-time RT-PCR 
 
Equal amount (300ng) of different mutant dof DNA constructs were transiently co-transfected 
with 300ng of pDeGFP in Drosophila S2 cells as described above. Cells were harvested and split 
into 3 parts. The first part containing 500 µl of the 3 ml cell suspension was lysed in 83 µl PLC-
TX0.5 buffer and Dof protein level of whole cell lysates was analysed on Western blot. In parallel, 
RNeasy Mini kit (Qiagen) was used to prepare total RNA from the two other parts containing equal 
volume (1250 µl each) of cell suspension in two independent reactions according the 
manufacturer’s instructions. Samples were homogenised by passing the lysate 5 times through a 20-
gauge needle fitted to an RNAse-free syringe. RNA was eluted from the column two times with 40 
µl RNAse-free water. After an RNAse-free DNAse I (Roche) treatment for 30 minutes at 37 °C 
RNA was precipitated with LiCl and redissolved in 30 µl RNAse-free water. Reverse transcription 
was carried out using ThermoScript reverse transcriptase kit (Invitrogen) according the 
manufacturer’s instructions following the determination of the RNA concentration. 1 µg of total 
RNA of each sample was reverse transcribed in a 20 µl reaction using 50ng random hexamer 
primers and in a separate reaction 10 pmol dof specific primer with the sequence 
TGCACAGGCGATTCAGGCCC. For negative control reverse transcription reaction was carried 
out without the addition of the enzyme. Random hexamer primers were first elongated in a 10 
minutes incubation step at 25 °C followed by 45 minutes incubation at 50 °C. Reverse transcription 
with dof specific primers was carried out directly at 50 °C for 45minutes. 2 µl of each reaction was 
used for real-time PCR. 
Quantitative, real-time PCR was performed on a Light Cycler I machine supported by the 
LightCycler software version 3.0 (Roche). PCR was carried out using the QuantiTect SYBR 
Green PCR kit (Qiagen) according the manufacturer’s instruction with the following primers: 
dof amplification  RTdof_5’ AGGTGCAGATCAGCAATATCC 
RTdof_3’ ATCCCTCGGTGCAGCTAGAG 
GFP amplification RTGFP_5’ GCTTGCCGGTGGTGCAGATG 
       RTGFP_3’ CTCGTCCATGCCGAGAGTG 
dof primers amplified a 140 bp long product, nucleotides 504-644 of the dof coding sequence. GFP 
primers amplified nucleotides 598-710 of the eGFP coding sequence (112 bp long product). The 
PCR program contained an initial 15 minutes activation step at 94 °C followed by 55 cycle of 15 
sec at 94 °C, 30 sec at 50 °C and 20 °C at 72 °C with an aqusition at the temperature of the 
extension. Melting curve was analysed between 65 and 95 °C. Real-time PCR with GFP primers 
was carried out on each random-hexamer reverse transcription reaction and on negative controls. 
Standard curve was generated using 2x103 – 2x109 copies of the pDeGFP plasmid. dof real-time 
PCR was done on all reverse transcription reactions. Standard curves were generated using 2x105 – 
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2x109 copies of the different mutant Dof DNA constructs used for transient transfection. The Ct 
value of each dof and GFP reaction was determined followed by the calculation of the amount 
(copy number) of the templates in the samples using the standard curves. The obtained dof amounts 
were corrected with the difference in length of the transfected dof constructs relative to the full 
length dof construct, since the equal weights used in transfection did not correspond to equal copy 
numbers of the different dof plasmids due to the different length of the dof insertions. The ratio of 
the resulted dof amount and GFP amount in each sample was determined. Results are presented as a 
fold expression of the different mutant dof RNAs relative to full length dof RNA. 
 
Immunocytochemistry 
 
Drosophila S2 cells were transiently transfected with different constructs by the standard 
procedure. pDeGFP construct (kindly provided by M. Reth) was co-transfected to identify 
transfected cells by GFP autofluorescence. 24 hours following transfection cells were induced for 
protein expression and from this point towards cultured on cover slips. After additional 24 hours 
culture media were removed, cells were washed once with phosphate buffered saline (PBS), fixed 
with 4% formaldehyde diluted in PBS for 10 minutes on cover slips and permeabilised with 0.5% 
Triton X-100 for 30 seconds. Following several wash steps and blocking with 1x PBS 
supplemented with 1% (w/v) BSA and 0.1% (v/v) Tween 20 standard procedure of immunostaining 
was carried out using rabbit anti-Dof (1:200) (Vincent et al., 1998) and anti-HA 3F10 (1:6000) 
(Boehringer Mannheim) primary antibodies and anti-rabbit and anti-rat secondary antibodies 
coupled with Alexa568 and Alexa647 fluorochromes (Molecular Probes) respectively. 
 
Drosophila strains and genetics 
 
UAS-DofD587E transgenic flies were generated by the standard procedure of P element 
mediated germ line transformation. UAS-Ras1V12/CyOwglacZ; dof,e/TM3elavlacZ, UAS-
Raf*,dof,e/TM3elavlacZ, twiGal4,dof,e/TM3elavlacZ and btlGal4; dof,e/TM3elavlacZ flies were kindly 
provided by R. Wilson. UAS-Ras1V12,S35, UAS-Ras1V12,G37 and UAS-Ras1V12,C40 flies were 
provided by A. Rubin whereas UAS-Rgl1CAAX and UAS-Rgl2CAAX by J. Camonis. UAS-DRalwt, 
UAS-DRal20V and UAS-DRal25N transgenic flies were provided by H. Okano. UAS-Rap1wt, UAS-
Rap1V12 and UAS-Rap1N17 were obtained from U. Gaul. SevGal4,UAS-Gap1/TM3 flies were 
provided by M. Mlodzik. rala mutant flies with the P element insertions PL056, PG069 and PG089 
were kindly provided by A. Vincent. FRT40A lwr4-3/CyO and FRT40A semi107/CyO flies were 
kindly provided by S. Tanda. pita3 and dcp-1Prev-1 flies were obtained from K. McCall. UAS-
droncCARDonly, UAS-∆N-dronc, UAS-pro-dronc and UAS-pro-dronc(C>A) flies were generously 
provided by P. Meier. l(2)k01211, lwr05486 and lwr02858 lines are part of the Berkely Drosophila 
Genome Project (BDGP; (Spradling et al., 1999; Spradling et al., 1995)). hs-RalA28N (BL4843), 
UAS-RalA72L (BL4844), UAS-Ras85DN17 (BL4845), UAS-Ras1N17 (BL4846), l(2)04993 
(BL11378), Df(3L)AC1 (BL997), UAS-p35 (BL6298, BL5072 and BL5073) and P{PZ}Dcp-102132 
(BL11179) flies were obtained from the Bloomington stock center under the stock numbers 
remarked in brackets. btlGal4 flies (Shiga, 1996) were used for overexpression studies in the 
tracheae and twiGal4 flies (multiple insertions on the first chromosome, constructed by N. Brown) 
for mesodermal overexpression. 
To remove maternal contribution of a gene the autosomal FLP-DFS technique was used (Chou 
and Perrimon, 1996). To combine l(2)04993 with the FRT40A site standard genetic recombination 
and selection techniques were used (Theodosiou and Xu, 1998). 
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For rescue experiments dof1 allele (Vincent et al., 1998) was combined with UAS-transgenic 
strains and crossed to the appropriate driver lines. dof mutant embryos were identified by using 
balancer chromosomes carrying P[ry+, elav-lacZ] insertions. If necessary standard genetic 
recombination was used and flies carrying P[w+, UAS-transgene] insertions were selected and 
tested for complementation with the dof1 allele. In case of the recombination of two P[w+, UAS-
transgene] insertions different eye colours were screened. Changes in eye colour were confirmed by 
the de-recombination of the two insertions. 
To test how UAS transgenes effect vitality by tissue specific expression flies heterozygous / 
hemizygous either for the UAS transgene or for the driver line were crossed to each other. Survival 
rate was calculated by dividing the number of emerged flies with transgenic expression (=flies 
emerged) through the number of emerged flies without transgenic expression (=flies expected). To 
follow chromosome segregation balancer chromosomes (CyO; TM3,sb; TM6B) or sex 
determination were used. 
 
Immunohistochemistry 
 
Standard procedures were followed to collect embryos, which were fixed over 30 minutes at 
37°C using a phosphate buffered saline with 3.7% (v/v) formaldehyde. Immunohistochemistry was 
carried out according standard protocols. Antibodies directed against Eve (1:5000) (courtesy of M. 
Frasch), 2A12 (1:20) (kindly provided by N. Patel) and beta-Galactosidase (1:1500) (Sigma G4644) 
were used to detect the appropriate proteins in situ by using the coupled peroxidase system 
(Vectastain ABC kit, Vector Labs). Two colour stainings were accomplished in sequential steps, 
with the addition of Ni and Co in the second detection reaction to produce a dark precipitate. 
Embryos were sorted and embedded in Araldite as described (Leptin and Grunewald, 1990). 
Photographs were taken on a Zeiss Axioplan microscope using a Kontron ProgRes 3008 digital 
camera, and the images were processed using Adobe Photoshop 7.0. 
Antibodies directed against Eve (1:5000) and diphospho-MAPK (1:400) (SigmaM8159) were 
used to detect the proteins in situ by using secondary antibodies coupled to fluorochromes Alexa568 
and Alexa488 (1:500) (Molecular Probes). Embryos were embedded into Vectashield mounting 
medium (Vector Labs) and photographs were taken on a Zeiss Axioplan2 Imaging microscope with 
Apotome system using AxioVision v.4.2. Images were converted and processed using Adobe 
Photoshop 7.0. 
 
Eggshell preparation 
 
Eggs were collected from apple juice agar plates fixed in glycerol : acetic acid (1:4) for 1 hour at 
60 °C and embedded into Hoyers medium (30 g gum arabicum and 200 g chloralhydrate in 50 ml 
water subsequently mixed with 20 g glycerol) mixed with lactic acid (1:1) and incubated under 
cover slips overnight at 60 °C. 
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Abstract 
 
The FGF signal transducer molecule Dof has been shown to act upstream of the Ras-MAPK 
pathway. It is unknown how Dof transmits the signal from the activated FGF receptor to the MAPK 
cascade. Several approaches were taken to analyse this mechanism. 
1. One way to resolve this question is to analyse Dof mediated interactions. In this work interaction 
of Dof with selected candidates of a yeast two hybrid screen was analysed biochemically. Most but 
not all of the tested candidates were able to form a complex with Dof in Drosophila S2 cells. The 
predicted capability of Dof for self-association was validated by showing that the molecule was able 
to form dimers/oligomers in Drosophila S2 cells. Co-immunoprecipitation studies of Dof with the 
FGF receptor Heartless showed that the DBB domain – an essential region of the molecule needed 
for dimerisation and shared with BCAP and BANK – is required for efficient receptor binding. A 
consensus sumoylation site is located within the DBB domain of Dof. Mutation of this site impaired 
binding to the FGF receptor Heartless. Dof interacted with the SUMO conjugating enzyme Ubc9 
and was sumoylated in Drosophila S2 cells suggesting that SUMO modification of the molecule 
might regulate interaction with the FGF receptor. 
2. As a second approach phosphorylation of Dof was analysed that might influence the activity of 
the protein in signal transmission. Dof becomes phosphorylated in the presence of an activated FGF 
receptor at the conserved tyrosine motifs for PI3K and Csw binding. In addition, we identified a 
novel tyrosine motif as a phosphorylation target which appears four times in Dof. Strikingly, it is 
also present in BANK and some other signalling molecules. The C-terminal part of Dof is also 
phosphorylated and might be involved in conformational regulation of the protein, since the 
removal of the last 200 amino acids improved the binding affinity of Dof to Heartless. 
3. Dof is cleaved in Drosophila S2 cells, which might give an additional level in the regulation of 
signalling. This cleavage is caspase dependent, regulated by Dronc and requires an intact caspase 
cleavage site in Dof. However, a Dof transgene mutant for the caspase cleavage site rescued 
efficiently dof mutant phenotypes indicating that this site is not essential for Dof functions assayed 
in this work. Mutant Dof constructs with C-terminal truncations of different lengths that removed 
the caspase cleavage site varied in their expression levels despite their similar stability in S2 cells. 
These differences were not seen in mRNA abundance but only in protein levels and higher 
expression levels correlated with the presence of a region in Dof identified as a binding site for the 
ribosomal protein S10. Full length Dof showed expression levels comparable to that of the mutant 
construct lacking the ribosomal protein binding site. Thus, this is the first indication that Dof 
cleavage products might have additional roles in the regulation of Dof function. 
4. One essential function of Dof is to activate the Ras-MAPK pathway in vivo. To find out if only 
the MAPK signalling panel is utilised by Ras activity the role of the three Ras effectors Raf, 
RalGDS and PI3K were determined in FGF signalling during Drosophila embryogenesis. This 
analysis showed that both the Raf and RalGDS effector pathways might have a function in FGF 
signalling but that additional Ras activity is required either to regulate these cascades or to turn on 
other effector pathways. Our results indicate that PI3K is not needed for FGF signal transduction. In 
addition to Ras, Rap1 might be also involved in FGF signalling downstream or in parallel to Dof. 
How Rap1 is activated and to what extent the two closely related Ras family GTPases share 
downstream effectors is not understood at present. 
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Zusammenfassung 
 
Es wurde gezeigt, dass Dof, ein mögliches Adapter-Molekül, im FGF-Signalweg überhalb der Ras-
MAPK Signalkaskade agiert. Es ist aber unbekannt wie Dof das Signal vom aktivierten FGF-
Rezeptor zu der MAPK-Kaskade weiterleitet. In dieser Arbeit wurden verschiedene Strategien 
angewendet, um diesen Mechanismus zu analysieren. 
1. Eine Möglichkeit diese Frage zu adressieren ist die Analyse der molekularen Interaktionen von 
Dof mit anderen Proteinen. In dieser Arbeit wurden die Interaktionen von Dof mit ausgewählten 
Kandidaten, die in einem Hefe-2-Hybrid Screen gefunden wurden, biochemisch untersucht. Die 
meisten dieser Kandidaten können in Drosophila S2 Zellen Komplexe mit Dof bilden. Die 
vorausgesagte Fähigkeit von Dof, Komplexe mit sich selbst einzugehen, wurde in S2 Zellen 
nachgewiesen. Ko-Immunopräzipitations-Untersuchungen mit Dof und dem FGF-Rezeptor 
Heartless zeigten, dass die DBB Domäne von Dof –eine essentielle Region, die nötig für 
Dimerisation ist und auch in den Proteinen BCAP und BANK vorhanden ist– notwendig für eine 
effiziente Bindung an den Rezeptor ist. Innerhalb der DBB Domäne von Dof liegt eine konservierte 
SUMOlations Stelle. Mutationen dieser Stelle verhindern die Bindung von Dof an Heartless. Dof 
interagiert mit Ubc9, einem SUMO konjugierenden Enzym, und wird in S2 Zellen SUMOliert. Eine 
SUMOlation von Dof könnte also die Interaktion mit dem Rezeptor regulieren. 
2. Die Phosphorylierung von Dof könnte die Aktivität des Proteins bei der Signalübertragung 
beeinflussen. Dof wird an den konservierten Tyrosin-Motiven für die Bindung von PI3K und Csw 
phosphoryliert wenn ein aktivierter Rezeptor vorhanden ist. Zusätzlich haben wir ein neues 
Tyrosin-Motif gefunden, welches viermal in Dof vorhanden ist und auch in BANK und anderen 
Signal-Molekülen präsent ist. Der C-Terminus wird ebenfalls phosphoryliert  und könnte bei der 
Regulation der Konformation notwendig sein, da die Deletierung der letzten 200 Aminosäuren am 
C-Terminus die Bindung von Dof an Heartless verbessert.  
3. Dof wird in S2 Zellen kaspaseabhängig gespalten. Dies könnte eine weitere Stufe der Regulation 
des Signalweges sein. Diese Spaltung wird durch Dronc reguliert und benötigt eine intakte 
Kaspasen-Spaltungsstelle in Dof. Ein Dof-Transgen, in dem diese Stelle mutiert ist, rettet jedoch 
effizient den dof Phänotyp in Drosophila. Dies deutet darauf hin, dass diese Stelle nicht essentiell 
für die Funktion von Dof ist, die in dieser Arbeit analysiert wurde. Konstrukte, bei denen der C-
Terminus in verschiedenen Längen, aber immer mit der Kaspasen-Spaltungsstelle, deletiert wurde, 
unterscheiden sich in ihrer Expressionsstärke, obwohl sie ähnlich stabil in S2 Zellen sind. Diese 
Unterschiede konnten nur auf Protein-Ebene, aber nicht auf mRNA-Ebene gesehen werden und die 
stärkere Expression korrelierte mit der Anwesenheit einer Bindungsstelle für das ribosomale Protein 
S10 in der Proteinsequenz von Dof. Die Expressionsstärke des kompletten Dof-Konstruktes 
entspricht den Deletions-Konstrukten, in denen diese Bindungsstelle fehlt. Dies ist der erste 
Hinweis, dass Spaltungsprodukte von Dof zusätzliche Funktionen bei der Regulation von Dof 
haben.  
4. Die Aktivierung des Ras-MAPK Signalweges ist eine essentielle Funktion von Dof in vivo. Es 
wurde untersucht ob die Ras-Aktivität nur die MAPK-Kaskade aktiviert. Hierzu wurde die Rolle 
der drei Ras Effektoren Raf, RalGDS und PI3K innerhalb des FGF-Signalweges während der 
Embryogenese von Drosophila untersucht. Die Raf und RalGDS Signalwege könnten eine Funktion 
in der FGF-Signalkaskade haben, aber zusätzliche Ras-Aktivität ist notwendig um diese oder andere 
Effektor-Signalwege zu aktivieren oder regulieren. PI3K hingegen wird für den FGF-Signalweg 
nicht benötigt. Zusätzlich zu Ras könnte auch Rap1 in den FGF-Signalweg involviert sein - abwärts 
oder parallel zu Dof. Wie Rap1 aktiviert wird und in wieweit diese beiden nah verwandten GTPasen 
der Ras Familie ihre Signalwege teilen ist zurzeit nicht bekannt. 
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Abbreviations 
 
bp   base pairs 
BSA   Bovine Serum Albumin 
CHX   cycloheximide 
cDNA  complementary DNA 
Da   Dalton 
dsRNA  double stranded RNA 
EGTA  Ethilene Tetracetic Acid 
FGF   fibroblast growth factor 
g    gram  
GFP   green fluorescence protein 
GLC   germ line clones 
His   histidine 
k    kilo 
l    liter 
lacZ   beta-galactosidase 
M    mol per liter 
m    milli 
µ    micro 
mRNA  messenger RNA 
PAGE  polyacrylamide gel electrophoresis 
PCR   polymerase chain reaction 
PTK   protein tyrosine kinase 
RNAi  RNA interference 
RTK   receptor tyrosine kinase 
RT-PCR reverse-transcription PCR 
SDS   sodium-dodecyl-sulphate 
Z-VAD  N-Benzyloxycarbonil-Valine-Alanin-Asparagine 
35S   isotope of sulphur with atomic weight of 35 
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